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Summary
This thesis describes some attempts to model the e f fe c t  of  
environment on a molecule, in p ar t icu la r ,  the e f fect  of  solvent and of  
the receptor s i te  on the properties of  a drug molecule.
Chapter 1 describes the basic pr inciples of drug a c t i v i t y ,  the
forces responsible for  binding of  a drug to a receptor, and some of  the
consequences fo r  drug design. Chapter 2 b r ie f l y  reviews some of  the 
quant i ta t ive  s t ru c tu re -a c t iv i ty  data avai lable for  angiotensin 
converting enzyme, and describes the design of  a postulated active s i te  
by drawing an analogy with other zinc peptidases with known crystal
s tructures .
Chapter 3 b r ie f l y  describes the assumptions made in the INDO 
semi-empirical molecular orb i ta l  method used in this study, and goes on 
to describe the way in which the wavefunctions obtained can be used to 
calculate quanti t ies of inte rest  to a consideration of  drug-receptor 
in teract ions .  The SOLVATON model fo r  describing the e f fe c t  o f  medium 
on a molecule is discussed, and some examples of i ts  e f fec t  on small 
model systems are given. F ina l ly ,  a method of  modelling the receptor  
s i te  o f  a drug molecule is described, and this is i l lu s t ra te d  by i ts  
applicat ion to a model system.
Chapter 4 describes the use of the INDO method in conjunction with 
the SOLVATON model and the receptor s i te  modelling to obtain 
quant i ta t ive  s t ru c tu re -a c t iv i ty  relationships fo r  a series of  
inh ib i tors  o f  angiotensin converting enzyme. A fa i le d  attempt to model 
the course o f  reaction on a model substrate is b r ie f ly  mentioned.
Chapter 5 outl ines some shortcomings in the methods applied, and
makes suggestions for  some improvements.
Appendices describing the LCAO-SCF molecular orb i ta l  method, 
molecular mechanics and the torsion angle convention used are included,  
as is an appendix containing calculated indices fo r  the compounds 
exami ned.
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Drug Act iv i ty
Declare the past 
Diagnose the present 
Foretel l  the fu ture .
Hippocrates.
1.1 Quant itative S t ructure -Act iv i ty  Relationships.
The design of  new drugs is ,  to a large extent ,  a process based on 
chance, with a drug generally being the end resu l t  of  a programme of
optimisation of  a c t i v i t y  of a series compounds known to be act ive to a 
greater or lesser degree. This optimisation programme enta i ls  the 
synthesis and test ing ( in  vivo or in v i t r o )  of  a large number of  
s t ruc tu ra l ly  re lated compounds, while the i n i t i a l  discovery o f  a 
promising series of compounds is also the resu l t  of  screening a large 
number of more or less random compounds, general ly  in animal systems.
As well as being s c i e n t i f i c a l l y  inelegant,  th is  "blunderbuss" 
approach is very wasteful of  resources, with the large number of  
compounds that  must be synthesised, p u r i f ie d ,  tested and then discarded 
making a considerable contribution to the cost of  drug discovery.
Hith the need for  pharmaceutical companies to show a return on
investment, th is increase in the cost of  drug design e f fe c t i v e ly  
constrains the areas in which research is performed to those where 
r e la t i v e ly  large p ro f i ts  e i ther  by v i r tue  of  low other costs or large 
volume sales, can be expected.
An obvious a l te rn a t ive  to the random method is a ra t ional  approach 
based on a knowledge of  the relationships between chemical consti tution  
and drug a c t i v i t y .  The development o f  such re la t ionsh ips ,  and th e i r  
quant i f icat ion  to give quant i ta t ive  s t r u c tu r e -a c t iv i t y  re lationships  
(QSARs) has been a central  theme in the study o f  chemical pharmacology 
fo r  many years. Probably the f i r s t  step in th is  d i rec t ion  was the 
observation ( l ) ^ t h a t  the potencies of  many narcotics are inversely
related to t h e i r  water s o lu b i l i t y ,  and that  the isonarcotic potencies 
of homologous series of alcohols or hydrocarbons show an approximately 
geometric increase with the number of  methylene groups present,  
a c t iv i t y  increasing by a factor  of  about three fo r  each addit ional  
methylene group (2 -6 ) .  These phenomena were re in terpre ted  (7 ,8 )  in 
terms of  l ip id  s o lu b i l i t y ,  and this in te rp re ta t ion  was fu r th e r  extended 
(9-12) to a consideration of  p a r t i t io n  propert ies ,  anaesthetic potency 
being markedly re lated to the oi1-water p a r t i t io n  c o e f f ic ie n t  fo r  a 
compound. General anaesthetics such as the in e r t  gases (13,14)  and
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v o l a t i l e  organics (15) also have potencies which appear to depend on 
th is  quantity.
Such interactions are often termed s t ru c tu ra l ly  non-specif ic ,  since 
there appears to be no p ar t icu la r  group or arrangement of  groups within 
a molecule necessary to produce a response, as shown by the anaesthetic 
a c t i v i t y  of ,  fo r  example, xenon. Many mechanisms of  action for  such 
compounds have been suggested (16 ) ,  a l l  of  which revolve around 
interference with the properties of  the l ip id  membranes surrounding 
animal cel ls  (and nerve ce l ls  in p a r t ic u la r ) ,  giving the p o s s ib i l i t y  of  
a mechanistic in terpre ta t ion  o f  the dependence of  potency on p a r t i t io n  
coeffi  cient.
Most drugs, however, are highly s t ru c tu ra l ly  spec if ic  in th e i r
a c t i v i t y ,  and small modifications to a molecule may profoundly e f fec t  
i ts  a c t i v i t y .  A simple consideration of physicochemical properties is 
generally no longer adequate to explain the var ia t ion  in a c t i v i t y  in a 
set of compounds.
The most commonly used methods fo r  obtaining QSARs fo r  drugs which 
act in a s t ruc tu ra l ly  specif ic  manner are a l l  based on the concept of  
the l inear  free energy re lat ionship  (17) fa m i l ia r  from organic 
chemistry. The a c t i v i t i e s  of  a series of  s im i lar  compounds are re lated  
to that of  a "parent" compound by means of  a set o f  substituent  
constants which are intended to describe the manner in which the
a c t i v i t y  varies as the parent compound is modified, the assumption
being that the contributions are add it ive .  These constants are
generally  descriptors of various physicochemical propert ies ,  for  
example the changes in the e lectronic  structure of the molecule (c f .  
the Hammett and Taft  re la tionships ( 1 8 ,1 9 ) ) ,  s te r ic  propert ies ,  
p a r t i t io n  coe f f ic ien ts ,  pK values etc.
The f i r s t  application of  l inear  f ree energy re lat ionships to the 
problem of  biological a c t i v i t y  is due to Ormerod (20) who re la ted  the 
Hammett o parameters of  a series of  substituted benzylcholine esters to 
t h e i r  rate of enzymic hydrolysis.  Fukuto and Metcalf  (21) performed a 
simi lar  analysis for  acetylcholine esterase inh ib i t ion  by a series of  
phenyl phosphates, and a n t ip a ra s i t ic  (2 2 ,2 3 ) ,  an t ib a c te r ia l  (24 ) ,
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insect ic idal  (25) and antitumor (26) a c t i v i t i e s  of  series of  compounds 
have been rat ional ised in a s imilar  fashion. However, despite these 
and many other successes, the use of  Hammett type substituent constants 
to describe electronic features of  molecules has several shortcomings:
i )  the a values are e n t i re ly  empirical quanti t ies whose physical 
meaning beyond the primary d e f in i t io n  is questionable;
i i )  the "a -e f fec t"  of a substituent in a molecule is only r e l ia b ly  
represented by the tabulated value i f  the s i tuation bears a close 
structural  re lat ionship  to the standard chemical system for  which 
i t  was evaluated. Data are not available  fo r  a s u f f ic ie n t  range of  
chemical s i tuations;
i i i )  in the evaluation o f  a, the addit ion of  the substituent must 
produce a complex range of  changes in the electronic structure of  
the molecule, as expressed by the electronic wavefunction. A 
single descriptor based on changes in a pa r t ic u la r  rate or
equil ibrium constant cannot possibly be the best way to describe 
a l l  of  the potential  changes in chemical properties . Attempts have 
been made (27) to "factorise out" various types of  e lectronic  
e f fe c t  associated with a single subst ituent ,  with two independent 
ef fects  ( f i e l d  and resonance) being defined, but even two 
parameters can scarcely describe a l l  of the relevant  e lectronic
ef fects  of substi tution;
iv )  problems ar ise in the estimation of  the e f fe c t  o f  multip le  
subst itut ions.
v) a and other commonly used substituent constants re la te  purely  
to intramolecular e f fec ts .  Drug a c t i v i t y  is a resu l t  o f  
intermolecular interact ions,  and i t  would be desirable that the 
indices used to quantify i t  r e f l e c t  th is .
I t  has been observed (28-33) that the logarithm of  the p a r t i t io n
c o e f f ic ie n t ,  log10P, is an a d d i t iv e -c ons t i tu t ive  property of  a 
molecule. I t  is thus possible to assign f ractions o f  log10P, 
termed ir-values, to portions of  the molecular st ructure.
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ir = l o g 10 P /P Q 1 . 1.1
where P is the p a r t i t io n  co e f f ic ien t  fo r  a substituted compound, PQ
that fo r  the unsubstituted "parent" compound. The value of  ir 
associated with a p a r t ic u la r  structural  fragment remains constant 
wherever that fragment appears in a molecule. Such ir-values for  the 
n-octanol -  water system have been tabulated fo r  a wide range of
fragments (34 ,35) .  In the l ig h t  of  the importance of  p a r t i t io n  in 
a c t i v i t y  o f  certain types of  drugs, and in transport properties in
biological systems (see section 1 .2 ) ,  i t  is not surprising that  these 
constants have been employed in QSAR studies, ir parameters are of  
p ar t icu la r  value when considering QSARs in a series of  molecules with a 
common structural skeleton but d i f f e r e n t  substituents since the 
1ogl0 P va^ue comPound in question w i l l  simply be a constant
plus the sum of  ir-values fo r  the substituents. The sum of  tabulated  
values may thus replace log10P in any corre lat ion analysis,  
removing the need to measure P fo r  each molecule in the ser ies.
Hansch and Fuji ta (36) have described s t r u c tu r e -a c t iv i t y
relat ionships for  the t o x ic i t y  of  substituted benzoic acids on mosquito 
larvae, phenols on both gram posit ive and gram negative bacter ia ,  
phenyl ethyl phosphate insect ic ides on housef l ies,  the local  
anaesthetic potency o f  diethylamino ethyl benzoates in guinea-pigs, the 
thyrox ine- l ike  a c t i v i t y  of  thyroxine der ivat ives in rodents and the 
carcinogenicity of  a wide range of  chemical carcinogens in mice using a 
combination of Hammett parameters and ir-constants. The correlat ions  
obtained fo r  a l l  of  these systems except the carcinogens were quite  
s ign i f ican t .
The Hansch approach is based on the assumption that  the a c t i v i t y  
follows a re la t ion  o f  the type
pC = a + bir + co + dE$ 1 .1 .2
where a, b, c, d are constants, pC is minus the logarithm of  the 
concentration required to produce a p a r t ic u la r  e f fe c t ,  ir, a are as 
defined previously,  and Es is a parameter which describes the s te r ic
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properties of  the substituent.  The importance of  molecular size was 
suggested to arise from i ts  e f fe c t  on the a b i l i t y  of  a molecule to 
cross membrane barriers (37 ,38 ) ,  in the same manner as ir. Size indices 
which have been used in relat ionships with biological a c t i v i t y  include 
the van der Waals1 radius (39-42) ,  i t s  square root (43 ) ,  molecular 
volume (44 ) ,  the Taft  s ter ic  parameter (36,45) and Verloop's STERIMOL 
parameters (46 ) .  Other parameters which have been used to attempt to 
model the hydrophobic properties of drug molecules include the parachor 
(47) ,  molecular r e f r a c t i v i t y  (48) and parameters derived from high 
performance l iqu id  chromatography (49) and thin layer chromatography 
( 5 0 ) . .
..Hansch et a l . (45) have employed a model of the form
2
pC = a + bir + cir + da + eE 1 .1 .3r s
to obtain s t r u c tu r e -a c t iv i t y  re la tionships for  a series of  hypnotic
2
barbi turates.  The ir term is not a l inear  free energy term, but 
i ts  inclusion is j u s t i f i e d  in the l ig h t  of numerical analyses (51) to 
determine the rate of passage of  a molecule through a m ult i layer  system 
with a l te rnat ing  aqueous and l ip id  layers as a function of  log10P.
The use of  Hansch analysis has been recent ly  reviewed (5 2 ) ,  along 
with a rat ional  "decision tree" approach (due to Topliss (53 ) )  to aid 
the medicinal chemist in deciding which substituents to t ry  in 
attempting to optimise the a c t i v i t y  of  a series of  molecules.
A contrasting approach to the l inear  f ree energy re lat ionships of  
Hansch et a l . is due to Free and Wilson (54) .  Once again, a series of  
drugs is treated as a common skeleton with various subst ituents,  but 
rather than re la t ing  a c t i v i t y  to that  of  a parent compound i t  is 
related to the mean of  the series , with each substituent giving a 
contribution to the a c t i v i t y ,  a re la t ionsh ip  of  the form
pC = a + b[ s ub1] + ctsub2] + . . .  1 .1 .4
where a, b, c . . . are constants obtained by solution o f  the set
of  simultaneous equations obtained by expressing the a c t i v i t y  of
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members of  the series in this way by least squares f i t t i n g  of a
stra ight  l in e ,  and the terms [subl]  etc.  are simply 1 or 0 according as 
the substituent is present or absent in a par t icu la r  compound. The 
substituent contributions can, of course, be e i th e r  posit ive or
negative, and are assumed to be add it ive .  This method has the
advantage that ,  in contrast to Hansch analysis,  i t  is possible to 
distinguish between the e f fects  of  subst itut ion on opposite sides of a 
chiral  centre,  giving a means of distinguishing between the a c t i v i t i e s  
of  stereoisomers o f  a compound. The l i t e r a t u r e ,  however, contains very 
few examples of  the applicat ion of  Free-Wilson analysis (55 -57 ) ,  and
the vast majority  of  published QSAR studies are based on the Hansch 
method (58-75) .
The approaches to QSAR described so f a r ,  which could be gathered 
together under ihe  banner o f  "classical  QSAR," suffer from a number of  
drawbacks.
i )  In te rpre ta t ion  of  drug a c t i v i t y  in terms o f  bulk properties  
such as boil ing points,  hydrophobicity indices such as ir-constants, 
pK values and Hammett indices, and the ubiquitous use of
a
substituent constants w i l l  in general l im i t  such a QSAR study to a 
consideration of.molecules within a closely re lated ser ies.  When
the goal of the study is design of  novel compounds which e l i c i t  the 
same pharmacological response by the same mechanism, th is  is 
c lear ly  a serious shortcoming.
i i )  With the exception of  the Free-Wilson type o f  substituent  
constants, none o f  the indices described so fa r  w i l l  dist inguish  
the a c t i v i t y  of  a drug from that  o f  i ts  opt ical  isomer. I t  has 
long been recognised that  drug a c t i v i t y  is highly stereospecif ic  
(76) ,  and the a l te ra t io n  o f  the configuration of  one or more chira l  
centres in a molecule may have a profound e f fe c t  on i ts  a c t i v i t y ,  
not only in terms o f  magnitude but also mode o f  act ion.  The 
implications of  th is  fo r  drug research are enormous. I t  has been 
reported (77) that  the embryotoxic and teratogenic e f fec ts  of  
thalidomide are re s t r ic te d  to the S ( - )  isomers ( in  experiments on 
r a t s ) ,  with the R(+) isomers being free of such act ions,  implying 
that the thalidomide tragedy could have been avoided had the
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question of  the importance of  absolute configuration been given 
s u f f ic ie n t  a t tent ion at  the stage of  the i n i t i a l  test ing of  the 
compound.
The success o f  classical QSAR approaches cannot be denied, but this  
success must be placed in the context of  the type of biological  data 
which are,  in general,  being interpreted. Such studies have, for  the 
most par t ,  been aimed at ra t ion a l isa t ion  of  data obtained in whole 
animal experiments, and in such systems many factors apart from the 
a c t iv i t y  o f  the drug must be taken into consideration.
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1.2 Drug Acti vi t y .
The modelling of in vivo drug a c t i v i t y  presents an enormously 
complex problem to the medicinal chemist. Figure 1.2.1 i l l u s t r a te s  
schematically the possible routes of  administration of  a drug, and the 
various processes which can occur within the body a f te r  administration.
Oral '
topical etc.
Intramuscular
Intravenous
Intradermal
-»|Metabol i sm 
♦ [Excretion
Active s i te  1
Admi nistra tion
Absorption from gut, 
through skin etc.
Storage in f a t t y  t issue,  
protein binding etc .
Figure 1.2.1
The i n i t i a l  assumption in an approach to modelling drug a c t i v i t y  is 
that  the drug in question acts at a par t icu la r  localised s i te  within  
the body, the "receptor." C lear ly ,  to have any chance of being ac t ive ,  
a compound must be able to reach i ts  receptor. I t s  a b i l i t y  to do this  
w i l l  be governed by some or a l l  of  the processes shown in f igu re  1 .2 .1 .
The drug w i l l  generally be carried around the body from the s i te  of
administration to the s i te  of  action by bloodstream, so the f i r s t  
factor  which must be considered is the ease with which i t  can get into  
the blood. For drugs administered by in ject ion  this is not a problem, 
but for  absorption through the skin, from the in tes t ina l  t r a c t ,  through
the nasal mucosa etc.  this has important implications fo r  drug
structure. Absorption via such routes w i l l  involve the crossing of  
membrane barr iers ,  and this w i l l  require the drug to be s ig n i f i c a n t ly
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l ip id  soluble unless an active mechanism for  absorption exists .
The necessity o f  being l ip i d  soluble w i l l  place broad constraints 
on the pK values of  the molecule. To enter the l ip id  phase of  a 
membrane there should be a s ign i f ican t  proportion o f  the drug in i ts  
neutral  form at  physiological pH, l im i t in g  the pK values to between
about four and ten. Within a series of  compounds of s imilar  s tructure,
th is factor  w i l l  almost cer ta in ly  introduce a dependence of  the in vivo 
a c t i v i t y  on drug pK simply due to the e f fe c t  o f  ionisat ion state on
a.
absorption.
Once in the bloodstream the drug may be bound to serum proteins,
'• stored' in f a t t y  t issues, excreted, metabolised, or may have to cross
fur the r  membrane barr iers to reach i ts  s i te  of  action. All of  these
fac tors ,  the pharmacokinetics of  the system, essent ia l ly  act as
modifiers of the concentration of  the drug at the receptor,  and w i l l  
thus exert a marked influence on the observed in vivo a c t i v i t y  of  the 
drug. Any attempt to ra t ional ise  the var ia t ion  in a c t i v i t y  of  a series  
of drugs in so complex a system with so many variables and unknown 
factors is almost doomed to f a i l u r e  before the question of  how
ef fe c t ive  the drug is at the receptor has even been addressed.
I t  could be argued that the successes of classical QSAR in 
in terpret ing  in vivo biological data general ly  have l i t t l e  or no 
mechanistic basis,  and are simply rather  convoluted means of  describing  
the pharmacokinetic properties o f  the drug in the animal, and hence the 
concentration o f  the drug at the act ive s i t e .  While such information  
is very valuable to the pharmacokineticist,  i ts  u t i l i t y  to the
medicinal chemist whose task is to design drugs to in te rac t  with a
specif ic  active s i te  is questionable.  The l im i t ing  fac tor  in drug 
a c t i v i t y  must be the a c t iv i t y  of  the drug at  the act ive s i t e ,  with the 
pharmacokinetics o f  the drug- animal system simply being a modifier  
( a lb e i t  one o f  the utmost importance) to th is ,  capable of  being 
surmounted, fo r  example by the use of  improved drug del ivery  systems or 
design of  drugs which are metabolised to t h e i r  active form when already 
at  the active s i t e .
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1.3 A c t iv i ty  at The Receptor.
Having te n ta t iv e ly  iden t i f ie d  a c t i v i t y  at the act ive s i te  as the 
u l t im ate ly  l im i t ing  fac tor  in the response e l ic i t e d  by a drug molecule, 
i t  is now necessary to examine more closely what is meant by the terms 
"active s i te"  and "receptor." H is t o r ic a l l y ,  the concept o f  a receptor 
is about a hundred years old; Ehrl ich having observed that bacteria can 
be stained se lec t ive ly  by certain dyes, concluded from this that  there 
might be parts of the bacter ia which interacted s p e c i f ic a l ly  with the 
dye molecules, while Langley suggested at about the same time that  
atropine might combine with a specif ic  substance in l iv in g  c e l ls .
- In the succeeding years, various general, observations o f  the nature 
of drug a c t i v i t y  have led to a greater  understanding o f  what might 
consti tute  a receptor,  and where i t  might be located.
The amounts of  a drug required to produce a biological response are 
in many cases very t in y ,  ce r ta in ly  f a r  too small to be consistent with 
the drug simply covering the surface of  a cel l  and preventing i ts  
normal function.  I t  has, fo r  example, been estimated (78) that the 
area which could be covered by the acetylcholine required to reduce the 
rate of  beating of  the frog heart by 507o is only about 1/6000 of the 
to ta l  area o f  the c e l ls ,  while non-specif ic substances such as long 
chain alcohols are e f fec t ive  only in concentrations approaching that  
required to form a monolayer covering the c e l l .  Figures fo r  the e f fe c t  
of  certa in  substances such as Botulinus Toxin type D are even more 
remarkable (79 ) ,  with a minimum lethal  dose fo r  a mouse being of  the 
order o f  only 1000 molecules. This,  together with the observation that  
biological  response is highly stereospeci f ic  and that  biological  
response can be reproduced or antagonised by compounds which are 
closely  s t ru c tu ra l ly  related implies that a receptor is a highly  
special ised and geometrically well defined structure.
Most, though by no means a l l ,  drugs show an extremely rapid onset 
of response, and th is  response is often rapid ly  reve rs ib le .  The 
implicat ion of  th is is that  the receptor is very often si tuated on, or 
at  least  very closely associated with the cel l  membrane. 
A l te r n a t iv e ly ,  the receptor could be e x t ra c e l lu la r ,  removing the need
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f o r  the drug to penetrate the ce l l  membrane.
Mautner (80) has c lass i f ied  drugs into three categories;
i )  drugs a l te r in g  or inh ib it ing enzymes
i i )  drugs a f fec t ing  membrane permeabil ity
i i i )  drugs a l te r in g  template molecules
Clear ly ,  the last category includes drugs such as some cytotoxic  
compounds used in cancer chemotherapy which are believed to act  
d i r e c t ly  on the DNA of a c e l l .  These substances are l i k e ly  to be 
exceptions to the generalisation that  onset of action is rapid simply 
because the processes affected are slower than membrane-controlled
events. The f i r s t  two categories may be d i f fe ren t  manifestations o f
the same event, since the active transport of substances across 
membranes (as opposed to simple passive d i f fusion)  is thought to be 
mediated by membrane-bound proteins.
From the preceding discussion the central concept emerges that  a
biological  response is,  at  least in the f i r s t  instance, the re s u l t  of  
the combination of  a drug ( in  general a small molecule) with a 
biopolymer. This study is p a r t ic u la r ly  concerned with drugs f a l l i n g  
into  category i )  of Mautner's c lass i f ica t ion  where the bio logical
response is not due s p e c i f ic a l ly  to the drug but rather  to i ts
interference with an enzyme producing i ts  normal e f fe c t .  For this
s i tuat ion  a simple equil ibrium can be wri t ten,
E + S + I  ■ ES + I
i  „  i
El + S  -p f------------- *  response
where E represents the enzyme, S i ts  normal substrate and I the 
in h ib i to r .
This equil ibrium is only s t r i c t l y  applicable for the case where the 
in h ib i to r  and substrate are competing for the same binding s i te  on the 
enzyme. I f  d i f fe ren t  binding si tes are involved then formation of  the 
ternary complex ESI and whether th is  complex gives rise to a response
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must be considered. In th is case the order in which I  and S bind to
the enzyme may be of s ignif icance,  and this wil l  fu r the r  complicate the 
picture (81 ) .  For> revers ible  competitive inh ib i t ion  of  an enzyme,
however, th is  equil ibr ium adequately describes the system, and the
problem of  drug a c t i v i t y  has been reduced to a piece of  simple
equil ibr ium thermodynamics.
1.4 Thermodynamic Aspects of  Enz.yme-Inhibitor In teract ions .
From the equil ibrium in 1.3.1 i t  can be quite eas i ly  shown that
CES] = [Ep][S]  1___________ 1.4.1
tTsJt-Ks( l  + CI ] / < ! ) ......
where K$ and Kj are the dissociation constants of the
enzyme-substrate and enzyme-inhibitor complexes respect ive ly ,  [Eq ] is 
the to ta l  concentration of  the enzyme, CS ] and [ I ]  are the
concentrations of substrate and in h ib i to r  respectively and [ESI the
concentration of the complex formed between the enzyme and i ts
substrate.  I t  is not unreasonable to postulate that  the magnitude of  
the biological  response due to the substrate w i l l  be proportional to
the rate  of breakdown of  the enzyme-substrate complex and hence, in the
steady state at leas t ,  to CES], provided that the breakdown of  the
complex is a f i r s t  order process.
In a whole animal system the medicinal chemist has no control over 
CS], [Eq ] or K$ , and [ I ]  w i l l  be determined by the pharmacokinetic 
properties of the system. From a therapeutic point o f  view, since most 
drugs have undesirable side e f fe c ts ,  i t  is desirable to be able to keep 
[ I ]  at  as low a value as possible in order to minimise the dosage 
required to produce a given e f fe c t .  I t  is thus Kj which is the
fac tor  over which the medicinal chemist has control and w i l l ,  to a 
f i r s t  approximation, be the deciding factor  as to whether or not a 
p a r t ic u la r  compound w i l l  be an e f fe c t iv e  inh ib i to r .
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From equation 1.4.1 i t  can be seen that the presence of the 
in h ib i to r  leads to an apparent increase in the value of  K$ by an 
amount [ I ] / K j .  Given the dependence of  [ I ]  on the transport and 
metabolism of  the substance in question, and the d e s i r a b i l i t y  of  
keeping th is  quantity as low as possible,  i t  is clear that the aim of  
the medicinal chemist should be to design a compound (or group of  
compounds) with as small a value of  Kj as possible.  The value of  
Kj is ,  of  course, simply related to the f ree energy of formation of  
the enzyme-inhibitor complex,
AG = RT In Kj 1.4.2
An idea of  the s e n s i t iv i t y  o f  enzyme in h ib i t io n . to  changes in AG can be 
obtained from a consideration of  the s i tuation where two d i f f e r e n t
inh ib i tors  are being compared. From equation 1.4 .2  i t  follows that
AAG = RT In K1/K2 1.4.3
where Kx and K2 are the dissociation constants of  the two 
d i f fe re n t  enzyme-inhibitor complexes and AAG is the difference in th e i r
_ i
energies o f  binding. For an energy difference of  25 kJ mole
(within the range for  a single hydrogen bond (82) )  the r a t io  of  K 
values is around 3000. A range of  Kj values in a series o f  compounds 
covering seven orders of  magnitude w i l l  be accompanied by a change of
_ i
only 40 kJ mole in th e i r  binding energies. Since the therapeutic  
ef fec t  is governed by [ I ] / K T, i t  follows that th is  di fference in
1 7
binding energy would have to be compensated for  by a fac tor  o f  10 
in the concentration o f  the drug at the act ive s i te .  C lear ly ,  
s e n s i t iv i t y  to AGbinding ma9nitude implies that  th is
quantity is o f  overriding importance, and an improvement of  only a few 
kJ mole-  may well more than compensate fo r  any deleterious e f fe c t  
on a drug's pharmacokinetic propert ies.
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1.5 Quant if icat ion of  Drug A c t iv i ty .
From the preceding discussion i t  is clear that primary data 
obtained in a whole animal system are of  l imited use in a search for
QSARs which are based sole ly  on the mechanism of action of  a drug at
i ts  receptor.  As well as the complicating factors of transport and 
metabolism mentioned in section 1.2,  i t  is clear from equation 1.4.1 
that  the biological  response is dependent on CS], thus i f  a negative 
feedback mechanism exists whereby lack of  response to the normal enzyme 
reaction leads to an increased concentration of the substrate,  then a 
fu r ther  complication is added to the system. The same cr i t ic isms apply 
to a lesser extent to data obtained from, for  example, organ bath 
preparations o f  isolated t issues.
C lear ly ,  an ideal system for  obtaining: "b io log ica l1 data is one in 
which the only components present are the receptor and the drug 
molecule, with Kj being measured d i r e c t ly .  This requires that  a pure 
preparation of the receptor be ava i lab le ,  and this requirement is
unfortunately very d i f f i c u l t  to achieve, though the applicat ion of
a f f i n i t y  chromatography to the problem of  receptor iso la t ion  (83) gives 
grounds for  optimism in the future .  A more r e a l i s t i c  s i tuat ion  is one 
in which the receptor molecule of in te res t  ( fo r  example an enzyme) is 
isolated from the tissue in which i t  occurs, and as much of  the other  
material  is removed to give a system in which other f ract ions are 
present,  but in smaller amounts than in the animal system, while the 
problems of transport and metabolism have been removed.
Having obtained an in v i t r o  system which corresponds as closely as 
possible to a pure receptor f ra c t io n ,  the dissociation constant fo r  the 
enzyme-inhibitor complex can then be obtained by, fo r  example, 
spectroscopic methods. An a l te rn a t ive  to this proceedure is to 
determine I 50, the concentration of  in h ib i to r  which, in a given 
assay system, causes the rate of reaction of the enzyme with a 
substrate to be reduced by ha l f .  This is a p a r t ic u la r l y  useful 
quantity,  since i t  can be shown from equation 1.4.1 that
I50 = Kj(l + [S3/K ) 1.5.1
Thus for  a given K$ and [S] (which can be defined by the chemist in
an in v i t r o  system), I 5Q is a function only of K j . When comparing 
a series of  compounds, the r a t io  of  th e i r  Kj values w i l l  thus be
given by the r a t io  of the i r  I 50 values. I 50 values are 
frequent ly  reported as p l 50
P^5o = _ ^ 9 i o ^5o 1 .5 .2
Hence from equation 1.4 .3  i t  is obvious that the di fference in the 
f ree energy of  binding of two compounds is l in e a r ly  re lated to the
dif ference in th e i r  p I 5Q values,
AAG = -2.303RT Apl50 1 .5 .3
In ,this. work, al 1 data pertaining to enzyme-inhibitor interactions are 
in thi s form.
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1.6 Drug-Receptor Complementarity.
The highly specif ic nature of drug-receptor interact ions as
evidenced by the s tereospec i f ic i ty  of drug a c t i v i t y  implies that  
features of the drug molecule must bear a close three-dimensional  
rela tionship  to complementary features on the receptor.  The concept of  
drug-receptor complementarity was f i r s t  propounded by Fischer (84) ,  who 
l ikened the receptor to a lock and the drug molecule to a key. The 
modern view, due to Haldane (85) and extended by Pauling (86 ,87 ) ,  sees 
both drug and receptor as having a degree of f l e x i b i l i t y ,  a si tuat ion  
closer to a "hand and glove" than a "lock and key." The differences  
between the two views are not, however, great,  and the concept of the 
drug f i t t i n g  more or less t ig h t l y  into a binding s i te  with 
complementary structural  features is common to both. The par t icu la r  
arrangement o f  atoms or groups needed to in te rac t  with a given receptor 
is often referred to as the pharmacophore.
The nature of  the features that drug and receptor recognise in one 
another are c lear ly  of paramount importance to any discussion of  drug 
a c t i v i t y  in the context of action at the receptor,  and i t  is pertinent  
to consider at th is point the specif ic interact ions that contribute to 
the free energy of  binding of  the drug, and thus exert an influence on 
the biological response to the drug.
The free energy of  binding of  the drug to i ts  receptor is ,  of  
course, made up of both enthalpic and entropic contributions.  
Interact ions which might contribute to each, and thus influence drug 
a c t i v i t y ,  are now considered in turn.
i )  Covalent bonding. The formation of  a f u l l  covalent bond
between a drug and i ts  receptor has been noted in certa in cases, 
for  example the action of  some fluorophosphate inh ib i tors  of
acetylcholine esterase (88 ) ,  the p e n ic i l l in s  and cephalosporins
(89) ,  and ant ineoplast ic  a lky la t ing  agents (90) .  I t  has, however, 
been noted above (section 1.2) that drug a c t i v i t y  is often rapidly  
revers ib le ,  and the magnitude of  the energy changes involved in 
covalent bond formation of  the order of  several hundred kJ
_i
mole ) is not consistent with th is .  For revers ible  inh ib i t ion
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of an enzyme, covalent bond formation is thus not considered to be 
an important phenomenon.
i i )  E lec t rosta t ic  in te ractions.  The drug molecule under 
consideration and the amino-acid side-chains surrounding the 
binding s i te  on the receptor may carry formal charges. Even i f  
th is is not the case, the presence of polar groupings on drug or 
enzyme w i l l  lead to the presence of  par t ia l  charges on the system, 
and these pa r t ia l  charges w i l l  in teract  with one another. The 
energy of  the interaction between two point charges is given by
E = Q1Q 2 1.6.1
er
where Qx , Q2 are the charges, r  is the distance between 
them and e is the d ie le c t r ic  constant of the intervening medium. 
For two unit  charges separated by 5A in water (e = 78 ) this
_ i
in teract ion  is around 1.5 kJ mole , and this wil l  be larger  in 
a medium of  lower d ie le c t r ic  constant, so in the l ig h t  of  the 
discussion in section 1.4,  such interactions seem l i k e ly  to play an 
extremely important role in enzyme-drug binding reactions, and 
should be considered in any reasonable model.
i i i )  Dipole-dipole in te ractions.  Separation of charge within a 
bond between two atoms of  d i f f e r in g  e lectronegat iv i ty  w i l l  lead to 
a permanent displacement of  electron density towards the more 
electronegative atom. This permanent dipole can in te rac t  with 
other permanent dipoles, the energy of  th is interact ion fo r  a "head 
to t a i l "  arrangement of  dipoles being given (91) by
E = 2MaHb 1 . 6 . 2
er
where ]ia , \ i  ^ are the magnitudes of  the two dipoles.  The 
ordered a -h e l ic a l  structure of  a protein can give r ise  to very 
large dipole moments. In this case, quite small var iat ions in the 
dipole moment o f  the in h ib i to r  could cause marked changes in the 
energy of  in te rac t ion ,  and hence in the to ta l  binding energy.
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A permanent dipole can induce a dipole in a neighbouring 
molecule. These interact ions are,  however, quite small, and f a l l  
o f f  with the sixth power o f  the distance between the dipoles.
iv )  Hydrogen bonding. A hydrogen bond is formed between a 
hydrogen atom attached to an electronegative atom, and another 
electronegative atom. The bond energy is generally in the range 8
_ i
-  40 kJ mole (82 ) ,  and the phenomenon is largely ,  though not 
e n t i re ly  e lec t ro s ta t ic  in nature. There is no doubt that hydrogen 
bonding is important in drug-receptor in teract ions. However, i t  
should be remembered that groups involved in hydrogen-bonding 
interact ions can be solvated in aqueous solution with l i t t l e  
energetic preference compared to binding to a receptor s i te .
v) Dispersion interact ions.  These forces, also known as London or 
van der Waal s' forces,  can be thought of  as ar is ing from the 
in teraction of instantaneous e le c t r ic a l  moments in a molecule with 
those in a neighbouring molecule, arising from f luctuations in the 
positions of the electrons. The energy of interaction between two 
ident ical molecules can be approximated by
E = - 3AEa2 1 .6 .3
~4r*
where AE is an average excitat ion energy and a is a 
p o la r isab i1i t y .  The interact ions are small, for  example the 
dispersion contribution to the l a t t i c e  energy o f  the solid state
_ i
alkanes is about 8 kJ mole per CH2 group (82 ) ,  but they 
are addit ive and can thus add up to a s ign i f ican t  amount in large 
molecules. These forces are found between a l l  molecules, but are 
of par t icu la r  importance in neutra l ,  non-polar molecules where they 
are essent ia l ly  the only a t t r a c t iv e  force operating.
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b) Entropic Terms.
i )  Enzyme and drug molecule. The combination of two separate 
molecules to form a single species w i l l  resu l t  in a decrease in 
entropy due to the replacement o f  two sets of translational  and 
rotat ional  entropy by one. In addit ion to th is ,  there may be a 
fu r the r  decrease in entropy due to the re s t r ic t io n  of internal  
rotat ions in e i ther  or both of  the drug molecule and the enzyme on 
complex formation. This wi l l  be p a r t ic u la r ly  unfavourable fo r  very 
f l e x ib l e  drug molecules.
i i )  Solvent.  Both the drug molecule and the receptor binding s i te  
w i l l  be solvated in the absence of  complex formation, and on
binding some or a l l  of this bound water w i l l  be released. The 
presence of  hydrophobic groups in an aqueous environment gives r ise  
to a local ordering of  the structure of water in order to preserve 
the hydrogen bonding interactions.  When hydrophobic groups become 
associated with one another this ordered water can be expelled to
form essen t ia l ly  bulk water, a much less ordered state ,  and th is  is
an entrop ica l ly  favourable process. This entropy driven tendency 
of hydrophobic groups to become associated has been termed 
"hydrophobic bonding" by Kauzmann (92) .  The phenomenon is well
known (9 3 ) ,  fo r  example in the formation of  detergent micelles in 
water, and fo r  a drug-receptor system where both have hydrophobic 
groups the process is doubly favourable due to the presence of  two 
unfavourable in terfaces.
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1.7 Enzyme Cata lys is :  Impl icat ions f o r  Drug Design.
The discussion of  drug design has so fa r  centred on the importance 
of Kj and the types of  interact ion which w i l l  influence i ts  value.  
At this point i t  is pertinent to consider what types of molecule w i l l  
in teract  e f fe c t iv e ly  with a part icu la r  receptor. In the context of
enzyme inh ib i t io n ,  i t  is necessary to consider the manner in which an 
enzyme operates in order to deduce the arrangement of  groups in the
pharmacophore which w i l l  give optimal binding.
An enzyme is simply a biological ca ta lys t ,  and l ike  any other
catalyst  has no e f fe c t  on the posit ion of  equil ibr ium of  a reaction,
but causes the rate of  the reaction to increase. This is done by 
reducing the act ivat ion  energy for  the reaction, and i t  is quite eas i ly  
shown (98) that  the optimal way in which this can be achieved is i f  the
binding energy o f  the enzyme-substrate system is at a maximum for  the
trans i t ion  state of  the reaction rather than the reactants or
products. Plots o f  f ree  energy against reaction coordinate fo r
situations in which optimal binding is achieved for reactants ( i ) ,  
t rans i t ion  state  ( i i )  and products ( i i i )  are shown in f igure  1 .7 .1 .
Figure 1.7.1
Energy
Reaction coordinate
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Clear ly ,  i f  we denote the reduction in binding energy on forming the 
t rans i t ion  state from the reactants fo r  the case where binding is 
optimal fo r  the reactants by AGX, and the increase in energy of  
binding on forming the t rans i t ion  state in the case where binding is 
optimal fo r  the t rans i t ion  state by AG2 , then i t  is clear that  
comparing two hypothetical enzymes which give r ise to these binding 
character is t ics ,  the act ivat ion  energy fo r  the reaction would be lower 
by AGX + AG2 fo r  the enzyme which binds most e f fe c t iv e ly  to the 
t rans i t ion  state than for  that which optimally  binds the reactants.  
Similar  arguments can be used to show the super ior i ty  of  preferent ia l  
binding of  the t rans i t ion  state over products Thus i t  would be 
expected that an inh ib i to r  which mimicked the t rans i t ion  state of  the 
reaction should bind more e f fe c t iv e ly  to the enzyme than e i ther  a 
substrate or product mimic.
The implication of  this for  drug design is quite clear;  enzymes 
have evolved in a manner designed to optimise th e i r  in te raction with 
the t rans i t ion  states of  the reactions which they catalyse, so the best 
"template" for  design of an inh ib i tor  fo r  a specif ic enzymic reaction  
should.be the t rans i t ion  state for  that reaction. The modelling of  
t rans i t ion  states is discussed in chapter 4.
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1.8 Modelling the Druq-Receptor Binding Reaction,
From the preceding discussion i t  follows that any attempt to model 
drug a c t i v i t y  (or at least receptor a f f i n i t y )  in terms of  events taking 
place at the molecular level must take into account as many as possible 
of the enthalpic and entropic terms discussed in section 1.6.  A 
fu r ther  enthalpy term which is im p l ic i t  in the discussion of  section
1.7 is a conformational contribut ion; in general the conformation of  
the drug, molecule which wi11 bind most e f fe c t iv e ly  to the receptor w i l l  
not be i ts  global minimum energy conformation but one which has been 
distorted to a greater or lesser extent.  The energetic cost o f  bond 
stretching or bond angle bending o f  any magnitude is l i k e l y  to preclude 
these types o f  d istort ion  (see appendix B), but tw ist ing  about 
torsional angles is very l i k e ly  to occur, and even i f  the cost in 
energy is quite small, i t  was seen in section 1.5 that even a few kJ 
mole” may have a marked e f fe c t  on Kj for a compound. The 
problem of  conformational analysis and i ts  relevance to drug design is 
discussed in the next section.
One fu r ther  property of the system which should be borne in mind 
when considering the modelling of  drug-receptor binding reactions is 
the d ie le c t r i c  constant. A drug molecule free in the c e l lu la r  or 
e x t ra c e l lu la r  f lu ids  (or in the solvent of an in v i t ro  assay system) is 
in an essent ia l ly  aqueous environment which has a r e l a t i v e l y  high 
d ie le c t r i c  constant. The in te r io r  of an enzyme has been described (94)  
as the biochemical equivalent of  the organic chemist's non-polar 
solvent,  and the d ie le c t r ic  constant in the binding s i te  may well 
r e f l e c t  th is to some degree. The e f fe c t  of  d ie le c t r ic  constant on 
molecular properties is well known (see section 3 .4 ) ,  and th is  may well 
have implications fo r  the modelling of drug-receptor in teract ions .
To summarise, the drug-receptor binding reaction can be thought o f  
as being a combination of  several processes. F i rs t  the drug must be 
twisted from i ts  aqueous solution global minimum energy conformation 
into one which interacts e f fe c t iv e ly  with the receptor s i t e .  Second, 
the aqueous environment must be removed and replaced by a receptor s i te  
surrounding the molecule in such a manner as to in teract  with specif ic  
features of i t s  electronic structure (the pharmacophore) in a highly
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specif ic  fashion. Third, the d ie le c t r ic  constant in the v i c i n i t y  of  
the drug molecule may well change from a large value to a much lower 
value ( fo r  example i t  has been estimated (95) that the d ie le c t r ic  
constant of  the active s i te  of  lysozyme is about 5) .  The enthalpy and 
entropy changes associated with a l l  of  these processes contribute to 
the free energy of  binding of  the drug to the receptor, and an attempt 
to include them in any model of  the reaction should be made.
1.9 Drug Conformation.
The importance of  the conformational properties of  a drug molecule 
has already been stressed, with the amount of  energy needed to tw is t  a 
drug molecule from i ts  global minimum energy- conformation in to  that
conformation which interacts optimally with the receptor probably
providing a s ign i f ican t  contribution to the binding energy. Given that  
a method of ascertaining the re la t ive  energies of two conformations of  
a molecule can be found, the next problem which must be addressed is 
"Which conformations are of  interest?"
A var ie ty  of  methods are available to the experimental chemist to 
study the conformation of a molecule. Probably the most d i rec t  of  
these is the use of  X-ray crystal lography (96) to determine the
positions of  the atomic nuclei .  This method, however, has the drawback 
that  i t  only examines a single point on the potent ia l  energy surface of  
the molecule, and while the conformation observed in the crystal  may be 
the global minimum energy conformation of the molecule, th is  is by no 
means necessari ly the case, and crystal  packing forces may well d is to r t  
the molecule, p a r t ic u la r ly  about torsional angles, or the compound may 
c ry s ta l l i s e  in another low energy conformation. The method gives no 
information about the shape of  the potent ial  energy surface such as 
barr iers to ro ta t ion ,  or the r e la t iv e  energies o f  other low energy
conformers.
For molecules which are highly conformationally re s t r ic te d ,  X-ray  
crystal lography w i l l  probably r e f le c t  the solution conformation o f  the 
molecule (97 ) ,  but for  molecules with a number o f  f r e e ly  ro ta tab le
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bonds this may not be the case. A knowledge of the NMR sh i f ts  and 
coupling constants can be interpreted to give information about the 
conformers of  a molecule present in solution (98) ,  the r e la t i v e  
populations of these conformers, and the ease with which they are 
interconverted, but once again, only certain portions of the energy 
surface are amenable to this type of  analysis.
Theoretical methods using sel f -consistent  f i e l d  (SCF) or molecular 
mechanics calculations do not suffer  from these drawbacks since the 
chemist can define the positions of  the nuclei and calculate the energy 
of the molecule fo r  a par t icu la r  conformation of  in te re s t .  Such 
calculat ions therefore provide a means o f  examining the whole of  the 
conformational space of  the molecule or of  any par t icu la r  region that  
may be of  in te res t .  Both SCF methods and molecular mechanics have 
th e i r  drawbacks which are discussed la te r  (chapter 3 and appendix B 
respect ive ly ) ,  but provide powerful tools for  the chemist to 
invest igate a molecule and i ts  immediate environment in a degree of  
deta i l  which is seldom avai lable to the experimentalist (except in very 
small systems). From the point of view of  drug design, there are very 
great advantages in using theoret ical  methods: i f  those properties of
a molecule which are essential  fo r  pharmacological a c t i v i t y  can be 
id e n t i f ie d  then theoret ical  (and p a r t ic u la r ly  SCF) methods can probe 
the properties of a novel compound in very great detai l  to see i f  i t  is 
l i k e ly  to be act ive;  the need fo r  synthesis and p u r i f ica t ion  at  a very 
ear ly  stage of  screening of possible compounds is removed; the 
molecular wavefunction obtained from an SCF calculation contains a 
great deal o f  information ( in  pr inc ip le  any property of  in te re s t  can be 
obtained from i t )  about the molecule, in question, and th is  w i l l  
describe the molecular properties of relevance to pharmacological 
a c t i v i t y  more accurately than a simple consideration o f  Hansch 
ir-constants, Taft  s ter ic  parameters etc.  can ever do.
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1.10 Theoretical Methods and QSARs.
The applicat ion of the techniques of  theoret ical  chemistry to the 
search fo r  QSARs has grown rapidly over the last  few years with the 
increased a v a i l a b i l i t y  of computers powerful enough to perform the 
necessary calculat ions.  I n i t i a l  attempts in this area were constrained 
severely by the lack of  powerful computing f a c i l i t i e s  to very 
approximate calculations using the Huckel (99) or Extended Huckel (100)  
methods, generally in quite small systems.
Much of  the ear ly  work is devoted to re la t ing  the acetylchol ine-  
esterase a c t i v i t y  of  series of compounds to quantum chemical indices.  
Pullman and Valdermo (101) observed that the charge on the phosphorus 
atom of  f i v e  organophosphates para l le ls  the ir  a c t i v i t y ,  while Fukui et  
al (102) observed a qua l i ta t ive  re lat ionship between the nucleophi l ic  
superdelocalisabi1i ty  (103) of  the phosphorus atom and a c t i v i t y  
for a series of f i f t e e n  diethyl-phenyl phosphates. Purcell (104) has 
noted a correlat ion between amide nitrogen charge and a c t i v i t y  fo r  a 
series of  six carbamoyl piperidines. Inouye et al (105) have noted a 
correlat ion between the nucleophilic f ro n t ie r  electron density (106) of  
the carbonyl carbon of four n ico t in ic  acid der ivat ives and th e i r  
a c t iv i t y .
In other systems, Perault and Pullman (107) observed an approximate 
paral le l ism between the Huckel charge and nitrogen f ree valence in a 
series of  aryl  amines and the ir  rate of  enzymatic ace ty la t ion .  Bell 
and Roblin (108) noted that the ordering of  the bac ter ios ta t ic  a c t i v i t y  
of some sulphonamides followed that of the charge on the amide 
nitrogen, while a s imilar  re la tionship  was observed between the binding 
of sulphonamides to serum albumin and the charge on the f i r s t  carbon of  
the amide substituent (109).  Snyder and Merri l  showed a marked 
covariance between the energy of the highest occupied molecular o rb i ta l  
(HOMO) and the hallucinogenic a c t i v i t y  of a var ie ty  of  d i f f e r e n t  types 
of drug (110) .  Inouye et al (105) have reported a corre la t ion  between 
the rate  of hydrolysis of nine phenyl acetates by bu ty ry l -  
cholinesterase and the e lectrophi1ic f ro n t ie r  electron density f^  of  
the phenyl carbon to which the acetate is attached. Pullman et  al 
(111-114),  in what is probably the e a r l i e s t  applicat ion of  M0 methods
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to a biological problem, have carried out a study of  carcinogenic 
hydrocarbons in an attempt to explain th e i r  a c t i v i t y  in terms of  Huckel 
r e a c t i v i t y  indices.
For most of the above examples, no attempt is made to quant ify the 
apparent trends, nor are they submitted to any s t a t is t i c a l  tests of  
signif icance.  Thus the inferences of the authors are quite subjective  
and open to cr i t ic ism .  Martin (115) has re-examined the data of  Inouye 
(105) using regression analysis,  and found that the corre lat ion between 
f^ and acetylcholinesterase inh ib i t ion  has no s t a t is t i c a l  
signif icance according to accepted c r i t e r i a ,  while Hansch et  al (116) 
have performed regression analyses on the data of Perault  and Pullman 
(107) which show that the rate of  acetylation is  poorly correlated with 
the charge on the amine nitrogen alone, but well correlated with this  
quantity along with ir, the l ip op h i l ic  substituent constant described 
e a r l i e r .
The lack of  inclusion of  a o rb i ta ls  in the Huckel method is a 
severe r e s t r ic t io n ,  p a r t ic u la r ly  for systems which are not planar.  The 
f i r s t  attempts to include the ef fect  o f  the c electrons were based on 
the empirical method of  Del Re (117).  The charges so calculated may be 
combined with the charges calculated by the Huckel method, al lowing the 
tota l  valence charge or the net charge at any centre to be used in the 
search for  correlations.
Cammarata and Stein (118) have considered the acetylchol inesterase  
in h ib i t in g  a c t i v i t y  of  six substituted 3-hydroxyphenyl 
trimethyl ammonium sa l ts .  They calculated the Huckel ir charges and 
superdelocal isabi l i ty  at various centres, and the Del Re a charges at  
the same s i tes .  No correlat ion was found using the ir charges alone,  
but a good correlation is obtained using the net (ir + a) charge and 
e lec t ro p h i l ic  superdelocalisabi1i t y  for  the phenolic oxygen atoms.
Bass et al (119) have made Huckel/Del Re studies of  33 chloroquine
analogues with ant imalar ia l  a c t i v i t y .  A mechanism of  action involving
2
DNA in te rca la t ion  is postulated, and l ip o p h i l ic  ir and ir terms are 
included as a measure o f  b io a v a i l a b i l i t y  as in vivo data are used. On 
breaking the series down into three subsets, correlat ions are obtained
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with the valence charges at certain centres, and this is interpreted in 
terms of  an e lec t ro s ta t ic  interaction with the DNA. The reduced 
a c t iv i t y  of  those compounds with bulky substituents is taken as 
evidence of s ter ic  inh ib i t ion  of in te rca la t ion .
The use of Huckel indices in tandem with the Del Re procedure for  
consideration of  a l l  valence electrons has the great drawback that  the 
a and ir systems are assumed not to in te rac t  with one another in any 
way. The introduction of  more rigorous methods to consider a l l  valence 
electrons by Pople et al (see appendix A and chapter 3) has enabled the 
search for  QSARs using MO methods to be put on a sounder theoret ica l  
basis. Calculations at  the CNDO and INDO levels of  approximation have 
been widely used in developing QSARs. Early work in th is  area is 
comprehensively reviewed elsewhere (120).
More recently ,  Webb et al (121-127) have used CNDO and INDO 
calculations to obtain correlations with the a c t i v i t y  of  d iacr id ine and 
cis-diaminoplat inum(I I)  complex antitumor agents, and two series of  
dihydrofolate reductase inhib itors .  Goldblum has employed ab i n i t i o  
methods to investigate some cholinesterase inhib itors  (128) .  Pullmann
et al have used PCILO calculations and an ab i n i t i o  method based on the
superposition of  fragments of DNA to study the e lec t ro s ta t ic  potent ia l  
of th is  macromolecule to investigate i t s  possible modes o f  in teract ion  
with small molecules (129-132).  Kollman et al (133,134) have
investigated the use of  point charge models to represent the receptor  
si te  o f  an enzyme in i ts  interaction with a model substrate in ab
i n i t i o  ca lculat ions,  and this approach has recently been extended by 
Richards et  al (135-137) to the modelling of  the binding of  a series of  
n-alkylboronic acid inhib itors  to a-chymotrypsin. Weinstein and Osman 
(138,139) have investigated the e f fec t  o f  receptor models on reactions  
of a model substrate by including the fragments e x p l i c i t l y  rather  than 
as point charges, but computational l im i ta t ions  r e s t r i c t  such studies 
to very small systems.
The importance of molecular shape and size in enzyme binding 
reactions has been approached largely from an empirical standpoint.  
Verloop (46) introduced the STERIMOL parameters to account fo r  s te r ic  
effects in enzyme-substrate sp e c i f ic i ty .  The advent of  high resolut ion
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computer graphics has allowed the representation of molecular envelopes 
based on van der Waals1 spheres, and Hopfinger (140) and Marshall et  al 
(141) have used quantit ies which describe the amount of  overlap of  a 
molecule with known active compounds to attempt to build up a picture  
of the ster ic  properties of  enzyme act ive s i tes ,  and to develop QSARs.
1.11 Thi s work.
The purpose of this research was to attempt to model drug-receptor  
interactions using techniques of  computational chemistry, in p a r t ic u la r  
molecular o rb i ta l  calculat ions,  in an attempt to produce quant i ta t ive  
s t ru c tu re -a c t iv i ty  relationships which could be applied to a wide range 
of compounds rather than simply to closely re lated series of  
molecules. Part icu lar  a t tent ion was given to the modelling of  the 
effects  of the medium surrounding the molecule, both in the bound and 
unbound states, that is the receptor s i te  and the solvent  
respect ively.  I t  was hoped to include a l l  of the interactions  
discussed in this chapter, e i ther  by means of  the computational 
techniques or empir ically ,  and thus obtain a r e a l i s t i c  model of  the 
drug-receptor binding reaction which could explain the a c t i v i t y  o f  a 
wide var ie ty  of  drug molecules.
Chapter Two 
Angiotensin Converting Enz.yme
What's the metre of the dictionary?
The size of  Genesis? the short spark's gender? 
Shade without shape? the shape of  pharaoh's echo?
Dylan Thomas 
Altarwise by o w l - l ig h t
2.1 In t roduc t ion.
Angiotensin Converting enzyme ( E . C . 3 .4 . 15.1,  peptldyl dlpeptlde  
carboxy hydrolase, A.C.E.) ,  also known as klnlnase I I ,  the enzyme of 
principal Interest  to this study Is a zinc containing peptidase which 
hydro ly t ica l ly  cleaves a carboxy terminal dlpeptlde unit  from a wide 
range of  peptide substrates. I t  Is one of a group of several 
peptidases which, along with the ir  protein and peptide substrates and 
products make up the anglotensln-renln system, one of  the body's 
mechanisms Involved 1n the control of  blood pressure. The components 
of  the anglotensln-renln system and th e i r  roles are I l lu s t r a te d  1n 
f igure  2 .1 .1 .
The normal function of the anglotensln-renln system is the 
restorat ion of  blood pressure and renal blood f low under conditions of  
decreased blood volume. However, malfunctions of  the system are 
recognised to be important contributary factors in certa in  types of  
hypertensive disease.
As can be seen from figure 2 .1 .1 ,  A.C.E. plays a pivotal  ro le  in 
the angiotensin-renin system: i t  cleaves a carboxy terminal His-Leu
fragment from the vasoinactive decapeptide angiotensin I to give the 
octapeptide angiotensin I I ,  a potent s a l t - r e t a in in g  substance and the 
most potent natura l ly  ocurring hypertensive substance known; i t  also
The Angiotensin-Renln System
XI I
I X
Figure 2.1.1
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cleaves a carboxy terminal Phe-Arg fragment from the potent hypotensive 
and n a t r iu re t ic  nonapeptide bradykinin, thus inact ivat ing  i t .  The 
formation of  angiotensin I I  is thought to be a f a i r l y  generalised 
action o f  the enzyme, taking place at the endothelial  surface of  the 
lungs and in other t issues (142) ,  while bradykinin degradation is 
thought to occur mainly in the kidney. I t  was o r ig in a l l y  believed that  
the two actions of A.C.E./kininase I I  were due to two d i f f e r e n t  
enzymes, but the ident i ty  of  A.C.E. and kininase I I  was demonstrated by 
Yang et al (143).
Both angiotensin I I  formation and bradykinin degradation can 
contribute to increased blood pressure, making the enzyme of  great  
therapeutic in terest ,  i t  being a candidate fo r  e f fe c t iv e  
pharmacological intervention in the angiotensin-renin system, with 
inh ib i t ion  of  e i ther  or both actions leading to hypotensive or 
antihypertensive a c t i v i t y .  Angiotensin I I  has many actions within the 
body (144) ,  fo r  example inh ib i t ion  of  aldosterone release, and fo r  this  
reason i t  might be therapeut ica l ly  desirable to attempt to design 
therapeutic agents which se lec t ive ly  i n h ib i t  the bradykinin degrading 
function of the enzyme.
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2.2 Occurrence, d istr ibut ion  and properties.
The therapeutic importance of ACE has meant that i t  has been the 
subject of  a large number of studies. I t  has been isolated and, to a 
lesser degree, pur i f ied  from a variety of sources including human, cow, 
pig, guinea-pig, ra t  and rabbit .  Within these sources the enzyme is 
widely d is tr ibuted,  with par t ic u la r ly  high concentrations being found 
in the kidney and the endothelial  surfaces of  the lung. Enzymes 
isolated from a l l  of  these sources show great s im i la r i t i e s  in th e i r  
properties, spectrum of  a c t i v i t y  and, by implicat ion ,  th e i r  structure.
The enzymes are a l l  glycoproteins, with molecular weights reported 
to vary from 120 000 to 400 000 (145),  sugar residues accounting fo r  
26% of  the dry weight in the case of  the enzyme isolated from rabbit
lung (146) .  In a l l  cases except that of  the enzyme from hog lung 
(147),  the enzyme is believed to consist of  a single polypeptide  
chain. The enzyme is largely membrane bound (though appreciable  
quantit ies can be isolated from blood plasma), and as a re s u l t  of  th is ,
no successful attempts to c rys ta l l ise  the enzyme have been reported.
Consequently, attempts to produce models of  the act ive s i te  must be
based on inferences from s t ru c tu re -a c t iv i ty  re la t ionsh ips ,  from the 
known properties of  the enzyme, and by analogy with s im i la r  enzymes 
which have been c rys ta l l ised  and the structures of  whose act ive si tes  
have been obtained by X-ray crystal lography.
Studies of p u r i f ie d ,  in v i t ro  preparations of the enzyme have 
revealed that i t  is able to catalyse the hydrolytic removal of  a 
carboxy-terminal dipeptide fragment from a wide v a r ie ty  o f  peptide 
substrates from N-blocked tr ipeptides upwards. I t  w i l l  not cleave
peptides with a terminal dicarboxylic amino-acid residue, or species
lacking a free terminal carboxyl group such as peptide esters or
amides, or peptides with a penultimate prol ine residue, a fa c to r  which 
prevents the fur ther  breakdown of angiotensin I I  by the enzyme.
The presence of  a metal ion is essential  to the peptidase a c t i v i t y  
of the enzyme. Removal of the zinc from the na tura l ly  ocurring enzyme, 
for example by d ia lys is  against solutions of  EDTA, completely and
reversibly  removes a c t i v i t y .  Reintroduction of  the zinc causes the
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enzyme to f u l l y  regain i ts  a c t i v i t y ,  and replacement of  zinc by other
metals can lead to enzymes which are more or less ac t ive ,  fo r  example
replacement with Mn + gives an enzyme which is 60% as act ive as the
2 +
native enzyme, while the Co enzyme is 160% as act ive .
2 2 2
Replacement by heavy metal ions such as Hg + , Cd + , Pb +
give inactive species (148).  I t  is reported (149) that  the enzyme
2.
shows greater a c t i v i t y  in d i lu te  Zn solutions, which suggests 
that the enzyme-zinc complex has an appreciable dissociat ion constant,  
and the suggestion of f a i r l y  weak binding of  the zinc is reinforced by 
the fac t  that heavy metals in h ib i t  the enzyme, presumably by 
displacement of  zinc from the active species.
One o f  the f i r s t  properties of  ACE to be recognised was that  i ts  
a c t iv i t y  was markedly dependent on chloride concentration (150) .  I t  
was la te r  found that other monovalent anions can act as ac t iva tors ,  
efficacy being in the order
Cl“ > Br“ > F" > N07 > CH3C0"
for  the enzyme from rabbit  lung using furanacroloyl -Phe-Gly-Gly as 
substrate (149),  while that fo r  human enzyme using 
benzyl-oxycarbonyl-Phe-His- Leu is reported (151) to be
Cl" > NO' > Br" > F" > I "
The degree of  chloride act ivat ion  is dependent on both substrate 
and pH (152) .  Weakly bound substrates such as angiotensin I are 
strongly dependent, with rates being neglig ib le  in the absence of  
chloride, and r is ing unt i l  the chloride concentration reaches about 
200mM. In contrast,  t i g h t l y  bound substrates such as bradykinin 
generally show much less dependence. Bradykinin is qui te read i ly  
hydrolysed in the absence o f  chlor ide,  the rate increasing s l ig h t ly  up 
to around [C l - ] = 20mM., then f a l l i n g  o f f  to a value s l ig h t l y  in 
excess of  the value observed in the absence of  chlor ide.  Small 
peptides with the terminal sequence Ala-Pro show very l i t t l e  dependence 
on chloride concentration, and may even be more rap id ly  hydrolysed in 
i ts  absence (153).
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Studies of  the bovine enzyme using a wide var ie ty  of 3 and 4 
membered peptides as substrate (152) have shown the chloride dependence 
to be bell-shaped at  pH 6, with maximal a c t i v i t y  being observed at  
around 200mM. chloride, while at pH 8.5 there appears to be a plateau 
around this value, with a c t i v i t y  subsequently r is ing  once more. The 
l a t t e r  phase is reported (154) to be dependent on ionic strength rather  
than sp e c i f ica l ly  on chloride concentration, as sulphate w i l l  also 
cause an increase in a c t i v i t y .  This f inding has recent ly  been disputed 
(149).  Shapiro and Riordan (155) have reported that  the presence of  
chloride protects a lysine residue from a lky la t ion  by formaldehyde and 
sodium cyanoborohydride, which suggests that  the chloride may be 
closely associated with th is  pos it ive ly  charged residue.
The mechanism of chloride act ivat ion is ,  however, not c lear .  
Activation has been described as essen t ia l , non-essent ia l , or as both 
depending on the substrate and conditions. One l i k e l y  explanation is 
that chloride can bind to the enzyme in such a way as to induce a 
sl ight  change in the t e r t i a r y  structure, causing a conformational 
change which a l te rs  the geometry of the active s i te .  The UV absorption 
spectrum of  the enzyme is dependent on chloride concentration (156) ,  
and this implies that the environment of the aromatic residues is 
altered,  in turn implying a change in the t e r t i a r y  structure.  A 
consequent change in active s i te  geometry would explain the dependence 
of chloride act ivat ion  on substrate.
The chloride dependence of  the enzyme may well be the mechanism by 
which i t  mediates i ts  action on i ts  two natural substrates: chloride
concentrations are lower in the kidney than in the rest  o f  the body, 
and this would lead to the observed predominance of  bradykinin 
degradation here, while angiotensin I I  formation would be expected to 
be the major reaction in the rest  of the body.
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2.3 A.C.E. i n h ib i t o r s .
A.C.E. can be inhibited in v i t r o  by a wide var iety  of compounds 
including metal complexing agents, the dipeptide and polypeptide 
products of  i ts  reactions with i ts  normal substrates and a large number 
of other peptides from dipeptides upwards. From the point of  view of  
producing a therapeutical ly  useful compound, however, none of these 
classes are pa r t ic u la r ly  he lp fu l .  C lear ly ,  on the grounds of  
s p e c i f ic i t y  the f i r s t  group would be unsuitable as they would in te r fe re  
with metal ions in environments other than the A.C.E. molecule,  
including other metalloenzymes, probably giving more unwanted than 
desirable e f fec ts .  Small peptides are in general only poorly bound to 
the enzyme, and are thus o f  l im ited use c l i n i c a l l y ,  while larger  
peptides are broken down in the gut, meaning that they cannot be given 
o r a l ly ,  which is a d is t inc t  disadvantage.
The f i r s t  inhibitors of  ACE to show promise as potential
therapeutic agents were the bradykinin potentiat ing snake-venom 
peptides f i r s t  isolated from the venom of  Bothrops ja ra raca ,  the
Braz i l ian "arrowhead" viper,  Agkistrodon halys Blomhoffi i ,  the Japanese 
p i t  v iper ,  and other Bothrops species. Intensive work in the s ix t ies  
led to the isolation and character isation o f  a number o f  these 
bradykinin potentiat ing agents, see table 2 .3 .1 .
The most inherently powerful in h ib i to r  of  this group o f  compounds 
is SQ 20475, but this compound also acts as a substrate fo r  the enzyme, 
and thus has a very short duration o f  action, and in terms of  
therapeutic action the nonapeptide SQ 20881 was found to be more 
e f fe c t iv e .  A large number of analogues of  these peptides were 
synthesised and tested for  bradykinin potent ia t ion and in h ib i t io n  of
angiotensin I I  formation in a var ie ty  of  in v i t r o  and in vivo assays
without any s ign i f icant  improvement on the a c t i v i t y  of  the o r ig ina l  
snake-venom peptides. The peptide SQ 20881 has been employed 
c l i n i c a l l y  in the treatment of  cer tain types o f  hypertension.
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Table 2.3.1  
Snake venom peptide inh ib i tors  of ACE
p t p tl df S t c u c t u r o Ac t l v i
e p A C C  I
SQ 204 7 • rp*« < G l u - L y * - T P- 1 - - r t o 7 3 - 9 0 0 1 5 7
SQ 2 0 < < 8 r p 9 « < C l u - T r p - P ( 0 - A f 9 - P f 0 - C i n - I • - c o - P t o 1 00 10 0 1 5 7
SO 2 0*5 • P P 1 0 « < G l u - S « r - T « p - P t o - C l y - P c o - A * n - I • - l o - P r o 20 1-4 1 5 7
SQ 7014 8 P P 1 0 b < G l u - A » n - T t p - P r o - A r < j - F r o - G l n - I • - t o- P t o 2 4 2 2 - 3 4 1 5 7
SO 20 5 B PP l Oc < G l u - A » n - T r p - P r o - H 4 » - P t o - C l n - I • - i o ' F i o 1 1 4-16 1 * 7
1 B P P l O d < G l u - G l y - A r ^ “ P * o - P r o - C l y - P r o - P o- U - P r o 0 . 0 05 - 1 5 4
BPP1 1 # < G l « - G l y - t « u - P r o - P t o - A r q - P f o - L y » - I • - I 0- P ( 0 5-70 1 9 1 5 B
6PP1 lb < G l u - L y i “ T r p - A i p - P r o - P r o - p f o - V i 1- s • - c o - P r o .04-1 .00 1 1 5 «
1
1 BPP1 1 c < G l u - C l y - L # g - P r o - P ( o - G l y - P f o - P ( o - I • - ( 0 - P ( 0 3-5 1 - 6 1 5 1
; SO 2 0 6 6 1 BPP1 Id < C l u - T r p - P r o - A r 9 - P r o - T h r - P r o - G I n - I • - t o - P r o < 11- 1 9 157
SO 20 7 1 8 BPP1 3 ♦ < G l u - G l y - G l y - T c p * P r o - A r ^ “ P f o - G l y - P f o - C l g - l •- r o - P i o 39- 4 9 4-13 1 5 7
A c t i v i l l • t * r  * • 4 « u c « d th« i t o o U  t u i c U  c o n l i i c u U 4 C ton © t  t> r * d y k i n t n IBP) or i i h i b i t i o n
o| *n<?i c c n v « r t i n q  « n i y a «  ( A C t  I I . A c t i v i t m  «r« « i p r « S i d os p o r c t n t i ^ o i  o t  t hat of B P P 9«  .
P o p t i d o s  w i t h o u t  «n SQ n u a b i r  «t« i t o U t a d  f rot A q k i s t r o d o n  h a l y i  B l o a h o H  i i .
While potent and specif ic inhib itors o f . A . C . E . ,  the snake venom 
peptides and the ir  synthetic analogues are fa r  from being ideal 
therapeutic agents. Due to the ir  large size and th e i r  peptidic nature 
they are not o ra l ly  act ive ,  but must be administered by in jec t ion .  In 
addit ion,  due to the i r  large size and complexity they almost ce r ta in ly  
have a degree of secondary and t e r t i a r y  structure,  and the structure-  
a c t iv i t y  relationships obtained by study of the e f fe c t  of  substitut ion  
of amino-acid residues can only be interpreted in very vague terms.
Probably the largest  breakthrough to date in the search fo r  an 
o r a l ly  act ive ACE inh ib i to r  occured with the rea l is a t ion  that  the 
enzyme is a peptidase which exhibits great s im i la r i t i e s  with othe z inc -  
containing peptidases, in par t icu la r  carboxypeptidase A and 
thermolysin, both of  which have been c rys ta l l ised  and whose structures  
have been obtained by X-ray crystal lography, both in the native state  
and with inh ib itors  bound in the act ive s i te ,  and whose mechanisms of  
catalysis have been well characterised by detai led k ine t ic  studies.
Ondetti et  al (159) postulated that a very close analogy could be 
drawn between the active si te o f  carboxypeptidase A and ACE. 
Carboxypeptidase A is a zinc-containing peptidase which cleaves a 
single carboxy-terminal amino-acid from a wide var ie ty  of  peptide
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substrates, and can also act as an esterase. Since peptidases often 
f a l l  into classes with respect to their  mechanism of action, i t  was 
suggested that the active sites of the two enzymes might possess 
essent ia l ly  the same gross structural features,  with a carboxy binding 
moiety for the carboxy-terminal carboxyl group, a zinc-containing group 
near the sc issi le  bond, and subsidiary binding sites fo r  amino-acid 
side chains. The major difference between the two enzymes was assumed 
to be that in carboxy-peptidase A the carboxy binding group and zinc 
moiety are separated by an amount which w i l l  accommodate a single  
amino-acid residue, while in ACE the separation is suitable  to contain 
a dipeptide un i t ,  hydrolysis at the penultimate rather  than the 
terminal residue being the consequence of th is .
Studies based on this simple model rap id ly  revealed that the 
presence of  a hydrogen-bond acceptor between the carboxy terminus and 
the zinc-binding group is necessary to convey high a f f i n i t y  on a 
compound, implying the presence of a hydrogen-bond donor on the 
receptor.  A schematic diagram of this s impl i f ied  act ive s i te  with a 
bound inh ib i tor  is shown in f igure  2 .3 .1 .
Figure 2.3.1
This postulation of a r e a l is t i c  model of the main features of the 
act ive s i te  of ACE rapidly precipita ted the synthesis and test ing o f  a 
large number of  compounds designed with the specif ic  intent  of
interacting with the model active s i te .  I t  was known from studies of  
the snake venom peptides that the teminal sequence Ala-Pro usually  
conveyed high a f f i n i t y  on a substrate or in h ib i to r ,  although the
dipeptide i t s e l f  is quite a poor inh ib i to r .  I t  was reasoned that  
coupling such a grouping to a species capable of  binding t i g h t l y  to the
zinc atom should give rise to an e f fec t ive  in h ib i t o r ,  and th is  is
indeed the case. This l ine of reasoning led very d i r e c t l y  to the 
development of  the f i r s t  o r a l ly  active ACE in h ib i to r  to be used
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c l i n i c a l l y ,  c a p to p r i l ,  f igure  2.3 .2 .
Captopri1 
Figure 2 .3 .2
A large number of  similar compounds, essent ia l ly  dipeptide mimics 
with a zinc binding moiety, have been investigated with a view to 
enhancement of  a c t i v i t y ,  and the results of  in v i t r o  testing of  such 
compounds provide a large body of  data from which i t  may be possible to 
derive a reasonable picture of the act ive s i te  between the sc iss i le  
bond and the carboxy terminus.
I t  is worthwhile at this point to summarise these data and the 
s t r u c tu re -a c t iv i ty  relationships obtained from them, and investigate  
the amount o f  var ia t ion  that the act ive s i te  can accomodate.
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i ) Zinc bindi ng 1i gand .
There Is room for considerable f l e x i b i l i t y  in th is portion of the 
molecule. The mercapto group is the most common zinc ligand in the 
compounds studied, for example captopri l ,  compound 1, but is by no 
means the only po s s ib i l i ty ,  as shown by compounds 2 and 3. The very 
low a c t i v i t y  of compound 4 i l l u s t r a te s ,  not surpris ingly ,  that  
compounds unable to ionise to give a negative charge to in teract  with 
the pos i t ive ly  charged zinc are unl ikely to be good inh ib i to rs .
Compound Act iv i ty  Reference
P^o
o
7.64 153
COT 0
8.92 160
3 161
HO
0
4 2.37 162
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i i )  Hydrogen bonding acceptor.
Compound 5 i l lu s t ra te s  that the lack of  this function is highly
deleterious to a c t iv i t y ,  though i t  need not be a peptide, or even a
carbonyl group, as shown by compounds 6 and 7. The specif ic presence
of a peptide l ink or hydrogen-bond donor is shown to be unnecessary by 
the carbocyclic compound 8 and the ester 9. This function appears to 
be obl igatory ,  the author being unaware of any reports of  e f fe c t iv e
inhib itors  which lack some type of  hydrogen-bond acceptor in th is  
region.
Compound A c t iv i ty  Reference
P l s o
5
CO;
3.19 163
0'
2.96 163
0
7 5.62 163
8 4.96 163
0
9 6.15 163
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i i i ) Carboxy termi nus
Ester i f ica t ion  or removal of the carboxy-terminal carboxyl group 
great ly  reduces a c t i v i t y ,  as shown by compounds 10 and 11, but 
replacement with other acidic groups such as te t ra z o le ,  phosphate, 
hydroxamate has a f a i r l y  small e f fe c t ,  compounds 13 -  15. This is 
consistent with ionisation and formation of a sa l t  l ink  with a 
pos it ive ly  charged residue at the enzyme active s i te .
Compound A c t iv i ty  Reference
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S c?j °10 4.77 164
0 u
11 “S' '  3.62 165o
0
T O 3 H 2
12 6 .5 9  166
0
CONHQH
13 S 7.66 166
n
14 ^  11 V N 5.77 166
Addition of  a second carboxyl group or rad ica l ly  a l te r in g  i ts  posit ion  
( fo r  example by a l te r ing  the configuration of  the chiral  centre in a
41
prol ine terminus) have a deleterious e f fe c t  on a c t i v i t y .  These points 
are i l l u s t r a te d  by compounds 1 5 - 1 7
Compound Ac t iv i ty  Reference
P^so
0
11 f215 2.75 162
0
- c /  / ^ c o r 2
16 5 ^  ^  2 3.31 162
0 c?i
17 ~ I 4.17 162
H
The 17 compounds described, along with many others (reviewed in 
re fs .  145 and 166) serve to i l l u s t r a te  the broad features o f  the act ive  
s i te .  Addit iona l ly ,  there is a large body o f  data ava i lab le  in the 
l i t e r a t u r e  fo r  dipeptide inhibitors which, due to the lack of  an 
e f fe c t iv e  zinc binding l igand, tend to be much weaker in h ib i to r s ,  but 
which might provide valuable information about the act ive s i te  in the 
region of the carboxy terminus.
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2.4 Structure of the Active S i te .
A further  clue to the structure of the active s i te  can be gained 
from a knowledge of the residues which are essential  for the ca ta ly t ic  
a c t i v i t y  o f  the enzyme. Studies with agents for  the specif ic  
modification of amino-acid residues (167) have shown that a lky la t ion  of  
h ist id ine  residues and reduction of disulphide groups have no e f fe c t  on 
a c t i v i t y .  However, there appear to be essential  arginine,  tyrosine,  
lysine and glutamate/aspartate residues present at the act ive s i te  
whose modification results in the complete loss of  hydrolytic  
a c t i v i t y .  These are the same residues necessary fo r  hydrolytic  
a c t i v i t y  in carboxy-peptidase A. I t  is thus instruct ive  at th is  point  
to examine in more deta i l  this active s i te ,  and the roles o f  the 
various functional residues.
The structure of  carboxypeptidase A has been determined by X-ray  
crystal lography (168),  and the structure of the act ive s i te  is thus 
known in some d e ta i l .  The terminal carboxyl group forms a s a l t  l inkage 
to an arginine residue, Arg-145. This brings the oxygen atom o f  the 
carbonyl group at the scissi le  bond into the v i c i n i t y  of  the zinc atom. 
Polarisation of the carbonyl group by the zinc promotes nucleophi l ic  
attack at  the carbon atom, e i ther  by an aspartate residue or by a 
hydroxyl group, possibly activated by coordination to the zinc with 
Asp-120 acting as a general base. There is evidence in the l i t e r a t u r e  
fo r  both possible mechanisms, the l ike l ihood being that both can occur 
under d i f fe ren t  circumstances. Assuming that at tack is by a hydroxyl 
group, the si tuation is then as depicted in f igure  2.4.1
A possible role for the essential tyrosine residue Tyr-248 is that  
i t  acts as a bridge for transfer of a proton from oxygen to nitrogen,  
f igure  2 .4 .2 ,  to give R-C02 and R'-NH2 as leaving groups, a more 
energet ica l ly  favourable situation than R-C02H and R'-NH-  obtained 
without the proton transfer .
Zn24
0"
H
Figure 2 .4 .2
I t  may be that  the i n a b i l i t y  of ACE to hydrolyse peptides with a
penultimate proline residue is due to interference with this proton
transfer  step, though the author is unaware of  any experimental
evidence to support th is .
In a recent paper (169) ,  Nakagawa and Umeyama have performed CNDO/2 
and ST0-3G molecular orb i ta l  calculations on a model o f  the active s i te  
with a view to elucidating a possible role  fo r  the carbonyl group in a 
"slid ing" mechanism in which i n i t i a l  binding of  the substrate is
followed by movement along the active c l e f t  by binding to a series of
arginine residues, Arg-71, Arg-127, Arg-145. The presence of  the
carbonyl would be expected to lower the energy bar r ie r  fo r  t ransfer
from one arginine to the next by a hydrogen-bonding in te rac t ion .  There 
is no d i rec t  evidence for  such a mechanism, but the calculat ions show 
quite c lea r ly  that presence of the carbonyl group lowers the act ivat ion  
energy fo r  the transfer  o f  the substrate from one arginine residue to 
the next quite markedly. I t  may be that  a s imi lar  mechanism operating 
in ACE may account for  the greatly improved binding o f  compounds with a 
hydrogen-bond acceptor in a suitable posit ion that  was mentioned 
e a r l ie r .
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2.5 A Postulated Act ive S ite  f o r  ACE.
The constancy o f  essential  c a ta ly t ic  residues between ACE and 
carboxypeptidase A suggests that the mechanism of  hydrolysis may be the 
same in both enzymes, with the functional residues performing similar  
functions. I t  was thus decided to base a model for  the act ive s i te  of  
ACE on the known structural features of that of  carboxypeptidase A.
The t ig h t  binding of  substrates with the Ala-Pro sequence at the 
carboxy terminus, and the fac t  that a number of  extremely e f fec t ive  
inh ib i tors  are based on i ts  skeleton suggest that the mutual 
or ientat ion  of  at least  two of the v i t a l  binding groups, the carbonyl 
and carboxyl groups is such that they in te rac t  e f fe c t iv e ly  with the 
active s i te .  The presence of the prol ine ring is helpful since this  
essent ia l ly  f ixes the re la t iv e  posit ions of  these two groups -  any 
other amino-acid would have an addit ional degree of  rotational  freedom 
in th is  region. Addit ional ly ,  the Ala-Pro sequence is one of  those 
which appears from the k inet ic  evidence to be bound more e f fe c t i v e ly  in 
the absence of  chlor ide,  which suggests that inh ib i tors  based on i t  
might p r e f e r e n t ia l l y  in h ib i t  the degradation of  bradykinin, a property 
which was suggested e a r l i e r  might have therapeutic advantages over 
inh ib i t ion  of  both normal functions of  the enzyme. I t  was thus decided 
to use acety l-A la-Pro as a model substrate template about which to 
build the model act ive s i te .
Having decided on a model substrate,  the next problem was to decide 
on i ts  conformation when bound in the act ive s i te  in order to f i x  the 
posit ions of  the essential  residues. In the absence of any evidence 
e i ther  in favour of  or against any p a r t ic u la r  conformation, i t  was 
decided that  the most sensible approach was to use the global minimum 
energy conformation of  the model substrate.  This was obtained by 
molecular mechanics, choosing the lowest energy conformation from those 
obtained from a va r ie ty  of l i k e ly  s ta r t ing  points. The r e la t iv e  
energies were checked using semi-empirical calculations at the INDO 
level of  approximation since energies from molecular mechanics are 
based e n t i re ly  on empirical functions, and may thus be unre l iab le  in 
certa in circumstances. The lowest energy conformation was, however, 
found to be the same by both methods. Full geometry optimisation using
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a geometry optimising INDO programme was i n i t i a l l y  attempted, but the 
amount of  computer time required was enormous, and this method had to
be abandoned before the minimum was reached. For such large systems,
only molecular mechanics provides a computationally feasib le  method of  
geometry opt imisat ion.
Having obtained the global minimum of  the model substrate as
closely as computationally feas ib le ,  th is  was used as a template to put 
in parts of  the act ive s i te .  A guanidinium ion (representing an 
arginine residue) was placed in a posit ion such that i t  could in te rac t  
e f fe c t i v e ly  with the carboxyl group of  the model substrate; a 
methylammoniurn ( to  represent the essential  lysine residue) was placed
where one o f  the hydrogens formed a hydrogen-bond to the carbonyl group 
of  the Ala-Pro bond, since this seemed to be a reasonable role  fo r  the 
residue which has no counterpart in carboxypeptidase A. The zinc atom 
was posit ioned by s t r i c t  analogy with the crystal  structure of  the 
g lyc iny l -L - ty ros ine  complex of  carboxypeptidase A whose structure is 
known from X-ray studies (170) with
Zn -  0 = 2.236 A
Zn -  0 -  C = 110.0°
Z n - 0 - C - N =  100.0°
(see appendix C fo r  a de f in i t io n  o f  the torsion angle convention used 
in th is  work). Three ammonia molecules were placed on the zinc in a 
tetrahedral geometry to represent the zinc binding l igands. In the 
absence of  evidence fo r  the placing o f  fu r the r  residues, i t  was f e l t  
that inclusion o f  the tyrosine and aspartate residues could not be 
j u s t i f i e d ,  and i t  was hoped that in any case, these three binding 
groups should provide most of the binding energy and thus consti tute  a 
s u f f ic ie n t  model of  the active s i te .  Due to computational res t r ic t io n s  
the act ive s i te  was then represented e i th e r  as a set of  point charges 
obtained from INDO calculations on the constituent par ts,  or simply 
ignored in an e x p l i c i t  sense, jus t  providing a set o f  posit ions around 
the in h ib i to r  molecules at  which to probe the molecular propert ies.
A typical  in h ib i t o r ,  captopri l  in the postulated act ive s i te  is 
shown in f igure  2 .5 .1 .  This provided the pocket into which the
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inh ib i tors  were required to f i t  for  modelling of the enzyme -  inh ib i to r  
binding reaction in the search for  QSARs in ACE inh ib i to rs .
The "bound conformation" used in calculations was one in which the 
relevant binding groups were brought into proximity with th e i r  
counterparts on the model active s i te .  Those compounds with thio l  
groups were placed in a conformation with the sulphur -  zinc distance 
being 2.1A. This is somewhat longer than the 1.9A reported in the 
crystal  structure of  thermolysin with a bound thiol in h ib i to r  (171) ,  
but the estimated errors in the coordinates fo r  the crystal  structure  
make 2 .1A within the bounds o f  error ,  and i t  was f e l t  that  1.9A was 
u n r e a l i s t ic a l l y  short (the Zn -  S distance in dichlorobisthiourea zinc 
is 2.35A (22 9 ) ) .  Inh ib i to rs  with a carboxylate zinc l igand were placed 
in a conformation with one oxygen in a position essent ia l ly  analogous 
to the carbonyl group of  the sc iss i le  bond o f  the model substrate.
F i g u re  2 . 5 . 1
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Chapter Three 
Approximate Molecular Orbital Methods,
Were I  to await perfect ion,  my book would never be f in ished .
Lao-Tse
3.1 The necessity  f o r  Approximate Methods.
The theoretical  basis of  the LCAO-SCF approach to e lectronic
structure is well described in the l i t e r a t u r e ,  and the main pr inciples
are summarised in appendix A.
The f u l l  specif icat ion o f  the matrix elements in the secular 
determinant involves the calculat ion of a large number of  two-electron
4 3 2
integrals ((n + 2n + 3n + 2n) /8  for  a system with n
basis functions) of the form
J «Sm<l)(6n(2> J _  «Jl<1)<6s<2> dx 3.1.1
r i 2
or,  in the notation of Dirac <mn11 s>. I f  we consider a system as
simple as benzene we have 42 electrons, and we w i l l  need a basis of at  
least 42 spin o rb i ta ls  (or 21 space o rb i ta ls )  to accommodate them.
5
This gives a tota l  of  more than 2 x 10 integrals to evaluate.  In 
general we w i l l  be concerned with systems considerably larger than
4
benzene, and the n dependence of the number of integrals  required 
makes complete specif icat ion of the matrix elements an extremely
laborious task. Furthermore, and pa r t ic u la r ly  i f  we are using S later  
type o rb i ta ls  rather than gaussian expansions, the evaluation o f  a 
great many of  these in tegra ls ,  especia l ly  those involving atomic 
orb i ta ls  centred on three or four atomic centres, is extremely
d i f f i c u l t  and time-consuming, even with the aid of  a computer, making 
the task p roh ib i t ive ly  slow fo r  a system of any reasonable size.
In order to reduce the number of integrals to be evaluated there 
are various approximations that can be introduced into the ca lcu la t ion .  
Perhaps the most obvious of  these is to consider only those electrons  
in the outer shells ,  the valence electrons. In this approximation the 
assumption is being made that  the inner electrons are e f fe c t i v e ly  bound 
so t ig h t ly  to the i r  nuclei as to form a non-polarisable core which has 
no e f fe c t  on the electronic properties of  the system save to modify the
potential  due to the nucleus with which they are associated to give a
"core potent ia l"  due to a point charge of  magnitude (Z-nc) where Z is 
the nuclear charge and nc is the number of  core electrons. This
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approximation is cer ta in ly  very reasonable, and for our example of  
benzene reduces the number of  electrons considered e x p l i c i t l y  to 30 and 
the number of  two-electron integrals involved by a factor  of  about 
four.  This is c lear ly  a worthwhile saving, but s t i l l  leaves a large 
amount of computation to be done.
3.2 The Zero D i f fe re n t ia l  Overlap (ZDO) Approximation.
Many of  the integrals of  the type shown in equation 3.1.1 have 
values very close to zero, in pa r t ic u la r  those with m, n, 1, s 
associated with three or four atomic centres.
A useful approach in developing approximate SCF methods is to 
systematically  neglect electron repulsion integrals having uniformly 
small values, and this can be done by means of the zero d i f f e r e n t i a l  
overlap (ZDO) approximation (172) whereby such integrals are assumed to 
be neg l ig ib ly  small. Under the ZDO approximation
<mnlls> = <mm111>6 6, 3 .2 .2mn 1 s
where 5.^ is the Kronecker delta (6.^ = 1 for  i = j ,  otherwise 0 ) .  
Applying this approximation a l l  of the integrals involving three or 
four atomic centres and a large number of  those involving two centres 
are el iminated.
Consistent with the ZDO approximation we may also el iminate o f f  
diagonal one-electron integrals
s lk  = 5lk  3 ‘ 2 ’ 3
H1 k = slk 3 -2 ' 4
Equation 3 .2 .3  is a convenient approximation since i t  allows the 
secular equations (A5.6b) to be fur ther  simpli f ied
E (Hlk  -  = 0 A5.6b
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giving the standard eigenvalue problem
3.2.5
or in matrix notation
H -  e.Sl  = 0 3 .2 .5a
where e is the diagonal eigenvalue matrix.
Such a s t r i c t  application of  the ZDO approximation means that there 
is no mixing of  o r b i ta ls ,  so the atomic o rb i ta ls  become the molecular 
o r b i ta ls .  C lear ly  th is is unsatisfactory,  and i t  is necessary to 
reta in  some of the effects of  d i f f e r e n t ia l  overlap to obtain even a 
rudimentary description of  chemical phenomena. For th is  reason 
equation 3 .2 .4  is not applied. The o f f  diagonal (1 *  k) elements of  
the Fock matrix,  otherwise known as resonance integrals 13  ^ carry the 
essence o f  covalent binding into the formulation of the method.
In the methods of in terest  to this study the resonance integrals  
are included semi-empirical ly .  This has to be done in a manner that  
retains rotat ional  invariance (173) .  This is done by assuming that the 
integrals B ^  are proportional to the overlap integrals which
can be shown to transform correc t ly .  Provided that the proport iona l i ty  
constant is the same for  a l l  pairs of o rb i ta ls  on the respective atomic 
centres, rotational  invariance is maintained, so the matrix elements 
can be wri t ten
where B^B is a constant character is t ic  of  the nature o f  atoms A 
and B. The assumption that the depend d i re c t ly  on the overlap of  
the o rb i ta ls  in question was f i r s t  suggested by Mull iken (174) ,  and is 
e n t i re ly  reasonable as i t  would be expected that  the capacity of  a pair  
of atomic o rb i ta ls  to form a molecular o rb i ta l  would increase in l ine  
with the extent to which they overlap.
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To reduce the need for empirical parameterisation, including 
d i f fe r e n t  &AB parameters for  a l l  possible pairs of  atoms, the 
proport ional ity  constant is defined as
6 ° b = 1 / 2 ( 13°  + 13° )  3 . 2 . 7
where the individual 13 values are simply parameters chosen to give
reasonable agreement with experimental results or accurate
calculat ions.  I t  is worth pointing out that the values of I3AB could 
be allowed to depend on the internuclear separation r AB without  
v io la t ing  the rotational  invariance condition, and this could have 
major repercussions where one of the variables in a set of  calculat ions  
is the molecular geometry. The implications of  this are discussed in 
the section on geometry optimisation (3 .4 ) .
One further  approximation needs to be made to the two-electron  
integrals  to maintain rotational invariance. In the same manner as for  
the resonance integrals i t  is necessary that non-neglected two-electron  
integrals  of  the form <mm111 > depend only on the nature of the atoms 
to which the o rb i ta ls  are attached, and not on the type of  o r b i t a l .  
Thus
<mmll1> = yab m on atom A, 1 on B. 3 .2 .8
Yab, the "coulomb integral"  is thus an average energy of  in teract ion  
between any electron on atom A and any electron on atom B.
The method as described so fa r  corresponds to the CNDO (complete 
neglect of  d i f f e r e n t ia l  overlap) method due to Pople, Santry and Segal 
(175) .  This method gives reasonable resul ts for  a wide va r ie ty  of  
properties including geometries, dipole moments and the q u a l i ta t iv e  
ordering of energy levels.  I t  does not, however, make sa t is fac tory  
allowance for  the d i f fe ren t  interactions between electrons o f  pa ra l le l  
and a n t ip a ra l le l  spins, p a r t ic u la r ly  when both electrons are associated 
with the same atom. The antisymmetry of the wavefunction requires that  
electrons of para l le l  spin may not occupy the same small region of  
space, and consequently i f  two electrons are in d i f fe re n t  o r b i ta ls  on 
the same atom they w i l l  have a lower energy of  interaction i f  they have
52
para l le l  spin (c f .  Hund's ru les (176)>. These interact ions are
characterised by integrals of the form
J* _ L  <Mn dT m*n 3 .2 .9
r i 2
These integrals are neglected in the CNDO approximation, and a l l  
interactions between d i f fe re n t  electrons on the same atom are replaced
by yAA, the one-centre coulomb in tegra l ,  regardless of th e i r  spin.
In consequence, such calculations are unable to give a correct account
of the separation of  states ar is ing from the same configurat ion, for
3 1 1  2 2 2
example the P, D, S states of the Is 2s 2p carbon
atom. In any s i tuation where electron spin is of in terest  CNDO gives
poor results ,  for  example in aromatic radicals i t  cannot lead to any
spin density in a o rb i ta ls  as is found with accurate calculat ions.
The simplest proceedure reta in ing rotational invariance which can 
take into account the relevant interactions is to re ta in  monatomic
d i f f e r e n t ia l  overlap in the one-centre case. This leads to the 
inclusion of one-centre two-electron integrals of  the form
J 0m$n J _  <Mn dT m*n 3 .2 .10
r i 2 m,n on same atom
This proceedure, the INDO (intermediate neglect of  d i f f e r e n t ia l
overlap) method due to Pople, Beveridge and Dobosh is described in
reference 177. In th is formulation only the yAA are calculated  
e x p l i c i t l y  from the basis functions, and other required integrals  must 
be included as semi-empirical parameters derived from spectroscopic
data. The computer programmes used in this study use the INDO level of  
approximation, but contain routines which calculate a l l  of  the 
necessary integrals d i re c t ly  from the basis functions (178) ,  reducing 
the need for  parameterisation and extending the scope of  the programme 
beyond the f i r s t  short period of  the periodic table as is usually the 
case.
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3.3 Indices Used In This Study.
In pr incip le  the molecular wavefunction can be used to calculate  
any property of  interest  in a given system. The pa r t ic u la r  
interactions which may be s ign i f ican t  in drug-receptor binding 
reactions have been discussed in section 1.6,  and i t  now remains to 
examine ways in which the calculated molecular wavefunction can be used 
to provide indices which wil l  be of in terest  in a QSAR treatment of  a 
series of  molecules.
Before considering the calculation of any of  these in deta i l  i t  is 
worthwhile to consider the formulation of one p ar t icu la r  matrix which 
is widely used in molecular o rb i ta l  studies and w i l l  be of p a r t ic u la r  
u t i l i t y  in calculat ing such indices, namely the f i r s t - o r d e r  density  
matrix,  usually referred to simply as the density matrix.  This matrix,  
defined ( fo r  the closed shell case) as
where the c.^ are MO coeff ic ients  and the summation is over a l l  
occupied orb i ta ls  (the factor of 2 arises from the double occupancy of  
the o r b i t a ls ) ,  gives a re f lec t ion  of  the electron density d is t r ib u t io n  
of the system ( re la ted ,  of course, to the square of the wavefunction) 
in terms of  the set of atomic o rb i ta ls  which make up the basis set.  
Diagonal elements give the expectation value of the occupancy of  the 
orb i ta l  in question while off-diagonal elements give a measure o f  the 
degree o f  bonding between two o r b i ta ls .  I t  is the density matrix which 
is used to give the electron d is t r ibu t io n  in the i t e r a t i v e  solution of  
the secular equations.
In chapter 1 the various interact ions involved in drug-receptor  
binding were out l ined , along with other quantit ies of  in te res t  such as 
molecular size,  the e f fec t  of  drug molecule conformation, the e f fe c t  of  
d ie le c t r ic  constant and the hydrophobic properties of  the molecule. 
The calculation of indices designed to r e f le c t  trends in these 
quant i t ies ,  where appropriate from the molecular wavefunction, w i l l  now 
be discussed in more d e ta i l .
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i )  Electrostat ic  interact ions.
I t  was seen in section 1.6 that a very large contribution to the 
binding energy of  a compound to a receptor w i l l  be due to the
interact ion of  par t ia l  charges on the atoms of the drug molecule with
those on the receptor molecule. I t  is thus of paramount importance to
extract  information about the par t ia l  charges present on the drug
molecule from the wavefunction. The most common method of obtaining  
this information from a molecular o rb i ta l  ca lculat ion is the Mulliken  
analysis (179).  This is a very simply programmed and mathematically 
well defined index which is often considered to give the tota l  charge 
on an atom. In physical terms, however, the meaning of  the Mull iken  
analysis is not as simple as th is .  The Mu 11 iken charge on an atom is 
defined by
and is thus simply a sum of  the diagonal elements of  the density matrix 
for  a l l  o rb i ta ls  centred on the atom in question. Since the atomic 
orb i ta ls  are three dimensional functions which spread over a l l  space, 
the in te rpre ta t ion  of the numbers obtained in this way as atomic 
charges is rather  opt im ist ic ,  though i t  is not e n t i re ly  u n ju s t i f ia b le  
as the atomic orb i ta ls  are centred on the par t icu la r  atom and f a l l  o f f  
with distance. I t  is ,  however, a point that should be borne in mind 
when examining the resul ts of a ca lculat ion.
One obvious a l te rna t ive  to the Mul1iken analysis fo r  obtaining the 
charge associated with a par t icu lar  atom in a molecular system would be 
to define a sphere centred on the atom and simply sum a l l  o f  the 
electron density inside that sphere by adding the contributions from 
a l l  atomic o rb i ta ls  in the system,
This is probably much more meaningful physical ly ,  but suffers from two 
drawbacks. F i r s t ,  the integrals required for  such an analysis are 
rather d i f f i c u l t  and time-consuming. Second, defining the sizes o f  the 
spheres introduces a degree of arbi trar iness into the analysis,  making
3.3.2
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the numbers obtained less well defined mathematically. C lear ly  this
arb i trar iness  is something that should be avoided, at least  unt i l  the 
"size" of  an atom, or the size of  the sphere over which the integrat ion  
takes place, has been unambiguously defined. For these reasons the 
Mu 11 iken analysis was employed in this work to give an indicat ion of  
the charge on an atom. Comparisons between the two methods of
obtaining atomic charges (180) have shown that there is a good 
corre lat ion between the numbers obtained, even i f  the absolute values 
d i f f e r  quite markedly.
i i )  Dipole-dipole interactions.
In addition to simple e lec t ro s ta t ic  interactions, i t  was noted in
section 1.6 that a property which may be of  interest  is the molecular
dipole moment. As well as dipole -  dipole interact ions when the 
substrate or inh ib i tor  is bound in the active s i te ,  the a -h e l ic a l  
backbone of  a protein provides a very large dipole moment (181) ,  and 
the interaction of this with the dipole moment of an incoming species 
may play an important role in the or ientat ion  of that species, guiding 
i t  into  a suitable posit ion for  e f fe c t ive  binding to the act ive s i te .  
Consequently, the magnitude of the molecular dipole moment (and i ts  
square), and i ts  components along the cartesian axes are included as 
indices in the current work.
Dipole moments calculated at the INDO (or CNDO) level of  
approximation are calculated as a sum of  two contributions,
11 = ^chg + ^hyb 3 ‘ 3 ‘ 4
^chg s^mP ^  *he contribution due to the part ia l  charges on the 
various atoms in the system (obtained from a Mulliken ana lys is ) ,
t'chg " 2 -M16|  V a 3 - 3 ' 5
where r  is the position vector of the nucleus in question and Q i ts  net 
charge, while p  ^  ^ is a hybridisation term which accounts fo r  the 
s h i f t  o f  electron density away from the atomic centres of  non-hydrogen 
atoms, depends on one-centre,  o f f  diagonal terms in the density
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matrix,  and is made up of  terms such as
“ hyb ■ 14-674J r ' P2s2p 3 -3 ' 6
where C is the orb i ta l  exponent of the orb i ta l  in question. The
factors 2.5416 and 14.674 are simply to convert from atomic units to 
Debyes.
Dipole moments calculated at this level of approximation in this
manner tend to be s l ig h t ly  overestimated for  polar molecules (182) ,  but 
generally show correct trends within a series of  compounds, and
deviations from observed values are very often less than those observed
with more sophisticated calculations.
i i i )  Hydrogen bonding.
I t  was noted in section 1.6 that hydrogen bonding is large ly  an
e lec trosta t ic  phenomenon. Thus the tendency of an electronegative atom 
to act as a hydrogen bond acceptor w i l l  be ref lected to a large degree 
by i ts  charge, atoms with a large negative net charge being l i k e l y  to 
be better acceptors than those with a charge closer to zero.
S im i lar ly ,  the tendency of  a hydrogen atom attached to an
electronegative atom to act as a hydrogen bond donor w i l l  depend on i ts  
charge, with a r e la t i v e ly  large posit ive charge favouring hydrogen bond 
formation. These trends w i l l  be ref lected in the Mulliken analysis for  
a set of molecules, and the Mulliken charges of  donor or acceptor atoms 
should thus be a useful descriptor in QSARs where hydrogen bonding is 
thought to be important.
An a l te rna t ive  approach is to consider the molecular e le c t ro s ta t ic  
potential  in the v i c i n i t y  of a par t icu la r  group. The e le c t ro s ta t ic
potential  at  a point is defined as the amount of  energy required to
bring a unit  point charge from i n f i n i t y  to that point.  Since in
hydrogen bonding the s i tuation is one where the acceptor atom is in the 
region of a pos it ive ly  charged hydrogen atom (which could to a f i r s t  
approximation be considered to be a point par t ia l  pos i t ive  charge),
then i f  a l i k e ly  position for the donor atom can be found, the 
e lec tros ta t ic  potential  at  that point should r e f l e c t  closely  the
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tendency of the molecule to form a hydrogen bond to a hydrogen atom 
situated there, the lower the e lec t ros ta t ic  potential  the greater the 
tendency. Conversely, for an atom acting as a hydrogen bond donor, i f  
a l i k e l y  position for i ts  corresponding acceptor atom can be defined 
then the e lec t rosta t ic  potential  at  that point should r e f l e c t  ease of  
hydrogen bond formation to an acceptor situated at that point ,  with a 
higher e lec t rosta t ic  potential  suggesting a greater tendency to 
formation of a hydrogen bond. This is l i k e ly  to be a worse 
approximation than that involved for  the hydrogen bond acceptor since 
a point negative charge is a worse model of an electronegative atom 
than is a point positive charge of  a proton, but i t  should s t i l l  be 
useful.  In both cases, the approximation wi11 break down completely i f  
the point chosen is very close to an atomic nucleus o f  the molecule, 
but judicious choice of the location of  the point to be invest igated  
should circumvent this problem.
This approach has the advantage over the use of the Mul l iken  
analysis that i t  can take into account the d i r e c t io n a l i ty  of  the atomic 
(or molecular) orbi ta ls  involved. I t  is also a property o f  the 
molecule as a whole rather than of any par t icu la r  atom, and as such i t  
is possible to examine, for  example, the e f fec t  of  subst i tu t ing  a 
methylene group for  a carbonyl in a series o f  molecules in a way which 
cannot be done with Mulliken analyses. The method also takes more 
e x p l i c i t  account of the molecular environment of a group, that  is ,  the 
e f fe c t  of  neighbouring groups in the molecule. Calculat ion o f  the 
e le c t ro s ta t ic  potential  is,  however, considerably more time consuming 
than a Mul1iken analysis,  so i t  is necessary to r e s t r i c t  the number of  
points chosen as possible donor or acceptor s i tes ,  and th is  necessari ly  
introduces a certain degree of arb i t ra r iness ,  though hydrogen bond
geometries are generally quite well defined, making choice of  a
reasonable posit ion quite feas ib le .
There are a number of  methods of calculat ing the e le c t r o s ta t ic  
potent ia l  due to a molecule at a point in space from CNDO or INDO wave 
functions, and this study uses method 3 of reference 183. The
e lec t ro s ta t ic  potential  at  a point p with position vector r is 
defined by
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Retaining monocentric terms only (an approximation consistent with 
INDO), we obtai n
V(V ■ I ZA - I E  vp \ n  3.3.8
* m
where V™n = <mni_Limn> 3 .3 .9
P 1 i>  1
and the summation is over occupied o rb i ta ls .  The two-centre one 
electron integral V represents the interact ion between a unit  point
r
posit ive charge with posit ion vector r w i t h  a charge d is t r ib u t io n  
<mn|mn>. The evaluation of  such integrals is described elsewhere 
(184).
At the same time as the calculation of the e le c t ro s ta t ic  p o ten t ia l ,
the programme used in this study calculates the components of  the
e le c t r ic  f ie ld  ( tha t  is the derivatives of the e le c t ro s ta t ic  po ten t ia l )
along the Cartesian axes by f i n i t e  differences.
A related property to the e lect rostat ic  potential  at  the point r
r
is Ep0 ^, the energy of polarisat ion of the molecule by a unit  point
charge placed at that point.  This quantity is a second order
interact ion energy, and can be obtained by solution of  the coupled 
Hartree-Fock perturbation equations (185).  Exact i t e r a t i v e  solution of  
the equations is time-consuming, so an "uncoupling" proceedure (186) is 
used in this study. Once again, only monocentric terms are included,
and the interact ion energy is defined by
E™ l ( r J  -  2^ <2- SaR>^ P AmnlcVnn'/ i S 3 .3 .10pol -p As AB nls p p
OCC {M io c t
where Am , = 1 1  c . c  . c , . c0 .
mn' s « i nil nj 11 sj
e . -  e •
1 J
m,n are on atom A, l , s  on B, e . ,  are the o rb i ta l  energies o f  the
i ' t h  and j ' t h  o r b i ta ls ,  §AB is the Kronecker de l ta  and the c's are MO
coeff ic ients .  The A . are independent o f  r , and can thus bemnls r —p
calculated once and used repeatedly for  a number of points p. The
values of  E  ^ obtained by th is  proceedure are consistently  
underestimated, but they correlate well with those obtained by exact 
i t e r a t iv e  solution of  the coupled equations (185) .  This expression has 
been used (187,188) successfully in studies of molecular interact ions.
iv) Van der Waals' interactions.
A complete theoretical treatment of  van der Waals' interactions  
would require a consideration of both configuration in teract ion  (Cl )  
and electron correlat ion (see appendix A).  Inclusion of  Cl is 
feas ib le ,  but great ly  increases the amount of  computer time needed fo r  
a calcu lat ion ,  while electron corre lat ion is not included in the 
Hartree-Fock SCF framework. I t  is thus necessary to employ less 
rigorous methods to consider these interact ions.  I t  was seen in 
section 1.6 that the van der Waals1 in te raction between two ident ica l  
molecules can be approximated by
F = -3AEa2 1.6.3
4 r6
so quanti t ies of in terest  are exc i ta t ion  energies and p o la r is a b i1i t i e s  .
Excitat ion energies can be obtained to a f i r s t  approximation from 
the wavefunction simply as differences between the o rb i ta l  energies 
e . , and the difference in energy between the highest occupied 
molecular o rb i ta l  (HOMO) and the lowest unoccupied molecular o rb i ta l  
(LUMO)
A = Ei -  e-t 3 .3.12homo 1umo
is included in this work as an estimate of  AE
The s e l f  atom pol ari  sabi 1 i ty irr r  has been defined fo r  Huckel 
molecular o rb i ta l  calculations as
OCC uiocc. 2 2
V  = ~4£ ? cj r ckr 3 .3 .13
V 8 j
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and this can be extended for  a i l  valence electron methods simply by 
summing over a l l  o rb i ta ls  on atom A,
This quantity is included as an index of pol ari  sabi 1 i ty ,  and is 
essent ia l ly  a second order interaction energy which represents the 
extent to which the centre A becomes polarised on the approach of a
previously,  since this considers the e f fe c t  on the whole molecule 
rather than just  one atomic centre,  but i t  does require that  the 
posit ion of  the incoming "reactant" be f ixed ,  introducing a certa in  
degree of  arbit rar iness which is not found for  the extension o f  the 
simple Huckel index.
A fur ther  quantity which may be of in terest  is the mean molecular 
polarisabi 1 i ty  amo-| • ' In this work i t  is calculated em pir ica l ly  as a 
sum of  atomic contributions for  each of the atoms in the molecule, the 
contributions having been obtained by least squares analysis o f  the 
po la r isab i1i t i e s  of a wide range of  small compounds (189) .
The indices described so fa r  are those relevant to the binding of  a 
drug molecule to a receptor in terms of  the enthalpic inte ractions  
discussed in section 1.6.  In section 1.7 i t  was seen that  the a b i l i t y  
of a drug molecule to mimic the e lectronic  structure of  the t ra n s i t io n  
state fo r  an enzymic reaction is of  relevance to the t ightness of  
binding of  an enzyme in h ib i to r ,  and i t  would seem reasonable to include 
some r e a c t iv i t y  indices in the consideration o f  the QSAR o f  a series of  
molecules to attempt to ascertain the extent to which various molecules 
are capable of  behaving as t rans i t ion  state mimics. Formation o f  the 
t rans i t ion  state from the ground state reactants may involve at tack of  
e i ther  nucleophilic or e lect rophi1ic species at various points around 
the molecule, and the su scep t ib i l i ty  to such at tack would seem to be a 
reasonable quantity to include.
Ortft OCX UAoGC.
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charged reactant.  A more r e a l i s t i c  index is Epol descri bed
v) Miscellaneous indices.
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In general an electrophi 1 ic species w i l l  in teract  with the highest  
occupied molecular o rb i ta l  (HOMO) while a nucleophile w i l l  in teract  
with the lowest unoccupied molecular o rb i ta l  (LUMO). Examples of these 
types of  interaction would be the postulated binding of the zinc moiety
to the carbonyl oxygen and nucleophilic attack on the carbonyl carbon
of substrates (or substrate mimics) of angiotensin converting enzyme as 
described in chapter 2.
Two indices which give an indication of s us cep t ib i l i ty  to such 
attack are the so-called f ro n t ie r  o rb i ta l  electron densit ies f^ and 
f^ .  These are defined as
f N = f c ^ h 3.3.14a
f E = 1 3.3.14b
where the summation runs over a l l  o rb i ta ls  on the atom in question, h
refers to the HOMO and 1 to the LUMO. In physical terms f^ can be 
thought of  simply as the electron density associated with the atom in 
question due to the HOMO, while f^ re f le c ts  the a b i l i t y  of  the LUMO
at that  atom to accept electron density from an attacking nucleophile.  
f £ and f^ as defined here are simply a l l -va lence  extensions of  the 
f ro n t ie r  electron densities o r ig in a l ly  defined for simple Huckel 
calculations (191).
C lear ly ,  closely associated with s u s cep t ib i l i ty  to e le c t r o p h i l i e  or
nucleophil ic attack on a molecule w i l l  be the energies o f  the HOMO and
LUMO, which are given simply by the eigenvalues e. .  I f  the HOMO is
very t ig h t l y  bound ( tha t  is i f  i t  has a large negative energy) then
transfer  of electrons to an incoming electrophi le w i l l  be a less
favourable process than i f  the HOMO were more loosely bound (higher in
energy). In a similar manner a LUMO of  high energy renders a system
less susceptible to nucleophilic attack than a LUMO of low energy. For
this reason e, and en  are included as indices in th is  study.homo 1 umo J
I f  the re a c t iv i t y  o f  the molecule in i ts  f i r s t  excited state is of
relevance then the lowest excitation energy, which w i l l  be approximated
by e .    -  c i   already mentioned in the context of van der Waals'J homo 1umo J
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interactions w i l l  be a quantity of in te re s t .  C lear ly ,  this takes no 
account o f  the d is t inc t ion  between singlet  and t r i p l e t  excited states,  
nor does i t  al low for  rearrangement of  the electronic d is t r ib u t io n  upon 
excitation. I t  is ,  however, much simpler and quicker than repeating 
the calculation for  the excited states and taking the energy difference  
(where we may be doubling the er rors ) ,  and is probably bet ter  than no 
attempt to include the quantity at a l l .  The inverse of th is quantity  
is also included as i t  w i l l  be the dominant term in any second order  
interaction.
The contribution to the drug-receptor binding energy due to 
twisting the drug molecule from i ts  global minimum energy conformation 
to that which binds to the receptor can be evaluated by comparing the 
total  energy fo r  the molecule in the two d i f f e r e n t  conformations. This 
requires that  two calculations be performed for  each molecule, but in 
the l ight  of  the importance of  this quanti ty  i t  was f e l t  that  the use 
of computer time was j u s t i f i e d .  The to ta l  energy of  the system using 
the INDO approximation can be part it ioned into diatomic and monatomic 
contributions,
where PAA is the electronic charge on atom A, P^v are density
matrix elements, VAB is the potential  of  these electrons due to the
core of atom B, ZA is the core charge on A, R is the A-B distance,
and other terms are as previously defined. The diatomic p a r t i t i o n  of
Etotal 3 .3 .15
where
3 .3.16a
U being the core in tegra ls ,  and 
PP
EAB " Ji U (2PpvB]iv (1-/ 2 * PiavYab*
+ zaz br paavab pbbv ba 3.3.16b
+ PAAPBByAB
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the energy for  a par t icu lar  pair  of atoms gives an indicat ion of the 
degree of bonding between them. The programme used for  ca lculat ion of  
most of  the properties considers a series of  molecules as a common core 
with associated substituents, and for  the common core a l l  of  the
diatomic contributions were examined to ascertain which pairs of  atoms 
were d i rec t ly  bonded, the c r i te r io n  for  deciding being that the energy 
par t i t ion  be less than - 3 .0  eV. For a l l  pairs of atoms fo r  which this  
was the case, the interact ion energy was included as an index, since 
the strength of the bond between two atoms should r e f l e c t  the 
re a c t iv i ty  of  the molecule in that v i c i n i t y .
The change in the diatomic part of  the energy as molecular geometry 
varies enables the method to be used to optimise the geometry of  the 
molecule such that the calculated to ta l  energy is a minimum. This use 
is discussed in the next section. The use of  the monatomic part  is
discussed below.
The binding energy ( tha t  is the tota l  energy minus the sum of
atomic energies) for  each molecule was also included as an index. This
roughly corresponds to a thermochemical heat of formation fo r  the 
compound, and as such can be considered to be a general guide to the 
s t a b i l i t y  of the compound. This is probably not of a great deal of  
relevance to this study, but for  i r rev e rs ib le  inhib itors  or drugs where 
covalent bond formation is thought to be important,  the r e f le c t io n  in 
this quantity of the general r e a c t i v i t y  of  a molecule may make i t  of  
some use.
A further  index which gives an indicat ion of the r e a c t i v i t y  at a 
part icu lar  centre is the atomic binding energy. This is a rather  
a r t i f i c i a l  quantity which represents the energy which would be 
required to adiabatical ly  remove the atom in question from the 
molecular framework and remove i t  to i n f i n i t y .  C lear ly ,  the less 
energy required for  this process, the more react ive the centre being 
considered, so for  a series of compounds E^ind may give an indicat ion  
of  r e a c t iv i t y  at a par t icu la r  centre.  The atomic binding energy is 
given by the monatomic part of  the to ta l  energy described above.
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A quantity of  in te res t  by vi r tue of i t s  importance in the Born 
continuum model for  calculat ing solvation energies (191) is the to ta l  
e lec trosta t ic  energy E  ^ the Born model, when an e le c t r ic
charge d is t r ibut ion  of  potent ia l  energy E  ^  ^ is immersed in a 
d ie le c t r ic  medium, the change in energy (assuming that no 
red istr ibut ion  of  charge takes place) is given by
Es o l v = <£=12 Es t a t  3 . 3 . 1 7
2e
From the v i r i a l  theorem, the potential  ( e le c t r o s ta t i c )  energy is simply 
twice i ts  tota l  energy. The binding energy (defined above) is the 
energy of the molecule below that  of  i ts  constituent atoms in th e i r  
neutral ground states. Hence by adding the Hartree-Fock ground state  
energies of each atom to the binding energy, the to ta l  energy of  the 
molecule below that  o f  the nuclei and electrons separated at i n f i n i t y  
is obtained. Doubling this gives an estimate of  E  ^  ^ which includes 
the exchange in teract ion  considered in the SCF method, although i t  
takes no account o f  electron correlat ion .
The quantit ies described so fa r  are a l l  concerned with the 
enthalpic terms of  sections 1.6 and 1.7.  I t  is possible using the 
techniques of s t a t is t i c a l  mechanics to evaluate entropic properties  
from the results of  SCF calculations, but in the l ig h t  o f  the major 
contributors to the entropic terms, i t  seems reasonable to attempt to 
include some empirical parameters to account fo r  these ra ther  than go 
through a time-consuming and complex series of  ca lculat ions.
The entropy change of  the enzyme molecule would be expected to be 
essent ia l ly  constant fo r  a l l  molecules in a ser ies, and can thus be 
ignored. Likewise, the loss of  t ranslat ional  and ro ta t iona l  degrees of  
freedom w i l l  be more or less constant fo r  any series o f  in h ib i to rs .  
This leaves the loss of entropy in the in h ib i to r  due to the hindrance 
of  internal ro ta t ions ,  and the change in entropy of  the solvent.
A very naive method to consider the loss o f  entropy due to hindered 
internal rotations is to simply assume that  each " f r e e ly  ro ta tab le"  
bond, that is each bond that is not a f u l l  or pa r t ia l  double bond or
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part of a r ing system, contributes the same amount to the entropy of  
the unbound in h ib i to r ,  and this is lost  completely on binding to the 
enzyme. Thus the loss of entropy on binding w i l l  depend l in e a r ly  on 
the number of f re e ly  rotatable bonds. This number was included as an 
index in this work.
The entropy changes due to the solvent can also be approximately 
t reated in a s im i la r ly  naive fashion. The number of solvent molecules 
expelled from the active s i te  on bonding of  the in h ib i to r  w i l l  depend 
on the volume of the inh ib i to r ,  so this quantity can be used to give an 
approximation to the entropy change due to release of solvent from the 
active s i te .  In this study the molecular volume was calculated 
e n t i re ly  empirically  using the method o f  Bondi (192).  The molecule is 
surrounded by a box which is divided up into 0.1A cubes. Each cube is 
then examined to ascertain i f  i t  l ies  within a van der Waals' radius of  
any of  the atomic nuclei present,  and the to ta l  volume is obtained 
simply by counting the number of  cubes which l i e  within the van der 
Waals' envelope of the molecule.
The number of  solvent molecules surrounding the unbound in h ib i to r  
w il l  be approximately determined by i ts  surface area. This quantity  
was also calculated empir ically  using the van der Waals1 envelope of  
the molecule, and included as an index in the hope that  i t  might 
r e f l e c t ,  at least to a f i r s t  approximation, the entropy change due to 
desolvation of the inh ib i to r .  The mean molecular van der Waals' radius 
was also included as an index of  molecular size.
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3.4 Geometry Optimisat i o n .
The breakdown of the tota l  energy of a system into  monatomic and 
diatomic contributions as described in section 3.3 provides a 
convenient method fo r  optimising the geometry of  the system such that  
the energy is at a minimum. For a pair  of atoms A and B the diatomic 
contribution is given by equation 3.3.16b
EAB = 1 1 (2PyvBjiv " /2 )ppvYAB>
A  V
+ W 1 -  PAAVAB -  PBBVBA 3 - 3 ‘ ,6b
+ paapbbyab
Clearly the tota l  energy gradient of  A along the A-B d irect ion  w i l l  be 
given by
ai>
dE = -ZAZBR"2 + 6y_ PaaPbB ~ I ~ PAA ~ PBB 
dR dr r  v
<mA
+ 2i38b 1 I PpvdSpv 
* dR
assuming that the density matrix is invar iant  to small changes in 
geometry, and that  dVAg/dR is dy/dR.
Thus i t  is quite feas ib le ,  having obtained the density matrix and 
the relevant gradients,  to calculate the energy gradients fo r  the 
system, and these can be used to calculate coordinate sh i f ts  which 
should lead to a geometry with a lower tota l  energy.
The condition fo r  an extremal point (minimum, maximum or saddle 
point)  in the energy is that  the matrix of the energy gradients should 
be the null matrix,
E1(x* )  = 0 3 .4 .5
*
where x represents the geometry at  the extremal point .  I f  the 
starting geometry x requires a correction ^x to get to the extremal 
point this can be rewri t ten
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E' (x + Sx) = 0  3.4.6
Expanding this as a Taylor series and truncating a f te r  the term l inear
in Sx th is  gives
E1( x + Sx) = E1(x) + E"( x)Sx = 0 3 .4 .7
Thus the corrections to the coordinates can be calculated as
S>< = -E' ( x ) / E n(x) 3 .4 .8
or more generally
Sx = -(3 E‘ (x ) /E " (x )  3 .4 .8a
where (3 is the step length. This is the general Newton-Raphson
optimisation method, and the fac t  that the Taylor series has been 
truncated means that the equations must be i tera ted  to solution rather  
than solved d i r e c t ly .
In pr incip le  i t  should be . possible to use such a method fo r  
conformational analysis,  at  least to the extent that i t  can be used to 
search fo r  the global minimum energy conformation of  a molecule.
However, the necessity of  repeating the SCF calculat ion many times
makes this approach proh ib i t ive ly  time-consuming for  a system of  any 
reasonable size,  p a r t ic u la r ly  when i t  is borne in mind that  i t  may be 
necessary to choose a number of s tar t ing  points for  the optimisat ion as 
there may be several candidates fo r  the global minimum geometry, and 
the programme searches for  the nearest rather  than the lowest minimum. 
As a tool fo r  conformational analysis,  geometry optimising SCF methods 
are thus l imited to rather small systems, and fo r  systems of  in te re s t  
to th is  work i t  was necessary to use the technique of  molecular
mechanics (described in appendix B). Molecular mechanics, being purely
empirical and based on experimental structural  data is ,  however, of
dubious value as a tool for  modelling the t rans i t ion  state fo r  a
chemical reaction since, in this case, there are no experimental data 
to parameterise the fo r c e - f i e ld .  Geometry optimising SCF calculat ions
were thus used fo r  th is purpose.
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3.5 Modelling Medium Effects.
The LCAO-SCF method fo r  calculat ion of molecular properties has a 
very serious shortcoming when the system is one as complex as a drug 
molecule in a receptor s i te  or free in solution, e i ther  in body f lu ids  
or the medium of an in v i t r o  assay in that i t  considers an isolated  
molecule in vacuo. C lear ly  this is not very r e a l i s t i c  though i t  may 
serve as a f i r s t  approximation. That the medium may have a marked 
effect  on molecular properties is well known, and seen in the solvent 
dependence of  NMR (193) ,  UV/visib le  (194) ,  IR/Raman spectra (195) and 
re a c t iv i t y  (196),  a l l  o f  which imply e i ther  changes in the e lectronic  
structure of  the molecule or in the posit ion o f  conformational 
e q u i l ib r ia ,  properties which are of  p a r t ic u la r  in te res t  in the context 
of drug-receptor binding reactions.
The treatment of  medium effects  within the LCAO-SCF framework 
presents an in te resting problem to the theoret ic ian .  I t  is possible to 
envisage at least two contrasting approaches to the problem: solvent
molecules can be included e x p l i c i t l y  in the ca lcu la t io n ,  the 
"supermolecule" approach (197);  a l te rn a t iv e ly  the solvent can be
considered simply as a continuum surrounding the solute.
At f i r s t  sight the supermolecule approach appears to give a much 
more r e a l i s t i c  picture of  the s i tuation in solution, but i t  has several 
large drawbacks. In the f i r s t  instance i t  is necessary to decide how 
many solvent molecules should be included in the calcu lat ion  in order 
to give a reasonable representation of the solution s ta te .  I t  is then 
necessary to f i x  th e i r  posit ions, a problem simply on the grounds of  
deciding where they should be and also in that  th is  i m p l i c i t l y
constrains the system to be s ta t ic ,  while the true s i tua t ion  is very 
fa r  from s ta t ic .
The l im i t ing  factor  in the f i r s t  case is l i k e l y  to be the storage 
capacity of  the computer being used to perform the ca lcu la t ions .  In 
pr inc ip le ,  having decided on the number of solvent molecules to be
included in the system, the second problem could be overcome by
performing a number o f  calculations al lowing the solvent molecules to 
occupy many d i f fe re n t  posit ions, and then taking a Boltzmann weighted
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average of  the set of resul ts obtained. However, this process would be 
enormously time-consuming, even for  a r e l a t i v e l y  small system, and must 
for a l l  pract ical  purposes be ruled out.
Continuum models based on classical e lec t ro s ta t ic  considerations of  
interacting systems, due to the work of  Born, Onsager and Kirkwood
(191,198 ,199) ,  .while i n t u i t i v e l y  less appealing, suffer  from none of
these drawbacks, and i t  may be that the lack of e x p l i c i t  inclusion of
solvent molecules might go some way towards reproducing the time and
space averaged nature of  the in teract ion  of  the solute with i ts  
surrounding solvent.
The SOLVATON model, a continuum model f i r s t  propounded by Klopman 
(200),  was chosen for this study fo r  a va r ie ty  of  reasons. I t  has been 
B shown (201,202) to give a reasonable in terpre ta t ion  of  the solvent  
dependence o f  NMR parameters in certa in circumstances, implying that  
application of  the model r e a l i s t i c a l l y  re f lec ts  the changes to the 
electronic d is t r ibut ion  of  the molecule, probably the major 
consideration from the point of view of  QSAR studies, and i t  is 
demonstrated la te r  in th is chapter that  the model is capable of  
reproducing, q u a l i ta t iv e ly  at leas t ,  the observed changes in a va r ie ty  
of solvent-dependent molecular propert ies.  The model is also  
computationally t ractable ,  and can be incorporated in to  an SCF-MO 
treatment o f  a system quite eas ily  and without too serious a time 
penalty.
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3.6 The SOLVATON Model
In the SOLVATON model the solute molecule is considered to be 
surrounded by a set of image charges, the "solvatons," one solvaton
being associated with each atom of  the solute,  i ts  charge being 
opposite in sign and proportional in magnitude to that of  i ts  
associated atom. These charges provide an e le c t r ic  f i e l d  around the 
solute which w i l l  cause i ts  electron d is t r ibu t io n  to be perturbed,
giving r ise to the changes in properties that occur in so lut ion. Such 
a f i e l d  is often referred to as a "reaction f i e l d , "  and the model thus 
f a l l s  into the category known as reaction f i e l d  models. This 
perturbation can be incorporated into the hamiltonian operator of the 
system and included in the SCF calculat ion
Htota l  ’  Hinh + Hsolv 3 ' 6 ' 1
where H. . is the inherent hamiltonian for  the solute as defined in1 nh
section 3.2 and Hsq^v represents the perturbation to the system due
to the presence of the solvatons. Hsolv w i l l  be given by
Hsolv ■ 1 1  V m  -  I  1 %  3 ' 6 ' 2
5 m r sm s 3 r js
where Q$ is the charge on the solvaton, Zm is the core charge on 
the m'th nucleus and the summation in m runs over a l l  nuc le i ,  that in j  
over a l l  electrons. C lear ly ,  the f i r s t  term represents the 
interactions between the solvatons and the nuclei while the second 
gives the solvaton -  electron interact ions.  I t  now remains to se t t le  
the deta i ls  of  the magnitude of  the solvaton charges and the manner in 
which the 1 / r .^  operators are treated.
I t  is necessary to decide on the constant of  p ropo r t iona l i ty  
required to obtain the charges on the solvatons from those on th e i r  
corresponding atoms. As the solvaton charges are the resu l t  of  
polar isat ion by the solute o f  the surrounding medium i t  is reasonable 
to suggest that  the proport ional i ty  constant be some funct ion o f  the 
polar isab i1i t y  of  the medium, o f  which the bulk d i e l e c t r i c  constant e 
is a convenient measure.
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In the l imit ing case of a solvent of d ie le c t r i c  constant unity we 
would wish the the hamiltonian for the system to reduce to that of the 
isolated molecule in vacuo, while at very high d i e l e c t r i c  constants i t  
would be reasonable to expect the perturbation to approach some 
l im it ing value. A suitable functional form for  such a dependence is a 
Born type potential  function, giving
where QA is the total  charge on the atom in question obtained from a
Mulliken analysis.
A simple Born function as shown above is perhaps not very adequate 
for  the current purpose since most of  the var ia t ion  in the function
occurs at values of very close to unity,  giving neg l ig ib le  d is t inc t ion  
between, for  example, a solvent of d ie le c t r i c  constant 8 and one of  
80. Experience t e l l s  us that this is not the case, and i t  would oe
desirable to shi f t  the var ia t ion  to higher values of e. This can be
done quite simply, for  example
where k is a constant. Plots of  the function for  various values of  k 
are shown in f igure 3 .6 .1 .
Figure 3.6.1
A 3 .6 .3
Hsolv -  ( c d l  I  I  0AZm -  n  Qa 3 .6 .4
G
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For this work a value of 2.5 was chosen fol lowing reference 202. 
I t  is tempting to attempt to j u s t i f y  inclusion of this fac to r  in the 
l ig h t  of the gross approximation being employed by assuming that the 
polar isabi1i t y  of  the medium at the molecular level is re lated so 
simply to the bulk d ie le c t r ic  constant. However, i t  is probably more 
reasonable to simply consider i t  as a fudge fac to r .
The treatment of the operators is s t r i c t l y  analogous to the
consideration of  the interact ions of  one electron with another or with 
a nucleus. For electron -  electron interactions we have integra ls  of  
the form
•fJ* $m$n 1 $i$s dT l dT2 3.1.1
r i2
The electron -  solvaton equivalent of this w i l l  be
JJ $mQ' 1 0iQ' dTidT2 3 .6 .5
r i 2
where Q1 represents the "wavefunction" due to the solvaton in volume 
element dT2 . A very quick and simple way to obtain the value of  
such an integral is simply to assume that the spatial  d is t r ib u t io n  of  
the solvaton is the same as that of an electron associated with that  
atom. The integral  now simply reduces to
V ab  3 - 6 - 6
This assumes, however, that  the solvaton charge d is t r ib u t io n  is 
superimposed d i r e c t ly  on the charge d is t r ibu t io n  of  the atom in 
question. I t  is more r e a l i s t i c  to consider that  the solvaton charge 
w i l l  be displaced from the nucleus, and this is accounted fo r  by 
including a scaling factor
QsyAB r AB 3 *6,7
r AB+VDWRA
where r . .  is the internuclear  distance and VDWR. is the van der 
1J 3
Waals' radius of  the atom with which the solvaton is associated. For
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the case where the solvaton and electron are associated with the same 
atom th is  scaling factor  reduces to zero, which is c lear ly  
unsat isfactory.  Here a simple 1/VDNR factor  is used in i ts  place.
The perturbations to the diagonal elements of  the e lectronic  part 
of the hamiltonian are thus given by
H ' , ,  = I  <5- 1 3 - 6 - 8
r .1 s
where the solvaton charges Qs and the modified 1/**^ operator are 
as described above. Off diagonal terms are also included, but this  
must once again be done in a manner that retains rotational  
invariance. As with the resonance integrals 13- ,^ this is done most 
simply by assuming that  the matrix elements are d i re c t ly  proportional  
to the overlap integrals  for  a given pair  o f  o r b i ta ls ,
H ' . .  = 0.5< H ' . ,  + H ' . .  )S , .  3 .6 .9
Incorporation of  this f i n i t e  perturbation into the i t e r a t i v e  SCF 
process allows a modified wavefunction for  the system to be obtained 
which includes the e f fe c t  of the surrounding medium, a lb e i t  in a rather  
naive manner.
There are various caveats that  should be borne in mind when
examining the resul ts of SCF calculations incorporating the SOLVATON 
model. The most obvious of these is that  i t  is an e n t i re ly
non-specif ic algorithm which takes no account o f  specif ic
solvent-solute interact ions such as protonation, ion isat ion  or 
hydrogen-bonding. The e f fec t  of  hydrogen-bonding may, in f a c t ,  be 
i m p l i c i t l y  included in the model: i f  we consider the types of  group
that  are l i k e ly  to be involved in such interact ions,  they w i l l  in 
general be highly polar groupings such as hydroxyl and carbonyl,  with 
r e l a t i v e l y  large p a r t ia l  charges on each atom. Consequently, the image 
charges w i l l  also be large, and th is  s i tuat ion  is not d iss im i la r  to 
that which would be observed in a hydrogen-bonding solvent.  In
contrast ,  non-polar groupings such as methyl groups w i l l  be composed of
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atoms with r e la t i v e l y  small charges, and w i l l  thus be associated with 
solvatons of  small charge. The placement of the charges a van der 
Waals1 radius away from the atomic centre in question is not an 
en t i re ly  unreasonable model of  a hydrogen- bonding s i tuat ion .
However, while the model shows encouraging trends in a f i r s t  
approximation to the e lec t ros ta t ics  of hydrogen-bonding, this optimism 
should not be over-extended to a claim that  the treatment is even 
approaching rigorous.
The problems of  protonation or ionisat ion can, of  course, be dealt  
with by performing the ca lculat ion on the protonated or ionised form of  
the solute,  but th is raises another s l ig h t ly  more subtle but equally  
serious problem with the model, namely i ts  treatment of charged 
systems. I f  we consider the sum of  the solvaton charges, this w i l l  be 
given by
■Qs o l v - - < e ^ J 2 Q tot  3 .6 .10
2e+k
where  ^ is the to ta l  charge on the system. For an uncharged 
system this presents no problem. I f ,  however, the system carr ies a 
formal charge and this quantity is non-zero then we have in e f fe c t  a 
charged solvent,  and have changed the tota l  charge of the system. This 
is quite c lear ly  an u nrea l is t ic  s i tua t ion ,  and leads to to ta l  energies 
for the system which can be great ly  in error ,  p a r t ic u la r l y  for  high 
d ie le c t r ic  constants. Consequently, i f  the tota l  energy is a quant ity  
of in te res t  then the model must be res t r ic ted  to neutral  systems, or 
counter-ions must be included to maintain e le c t r ic a l  n e u t r a l i t y .  A 
similar problem has been noted by Richards (137) in work on using point  
charge models of  enzyme act ive s i tes .  Properties other than the to ta l  
energy (which do not involve solvaton-core or solvaton-solvaton  
interactions)  appear not to be adversely af fected.
The e f fe c t  of  th is  formulation of  the SOLVATON model on some 
properties of  in te res t  to QSAR studies in some model systems w i l l  now 
be discussed.
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3.7 General e f fec ts  o f  the SOLVATON model on the wavefunct ion.
The e f fe c t  of the SOLVATON model is very much what would be 
expected i n t u i t i v e l y  in the l ig h t  of  the nature of the model. The 
solvatons can be thought of  as "additional nuclei" in the system
( a lb e i t  with e i ther  posit ive or negative charge),  and w i l l  thus cause 
the e lectronic  energy of  the system to become more negative due to the 
increased k ine t ic  energy of  the electrons in the presence of  an
increased potent ia l  f i e l d .  There w i l l  thus be a tendency for  the to ta l
energy and binding energy of  the system to become more negative, as the
core-core interact ions and atomic energies are assumed to be constant.  
The interactions between the atomic cores and the solvatons can e i ther  
augment or reduce the e f fe c t  of the e lectronic  energy on the to ta l  and 
binding energy.
Table 3.7.1
Effect  of  the SOLVATON model on the wavefunction of  formamide
Di e le c t r i  c 
constant 1.0 4.0 20.0 80.0
Mul1iken 
charges
0
C
N
H(N)
H(N)
H(C)
6.4081 
3.4961 
5.2596 
0.8693 
0.8585 
1.1084
6.4252 
3.4791 
5.2701 
0.8620 
0.8513 
1 .1122
6.4408 
3.4640 
5.2795 
0.8553 
0.8448 
1.1156
6.4456 
3.4594 
5.2825 
0.8532 
0.8428 
1.1166
Dipole
moments
X
y
tota l
3.6840 
1.2811 
3.9004
3.7896 
1.3287 
4.0157
3.8862 
1.3722 
4.1214
3.9161 
1.3858 
4.1540
For a polar species such as formamide, i t  would be expected that  
the solvaton f i e l d  would cause an increase in the magnitudes of  the
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c h a r g e s  a s s s o c i a t e d  w i t h  t h e  v a r i o u s  a t o m s :  t h u s  t h e  o x y g e n  s h o u l d
b e c o m e  m o r e  n e g a t i v e , ,  t h e  c a r b o n  m o r e  p o s i t i v e  a n d  s o  o n ;  t h i s  i s  f o u n d  
t o  b e  t h e  c a s e ,  a s  i l l u s t r a t e d  b y  t h e  r e s u l t s  s u m m a r i s e d  i n  t a b l e  
3 . 7 . 1 .  As  a r e s u l t  o f  t h e  i n c r e a s e d  p o l a r i s a t i o n  o f  t h e  m o l e c u l e ,  t h e  
d i p o l e  m o m e n t  w o u l d  be  e x p e c t e d  t o  i n c r e a s e  w i t h  i n c r e a s i n g  d i e l e c t r i c  
c o n s t a n t ,  a n d  t h e  r e s u l t s  i n  t a b l e  3 . 7 . 1  c o n f i r m  t h i s .
The change in the electronic d is t r ibu t io n  of the molecule would be
expected to have an ef fect  on its environment. Figure 3 .7 .1a and b
show a di fference map and isometric surface project ion for the change
in the calculated e lectrostat ic  potential  around the formamide molecule
as the d ie le c t r ic  changes from one to four.  The contours represent
EP(1)-EP(4), and i t  can be seen that the changes are in general quite
_  1 _  2
small, of the order of 10 to 10 eV, but quite noticeable.  
The posit ive region around the oxygen implies that this region is 
becoming more negative, while the hollows in the v i c i n i t y  of  the NH2 
group show that the e lectrostat ic  potent ia l  is increasing here.
S,s'  r r ' >
. j
* A*IS -If 
I A >  IS • I'O N U u jt-- •<( i c m  «
F i  g u r e  3 . 7 . 1 a F i  g u r e  3 . 7 . 1 b
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A s i m i l a r  d i f f e r e n c e  p l o t  f o r  t h e  m a g n i t u d e  o f  t h e  e l e c t r i c  f i e l d  
a r o u n d  t h e  m o l e c u l e  i s  s h o w n  i n  f i g u r e s  3 . 7 . 2 a  a n d  b .  I t  c a n  b e  s e e n  
t h a t  a t  a n y  r e a s o n a b l e  d i s t a n c e  f r o m  t h e  m o l e c u l e ,  c h a n g e s  a r e  
n e g l i g i b l e ,  b u t  t h e  e l e c t r i c  f i e l d  i n c r e a s e s  q u i t e  m a r k e d l y  c l o s e  t o  
t h e  m o l e c u l e  i n  t h e  v i c i n i t y  o f  c h a r g e d  g r o u p s .
<3-
•1-
- .1 -
» I ' I : I |- 5  - 3 - i { 3 5-
w
Figure 3.7.2a Figure 3.7.2b
Su scep t ib i l i t ies  to nucleophilic and e 1ectrophi1ic attack change 
broadly in the manner that would be expected on grounds of the changing 
atomic charges, while the atom se1f -p o la r i  sab i11 t ies  appear to become 
numerically s l ig h t ly  smaller without exception. Atomic binding 
energies become more negative. The e f fe c t  of  the model on some 
specif ic properties in some systems of  in te res t  is now examined.
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3 . 8  E f f e c t  o f  t he  SOLVATON model  on c o n f o r m a t i o n
Experimental data in the l i t e ra tu re  for the solvent dependence of  
conformational preference are, unfortunately , very rare.  Undoubtedly 
the best studied system is 1-2 di f  1 uoroethane which has been 
investigated by IR/Raman spectroscopy (203) and more recently by a 
consideration of  NMR coupling constants (204) .  A theoret ical  study of  
the system has also been carried out using a formulation of the 
SOLVATON model (205).
I n t u i t i v e l y  i t  would be expected that the conformer with the two 
f luor ine  atoms positioned trans to one another would be the favoured 
conformation due to the large ster ic  bulk, o f  the f luorines compared to 
hydrogen. However, the evidence from the IR/Raman studies suggests 
that the trans and gauche conformers (depicted as Newman projections in 
f igure 3 .8 .1 )  are of approximately equal energy in the gas phase, with 
the gauche conformer being marginally more stable but the difference  
being within the expected errors for the measurements ( < 800 J
mole ^),  while in solution the gauche conformer becomes increasingly  
more stable as the d ie lec t r ic  constant increases. The r a t io  of  
gaucheitrans is estimated as 2:1 in the gas phase and 9:1 in the pure 
1 iquid (e = 34 .4 ) .
3
The values of  increase as the d ie le c t r i c  constant
increases (204,205).  This would be consistent with a change in the 
r a t io  o f  conformers as suggested above provided that the coupling 
constant shows a Karplus type dependence on dihedral angle (as 
calculat ions (205) suggest i t  does), and the data have been interpreted  
in such a way. Watanabe and Ando do not quote energies in the i r  paper 
on calculated coupling constants using the SOLVATON model, but conclude 
that a change in the position of the conformational equil ibr ium is not
3
necessary to explain the var iat ion in though such a change
is not ruled out. Certainly,  a change in the opposite d i rect ion  ( that
f
Figure 3.8.1
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is,  with the proportion of trans conformer increasing as c increases)
is not consistent with the observed changes. In the l igh t  of the 
IR/Raman evidence i t  seems l ike ly  that the change does take place, and
3
the Karplus type dependence of  may &e reinforced by the
ef fect  of the solvent on the coupling constants of  the individual  
conformers.
SOLVATON calculations at the INDO level of approximation were
performed on 1-2-dif luoroethane usings standard bond lengths and angles
(206),  allowing the F -  F dihedral angle to vary from 0°  to 180° in 
30° increments for a variety o f  d ie le c t r i c  constants. The total  
energies re la t ive  to the positions of  lowest energy) obtained are shown 
in f igure 3 .8 .2 .
Figure 3 .8 .2
o
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As can be seen, the energies show the correct trend, with the gauche
conformer becoming increasingly more stable with respect to the trans 
as the d ie le c t r ic  constant increases. The energy d i fference increases 
from 2.364 kJ mole-  ^ at  e = 1 to 2.904 kJ mole-  ^ at  c = 20, giving
calculated ratios of gauche to trans of  2.6:1 and 3.2:1 respect ive ly .
There may be a number of reasons for  the lack of  quant i ta t ive  agreement 
between the calculated and observed resu l ts .  C lea r ly ,  the INDO method 
overestimates the energy difference for  the isolated molecule in vacuo, 
as seen in the results for e = 1. This may be an inherent weakness of  
the method, or i t  may be a consequence o f  the use of  standard 
geometries for the compound. Use of  f u l l y  optimised geometries (a t  the 
INDO level of  approximation) was t r i e d ,  but the geometries obtained
were very poor, with a considerably shortened C -  C bond. This is 
presumably due to inadequate parameter!sat ion. The energies thus
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obtained did not show any improvement, and in the l ig h t  of the poor 
geometry are probably meaningless anyway.
A fur ther  invest igat ion of  the e f fec t  of medium on conformational 
preference was conducted on 2-ami noethanol. Ab i n i t i o  calculat ion
(207) has shown that the preferred conformation of the isolated  
molecule in vacuo should be the in te rn a l ly  hydrogen-bonded form. 
Clear ly ,  in a polar solvent capable of  hydrogen-bonding to the hydroxyl 
and amino groups i t  would be expected that e i ther  the gauche or trans 
conformers would be preferred on the grounds of  s ter ic  crowding, with 
dipolar  interact ions possibly p re fe re n t ia l ly  s tab i l is ing  the gauche 
conformer.
Calculations were performed on the molecule in i ts  in te rn a l ly  
hydrogen-bonded form, and in the conformation with a f u l l y  trans 
C-C-O-H torsion angle al lowing the N-C-C-0 angle to vary from 0°  to 
180° in increments of 30°, once again using the r ig id  rotor  
approximation. All  geometries were standard values..
The to ta l  energies obtained are shown in f igure  3 .8 .3 ,  the 
continuous l ines being the values fo r  the conformers with the extended 
C-C-O-H and the single points being the in te rn a l ly  hydrogen-bonded form.
Figure 3 .8 .3
I t  can be seen that the in te rn a l ly  hydrogen bonded form is 
calculated to be the most stable in vacuo, but as the d ie le c t r i c  
constant increases, this form becomes increasingly less favourable
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re la t iv e  to the extended forms, and the gauche extended conformer is 
calculated to be the most stable.
A closely re lated problem to that of choice of preferred  
conformation in a molecule is that of calculat ing the barr iers to 
internal  rotation which hinder the interconversion of  conformers o f  a 
molecule. Figures 3 .8 .2  and 3 .8 .3  suggest that these barr iers are 
increasing as the d ie le c t r i c  constant increases, but for  these systems 
there appears to be no experimental data with which to compare the 
calculated results .
The barr ier  to internal rotation in the formamide molecule has been 
obtained by means of  NMR spectroscopy in a var ie ty  of  solvent systems
(208) and has been shown to increase from 70 kJ mole" at  e = 2 to
_ i
80 kJ mole in water at 293 K. The system has also been studied 
by ab i n i t i o  ca lculat ion (209) at the 4-31G leve l ,  and using a 
formulation of the SOLVATON model at the CNDO level of approximation by 
Duben and Miertus (210) .
The studies of  Duben and Miertus show reasonable agreement with 
experiment. However, CNDO is well known to give a most bizarre twisted  
lowest energy geometry for  formamide, so i t  was f e l t  that these results  
were not above c r i t ic ism .  The INDO method gives a good geometry for  
formamide, so calculations similar  to those of Duben and Miertus were 
performed using the author's formulation of  the SOLVATON model at  the 
INDO level of approximation. Geometries were taken from reference  
210, a ground state geometry from geometry optimising STO-4G 
calculat ions,  one in which the NH2 group had simply been twisted  
through 90° (the "unrelaxed twist"  form), and a "relaxed twist"  form 
of C2s symmetry obtained by restrained geometry optimising ST0-4G 
calculat ions, the las t  two geometries hopefully giving an idea o f  the 
"transit ion  state" in the interconversion reaction, with the relaxed 
tw is t  probably being the more r e a l i s t i c .  The results obtained are 
summarised in table 3 .8 .1 .
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Table 3.8.1
E f fec t  o f  the SOLVATON model on formamide ro ta t io n  b a r r ie r
D ie le c t r ic
constant 1.0 4.0 8.0 40.0
Total  
energi es 
(Hartrees)
Flat
geometry -37.148775 -37.171472 -37.191322 -37.197370
Relaxed 
twi st 
geometry
-37.115737 -37.135946 -37.153387 -37.158662
Unrelaxed
twist.
geometry
-37.115812 -37.137610 -37.157035 -37.162920
Barri er 
(relaxed) . .033038 .035976 .037935 .038708
Barr ier
(unrelaxed) .032963 .033862 .034287 .034450
I t  can be seen that both for  the relaxed and the unrelaxed twist
forms the barr ier  to interconversion is increasing with increasing
d ie le c t r i c  constant, as would be expected from the experimental data.  
For the relaxed form, the quant i ta t ive  agreement is quite reasonable,
_ i
the "relaxed" barr ier  r is ing  from 86.74 k3 mole to 101.63 k3
_ i  _ i
mole and the "unrelaxed b a rr ie r  r is ing  from 86.54 kJ mole
_ i
to 90.45 kJ mole . I t  is noteworthy that the unrelaxed form is 
calculated to be lower in energy than the relaxed form. In the opinion 
of the author this rather  anomalous resu l t  is l i k e ly  to be an a r te fa c t
of the INDO method. INDO is parameterised to give results  which are
reasonable at reasonable geometries, so the parameterisation o f  the 6 
values with no distance dependence seems l i k e ly  to introduce larger
errors at  poor geometries (such as the unrelaxed form) than at more
physical ly  reasonable geometries.
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To summarise, for  two of the systems investigated (1-2
d i f 1uoroethane and formamide), the quant i tative agreement between
calculat ion and experiment was quite acceptable.  For the 
2-ami noethanol system, the expected trends were observed, but the
calculated changes in energy appear to be fa r  too large to be
reasonable.
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3.9 E f fec t  o f  the SOLVATON model on e lec t ron ic  energy leve ls .
One of the most f a m i l ia r  aspects to chemists of  the solvent
dependence o f ; chemical properties must be the observation that  
UV/visib le  spectral absorbance maxima are solvent dependent (211) .  In 
p a r t ic u la r ,  the hypsochromic sh i f ts  of  n-ir* t ransi t ions and
bathochromic shi f ts  of ir-ir* bands are well known, and the solvent s h i f t  
of  a par t icu la r  band is often used as corroborating evidence in i ts
assignment. I f  the e f fe c t  of  the SOLVATON model on e lectronic  
structure is to be given any credence then i t  should be able to
reproduce these trends.
Table 3.9.1
Effect of  the SOLVATON model on electronic  energy levels
D ie lec t r ic
constant 1 .0 4.0 8.0 40.0
Acetone
E(n) - .439282 -.440889 -.441702 -.442747
E ( i r * ) .145343 .144007 .143365 .142547
4 E ( n V ) .584625 .584896 .585067 .585294
Pyridine
E('ir) - .482849 -.483041 -.483136 -.483266
E(n) -.404945 -.406364 -.406906 -.407576
E(ir*) .149990 .149265 .148952 .148538
E ( ttV ) .632839 .632306 .632088 .631804
E ( n V ) .554935 .555629 .555858 .556114
As test  systems, calculations were performed on acetone (whose 
lowest energy t rans i t ion  is an n--rr* band) and pyridine (which shows 
both n-ir* and ir-ir* bands in i ts  UV/visib le  spectrum). The differences  
in energy between the various o rb i ta ls  were taken to be a re f le c t io n  o f  
the t rans i t ion  energies, though i t  would be more accurate to compare
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energies fo r  the ground state and the f i r s t  excited s ing le t .  The 
t ra ns i t ion  energies were calculated d i re c t ly  from the eigenvalues while 
the o rb i ta ls  were id en t i f ie d  from an examination of the eigenvectors.  
I t  would probably be more accurate to examine the difference in energy 
between the ground state and the f i r s t  excited singlet in each case,
but the programme used did not have the capabi l i ty  to deal with open 
shell systems, so this could not be done. The results of the two sets 
of calculat ions are summarised in table 3 .9 .1 .
I t  can be seen that the model gives good qua l i ta t ive  agreement with 
experiment for  both the n-ir* t rans i t ion  of  acetone and fo r  both 
t rans i t ions  in pyr idine,  with the shi f ts  towards blue or red being
reproduced. I t  is also clear that the quanti ta tive  agreement is less
_i _i
than good, with the solvent shi f ts  being 146 cm , 226 cm ,
258 cm-  fo r  the acetone n-tr*, pyridine ir-ir* and pyridine n-ir*
t rans i t ions  respect ive ly ,  but th is is to be expected by the INDO method 
which does not give highly accurate energy levels .
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3_. 10 E f f e c t  o f  th e  SOLVATON model  oni h y d r o g e n - b o n d i n g ^
The uracil  - hydrogen f luoride system was chosen to study the 
ef fec t  of the model on hydrogen-bonding e q u i l ib r ia  as i t  has been 
studied using 4-31G ab i n i t i o  calculations (212) .  The uracil molecule 
has two NH groups, ei ther  of which can be used in hydrogen bond 
formation with,  for example, f luoride.  Calculations were performed on 
uracil  and i ts  two possible anions (formed by removal of a proton from 
ei ther  ni trogen) ,  hydrogen f luoride,  and the two possible urac i l"  -  H 
-  F complexes in order to see i f  application of  the SOLVATON model to 
the system showed any change in the preferred s i te  for hydrogen bond 
formation, and i f  the results obtained agreed q u a l i ta t iv e ly  with the ab 
i n i t i o  resul ts .  The possible reaction schemes are shown below.
[ u r a c i l  -  H -  F]~
N1 complex
U rac i1 + F"
[u rac i1 -  H -  F ]“
N3 complex
where the numbering scheme is
/ /
N r ^ \
H 0
I t  has already been noted that the to ta l  energies (which are the 
quanti t ies of  interest  in this experiment) for  charged systems are 
l i k e ly  to be in error ,  but i t  was hoped that since the tota l  charge 
remains constant for each part of  the reaction scheme (with one anion 
and a l l  other species neutra l ) ,  the errors would be more or less 
constant throughout the calculations.
The to ta l  energies for the various species at various values of the 
d ie le c t r ic  constant are summarised in table 3.10.1
urac i 1 + HF
N1 anion
urac i 1 + HF
N3 anion
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T a b l e  3 . 1 0 . 1
E f f e c t  o f  t h e  SOLVATON model  on e n e r g y  o f  u r a c i l  HF s y s t e m
Die lec tr i  c 
constant 1 .0 8.0 40.0
Total 
energi es 
(Hartrees)
Urac i1 -86.460945 -86.481473 -86.489659
HF -26.791312 -26.810100 -26.818090
[Uracil  N1]_ -85.641755 -86.415371 -86.706655
[Uracil  N3]~ -85.611401 -86.380958 -86.670935
Urac i1 -  HF (N1) -112.501792 -113.266341 -113.553743
Uracil  -  HF (N3) -112.518008 -113.280830 -113.567220
At a d ie le c t r ic  constant of unity,  the N1 anion is calculated to be 
the more stable by about 0.030 a .u . ,  and this preferent ia l  s t a b i l i t y  
increases to about 0.034 a.u.  at  a d ie le c t r ic  constant of  80. For the 
hydrogen-bonded complexes, however, this order of s t a b i l i t y  is reversed
at low d ie lec t r ics  with the N3 -  H -  F complex the more stable by 0.017
a.u. At e = 80 the difference is reduced to 0.013 a .u . ,  but the order  
remains the same. Including the energy of hydrogen f lu o r id e ,  i t  is 
seen that the reaction u rac i l -  + HF *  [uraci l  -  H -  F]_ is thus
more favourable at the N3 s i te ,  but is s t i l l  energet ica l ly  favourable  
at the N1 s i te ,  regardless of d ie le c t r ic  constant. The ab i n i t i o  
calculations of  r e f .  212 show this to be the case for  the system in 
vacuo, and appl icat ion of  a non-specific solvation algorithm (with no 
deta i ls  given) to the system also gives the N3 complex as the more
stab le .
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Results for  the f luor ide  anion are not included as the programme 
used is not designed for  calculations on monatomic species. However, a 
rough estimate of the energy can be obtained as follows:
INDO atomic energy: -27.55 a.u.
electron a f f i n i t y :  -0 .12 a.u.
t o ta l :  -27.67 a.u.
for  the ion in vacuo, and gett ing more negative as the d ie le c t r ic  
constant increases. Adding this to the value for  the isolated uracil  
molecule i t  is now found that  the system uracil  + F- is more stable 
than the hydrogen-bonded complexes, and becomes increasingly so at  
higher d ie lec t r ics .  I t  would cer ta in ly  be expected that in a 
hydrogen-bonding solvent the two species should be of  comparable 
s t a b i l i t y ,  thus i t  appears that the trend is in the correct d i rec t ion ,  
but i f  the ab i n i t i o  resul ts r e f le c t  what is actual ly  occurring, the 
star t ing  point is incorrect ,  since these predict a stable 
hydrogen-bonded system at the N3 s i te .  This may be a consequence of  
the very rough and ready estimate of the energy of  F- being inadequate, 
or of  the inadequacy of the SOLVATON model fo r  charged systems, or 
simply of  the INDO method which is known to give unre l iable  geometries 
(and hence, presumably, other resul ts )  for hydrogen-bonded systems. 
I t  is at least encouraging to f ind the correct trend in the s t a b i l i t y  
of the complexes with respect to the uracil  molecule and f luo r ide  ion 
as the d ie lec t r ic  constant increases (that  is ,  that  the re la t iv e  
s t a b i l i t y  of the complexes decreases).
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3.11 E f fec t  o f  the SOLVATON model on a tautomeric equ i l ib r ium.
The keto-enol tautomerisms 2-pyridone -  2-hydroxypyridine and 
uracil  -  4-hydroxyuraci1 provide an Inte resting example of the way In 
which medium can exert quite subtle ef fects  on chemical systems. For 
the 2-pyrldone system I t  Is well known that the keto form predominates 
In polar media, and that there Is an Increasing proportion of the 
hydroxy tautomer at low d ie lectr ics  (213) .  In contrast,  for  the uracil  
system i t  is found that the keto form is strongly favoured at a l l  
d ie le c t r ic  constants, with the equil ibrium constant estimated at
_ 4
10 in neutral  aqueous solution (214) and no evidence fo r  the 
presence o f  the hydroxy tautomer in the gas phase (215).  Calculations  
using the SOLVATON model were performed on both systems, and the 
results are summarised in table 3 .11 .1 .  Geometries for  the uracil  
system were taken from reference 216, while those fo r  the 2-pyridone 
system were obtained from molecular mechanics.
Table 3.11.1
Ef fect  of the SOLVATON model on tautomeric e q u i l ib r ia
D ie lec t r i  c 
constant 1.0 8.0 80.0
Total energies 
(Hartrees)
Uraci1 -86.458151 -86.485417 -86.497937
4hydroxyuraci1 -86.451396 -86.498776 -86.520641
2pyridone -65.666483 -65.674150 -65.677784
2hydroxypyridine -65.684796 -65.719153 -65.735280
Dipole moments (D)
Urac i1 4.264 4.460 4.550
4hydroxyuraci1 4.605 4.776 4.856
2pyridone 4.840 5.108 5.237
2hydroxypyridine 1.498 1 .479 1 .471
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I t  can be seen that for  both systems, a normal INDO calculat ion  
(e= l )  in both cases predicts correctly the tautomer which predominates 
at low d ie le c t r ic s .  For the uracil  system, as d ie le c t r ic  is increased 
the hydroxy tautomer is observed to drop in energy much more rapid ly  
than the keto tautomer, being calculated to be the more stable both at  
e = 8 and e = 80. Thus, the observed trend is what would be expected, 
though the magnitude of the changes is considerably too large.
For the 2-pyridone system, i t  is once again seen that the hydroxy 
form drops in energy more rapidly  than the keto form, and this is not 
what would be expected from the experimental evidence.
A s ign i f ican t  di fference between the systems can be seen in the 
dipole moments. For the uracil  system there is only quite a small 
change in dipole moment on tautomerisation, and there would hence be 
l i t t l e  preferent ia l  s tab i l isa t io n  of  one or other tautomer by dipole 
dipole interactions.  For the 2-pyridone system the dipole moment 
increases great ly  on formation of  the keto tautomer, and hence th is  
form w i l l  be p re fe re n t ia l l y  stabi l ised in polar media.
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3.12 Receptor Model 1i n q .
Modelling the e f fe c t  of a receptor s i te  on a drug molecule or 
enzyme substrate presents a problem which is ,  in many ways, s imilar  to 
that encountered when attempting to model the e f fec t  of a medium, the 
major difference being that a receptor s i te  is l i k e ly  to be much more 
sta t ic  than a solvent cavity .  Once again, i t  is possible to envisage 
two approaches which broadly paral le l  the possible treatments of  
solvent: the receptor s i te  can be included in an e x p l i c i t  manner by
the inclusion of  fragments to model parts of  the receptor ( fo r  example 
a guanidinium ion to model an arginine residue); a l te rn a t iv e ly  the 
receptor can be modelled by an array of point charges.
With receptor s i te  modelling, the posit ions of  the atoms 
representing the receptor are l ik e ly  to be more or less well defined,  
either  from a knowledge of  the crystal  structure of  an enzyme -  
substrate (or in h ib i to r )  complex, or from an ad hoc approach as 
described in chapter 2. In this circumstance, e x p l i c i t  inclusion of  
the receptor as a set of model fragments is l i k e ly  to be the best 
method, but this has the severe drawback that the size of the system is 
now greatly increased, to the point where the calculat ion rapid ly  
becomes computationally intractable  simply on the grounds of  size and 
time required. For this reason the point charge approximation was used 
in this work.
The e f fe c t  of an array of point charges on the hamiltonian fo r  the 
system can .be included in a manner e n t i re ly  analogous to the SOLVATON 
model, with the e f fec t  of  the point charges on the electron i given by
3.12.1
with o f f  diagonal elements being given by
3.12.2
in order to maintain rotational  invariance. For these calculat ions the 
1/r. . .  operator was treated simply as a sum of  1 / r . terms where
r . j  is the distance between the nucleus with which the atomic orb i ta l  
is associated and the point charge. This approximation w i l l  give 
q u a l i ta t iv e ly  the correct trend, but the interaction w i l l  be too large.  
I t  would be possible to assign each point charge to a spatial  
d is t r ib u t io n ,  say that of an s orb i ta l  of the atom being modelled, and 
use a gamma integral formalism as in the SOLVATON model, but in this  
case i t  would be necessary to calculate the integrals e x p l i c i t l y ,  
adding to the time needed for  the calculat ion.  This would probably be 
the best compromise between e x p l i c i t  and point charge models, but has 
not been tested. An a l te rn a t ive  would be to include a notional  
"d ie le c t r ic  constant" in the same way as in the molecular mechanics 
approach (see appendix B), but this could only r e a l i s t i c a l l y  be 
considered as another fudge fac tor .
As a test  of  the method, a set of calculations on the guanidinium 
and acetate ions, separately,  together,  and alone but with a point  
charge f i e l d  to represent the other were performed. The point charges 
for  the perturbing f i e l d  were obtained from the Mulliken analysis of  
the separated ions, and were placed at the positions of  the atomic 
nuclei o f  the "missing" ha l f  of the complex. The results  o f  these 
calculations are summarised in table 3 .12 .1 .  The geometries o f  the 
compounds were a l l  standard values rather than optimised values as INDO 
is well known to give hydrogen bonds which are considerably too short.
I t  can be seen from the Mu 11 iken analysis that the applied f i e l d  in 
both instances causes the charges to vary in the same manner as that  
observed in the complex, though the changes are somewhat la rge r .  I t  is 
also noticeable that in the calculation on the complex there is a 
t ransfer  of  charge from the acetate to the guanidinium ion of  about 
0.14 electrons. Clear ly ,  this is not reproduced by the point charge 
model, which simply causes a red is tr ibut ion  of  the charge within  the 
molecule, and this lack may well be of  signif icance.
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Table 3.12.1
Separate
ions
Comp 1e x Separate ions 
+ f i e l d
Total energies 
(Hartrees)
Acetate -50.219712 -61.016501
Guanidinium -52.278235 -45.955170
Total -102.497947 -102.708544 -106.971671
Mul1 iken Analyses
C (CH3) 4.052 4.052 4.054
H (mean) 1.047 1.022 0.984
C (C02) 3.489 3.456 3.482
0 (mean) 6.658 6.641 6.755
C (CH3) 3.467 3.471 3.415
H (CH3) (mean) 1.004 1.021 1.025
Na 5.176 5.205 5.240
Ha 0.828 0.852 0.831
Ca 3.800 3.792 3.756
Nfc, (mean) 5.225 5.271 5.337
Hfo (mean) 0.819 0.760 0.689
Hc (mean) 0.814 0.850 0.815
/
CH-C 
3 \
0
0
Hc
ib
V
H^N  /CH3
C-N.
^"Nb
He
The various tota l  energies give an indicat ion of the s ta b i l is a t io n  
of the complex with respect to the isolated ions. The energy of the 
complex is lower by 0.2 a.u.  (120 kcal mole- 1 ) than the sum of  
energies of  the separated ions, and this represents the lowering of  
energy due to complex formation. The sum of the tota l  energies for the 
seperate ions in the presence of th e i r  respective f ie ld s  should also
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r e f le c t  this s ta b i l is a t io n ,  and this is indeed the case with the sum of  
energies in the presence of the perturbing f ie ld s  being 4.5 a.u.
_ i
(3000kJ mole ) lower, however, the interaction is grossly 
overestimated.
This overestimation of the energy of binding is almost ce r ta in ly  
due in part to the neglect of the red is tr ibut ion  of charge. This 
phenomenon also highlights an aspect of the SOLVATON model which was 
not mentioned in the previous sections. When a charged solute is 
surrounded by solvent,  there w i l l  be a tendency for the charge to be 
transferred to the solvent molecules to a greater or lesser extent .  
Thus a solute with a formal charge of  +1 w i l l  generally have an actual  
charge which is somewhat less than this value, and be surrounded by a 
solvent with a pa r t ia l  posit ive charge. In the SOLVATON model the 
solute retains i ts  formal charge, and is surrounded by solvent with a 
net par t ia l  charge of  opposite sign. This may be one cause of  the 
already noted fact  that  the model gives poor tota l  energies fo r  charged 
systems.
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Chapter 4 
QSARs o f ACE inh ib itors
Do not force me onto the treadmill  of  mathematical calculations -  leave 
me time fo r  philosophical speculations, which are my only de l ight
Johannes Kepler
4.1 Select ion o f  compounds
A var ie ty  of  inh ib i tors  were selected from the l i t e r a t u r e  to
attempt to quant ify the s t r u c tu re -a c t iv i ty  relationships of angiotensin 
converting enzyme described in chapter 2 in terms of  the indices 
described in chapter 3, and to investigate the e f fec t  of the SOLVATON 
model on the indices and relationships obtained. The in h ib i to rs ,  shown 
in table 4 .1 .1 ,  f a l l  into three classes; mercaptans, succinate esters 
of  amino-acids, and dipeptides.
The selected compounds include some which lack one or more of  the 
v i ta l  groupings described in chapter 2. I t  was f e l t  important to do 
this as inclusion of  only compounds with a l l  of  these groups present 
would e f fe c t i v e ly  bias the regression equations obtained, with the 
importance of  the interact ions of  these groups simply being part o f  the 
constant term. For a model receptor to have any value as a predict ive  
tool i t  should take reasonable quanti ta tive  account of  a l l  of  the 
important interactions with an in h ib i to r ,  and not simply seek to 
explain away r e l a t i v e l y  small differences in potency between closely  
related members of a series of  compounds already known to be act ive .
The range of I 50 values for the selected compounds covers about six 
orders of  magnitude, and i t  was hoped that this would provide a 
s u f f ic ie n t l y  broad spread of potencies to al low a l l  of  the relevant  
interact ions to be considered in the regression equations, and provide 
a reasonable basis for  distinguishing between active and inact ive  
compounds.
A fu r the r  c r i te r io n  for  inclusion in the study was that  the 
molecule could be handled by the molecular mechanics force f i e l d
ava i lab le ,  and th is  precluded the inclusion o f ,  for  example, the
phosphate type inh ib i tors  (161) and a number of conformationally  
res t r ic ted  inh ib i tors  (217) which may well have been in s t ru c t iv e ,  but 
i t  was f e l t  to be preferable to use a r e l ia b le  force f i e l d  and choose 
the compounds studied accordingly rather than embark upon a major piece 
of force f i e l d  parameterisation.
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labje
Selected i n h i b i t o r s .
Compound
H
A c t i v i t y  ( p l 50) Reference
5.5528 162
6.0706 162
5.7959 162
6.3665 162
6.6990 162
7.6383 162
6.1871 166
3 . 3 0 9 8  162
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Tabl  e 4 . 1 . 1  c o n t
Sel ec ted i n h i b i t o r s .
Compound A c t i v i t y  ( p l 50) Reference
9 -0C 2.7011 162
10 2OC 2.8729 162
COJ
11
CH,
12
COJ
I
CH,
4.5086
5.5229
163
166
13
Coy
4.9586 162
0
14 - s /  ^  x nA 2.7447 166
15 20C 2.9586 162
3 .2 1 4 7 162
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T ab !e  4 . 1 . 1  c o n t
Selected i n h i b i t o r s .
Compound A c t i v i t y  ( p ! so) Reference
17 jOC 2.9830 162
18 ;oc 3.2596 162
19 .HN N ^ \
O '
3.3468 153
20
.HN
co:o 3.6383 153
21 01 cp; 3.3768 153
22 ,HN
r
3.8861 153
23
HN
& 3.2007 153
24
HN- K  ;0; O 3.7212 153
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JabJ_e 4 .1 . l__cont_ 
Selected inhib itors.
Compound Act iv i ty  ( p l 50) Reference
4.2757 153
3.0315 153
3.6198 165
4.7696 164
2.9586 163
8.0458 163
3.6198 163
3 . 1 9 3 8  163
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Tab!e 4 .1 .1  cont
Selected inhibitors.
Compound Activ i ty  ( p l 50) Reference
0
33 5.6198 163
0
34 ~S 4.4089 163
35 0 6.1549 163
Two approaches were made to derive QSAR's for  the ACE inh ib i to rs  
selected. The f i r s t  of these employed the programme MOREG (218) and an 
e n t i re ly  im p l ic i t  model of the receptor, that is simply invest igat ing  
the e f fe c t  of the inhib itor  molecule on i ts  surroundings at a va r ie ty  
of points defined by the model receptor. A second, minor approach 
considered the interaction of the inhibitors with a point charge model 
of the receptor s i te  described in chapter 2.
In both cases, the start ing point ("unbound" conformation) fo r  the 
consideration of the binding reaction was taken to be the global  
minimum energy conformation of the inhib itor  molecule. The size of the 
molecules under consideration precluded the use of SCF methods for  
geometry optimisation, so this was done by molecular mechanics. In 
general,  a number of start ing points were chosen, and the one with the 
lowest molecular mechanics energy on completion of the geometry 
optimisation was taken to be the global minimum. In a l l  cases for  the 
molecular mechanics geometry optimisation, an i n i t i a l  INDO calcu lat ion  
was performed on the molecule to obtain a set of charges for  inclusion  
in the optimisation. Only those atoms with charges considerably
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d i f fe r e n t  from zero were considered, a l l  other charges being set to 
zero. The "d ie le c t r ic  constant" in the molecular mechanics was set to 
4.0 throughout.
For both approaches the "bound" conformation of inh ib i to r  was taken 
to be that in which the inh ib i to r  was able to in teract  as e f fe c t i v e ly  
as possible with the constituents of the s i te  as described in chapter 
2. This was found simply by twist ing the molecule about single bonds 
unti l  a suitable  conformation had been obtained, al lowing no changes to 
occur in bond lengths or angles.
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4.2 Im p l i c i t  model o f  the receptor.
I n i t i a l  calculations at the INDO level of approximation were 
performed on both the "bound" and "unbound" conformations fo r  a series  
of 35 inhib itors  of ACE ( tab le  4 .1 .1 )  in order to obtain an estimate of  
the energy change involved in twisting the molecule from i ts  global 
minimum conformation into that necessary to bind to the model receptor  
s i te .
The bound conformations, along with the estimate of  the change in 
conformational energy, were then used as input to the programme MOREG 
(Molecular Orbital  and REGression). This programme was o r i g in a l l y  
writ ten to t re a t  a series of  molecules as a common "core" of  atoms plus 
a set of substituents. In view of the d ivers i ty  of the structures  
examined i t  was f e l t  desirable to keep this common core to a minimum, 
and only three atoms were used, the carbonyl oxygen and carbon atoms, 
and the atom a to the carbonyl group towards the carboxy terminus of  
the molecule. For molecules where the carbonyl group was not present,  
the corresponding atoms were taken to be the analogous carbon atom and 
one of  the hydrogens attached to i t .  Thus the only constant atom in 
the common core was the carbon, with the other two being variously  
oxygen or hydrogen in the one case or carbon, nitrogen or oxygen in the 
other.
The programme enables an INDO (or CNDO i f  desired) ca lcu la t ion  on 
each of  the input molecules to derive the molecular indices described 
in chapter 3, along with the monatomic and diatomic indices fo r  the 
atoms in the common core. In view of  changes in the common core of  
atoms from one molecule to another i t  was f e l t  that  any regression 
equations involving these quant it ies should be treated with a great  
deal of skepticism since i t  was not s t r i c t l y  speaking the same quant ity  
being calculated in each case. Addit ional ly ,  the programme calculates  
the e lec t ros ta t ic  po ten t ia l ,  e le c t r ic  f i e l d  and i ts  x, y and z 
components, and energy of  polar isat ion at a number of  user specif ied  
points around the molecule. These points are tabulated below.
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Table 4.2.1
Postulated "receptor points"
Poi nt Description Coordi nates
1 Zinc site 4 .629 , -4 .483 , -0 .903
2 carboxyl binding s i te 0.277, 3 .399, -3 .307
3 H-bonding site -1 .800,  0.000, 0.000
4 "control" 2.500, 7.000, 0.000
The axis system (of  relevance for  the in te rp re ta t ion  of  vector 
properties such as dipole moment and e le c t r ic  f i e l d )  was f ixed by 
placing the carbonyl oxygen of  an inh ib i to r  at  the o r ig in ,  the carbon 
of the carbonyl group on the posit ive x-axis ,  and the nitrogen of  the 
amide l in k  in the posit ive quadrant of  the xy plane, see f igure  4 .2 .1 .  
This allows the positions of the active s i te  fragments to be f ixed ,  and 
thus allows f i t t i n g  of a l l  inhibitors into  a common coordinate system.
Figure 4.2.1
A c t iv i t i e s  for  each of the compounds were obtained from the 
l i t e r a t u r e ,  and results using the rabbi t  lung enzyme under a set of  
standard conditions (see re f .  163) were selected. A number of  the 
compounds selected are imino-acid der ivat ives ,  and as such are capable 
of exist ing with the carboxyl group e i th er  cis or trans to the oxygen 
of the carbonyl group. NMR studies (163) of  such compounds suggest 
that the conformers are of  approximately equal s t a b i l i t y ,  and a 
solution contains equal amounts of each. Since i t  is un l ike ly  that  
both conformers are active, this conformational equil ibr ium e f fe c t i v e ly  
reduces the concentration of the in h ib i to r  by one h a l f ,  and as the 
purpose o f  this study was to attempt to examine the in t r in s ic  a c t i v i t y  
of molecules and not the ef fects of concentration, i t  was deemed to be
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reasonable to adjust the values of p l 50 to take account of  th is .
A c t iv i t ie s  in table 4.1.1 are before this adjustment was made. Except 
where spe c i f ic a l ly  stated, the regression equations are derived using
the adjusted values of  p l 50.
For each molecule, the calculated properties were stored, and 
l inear  regression analyses were then performed on the data.  Linear
regressions of  p l 50 on each of the recorded var iab les ,  each
possible pair of  variables and each possible set of  three variables  
were calculated. For pract ical  reasons, with more than s ix ty  variables  
present, for  the two and three variable cases only the best 25 
regressions (as determined by the variance r a t io  F) were kept fo r  
examination. Various other regressions, fo r  example of  p l 50 on the 
components of the dipole moment and of  the e le c t r ic  f i e l d  were also  
performed.
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4.2.1 One Variabl e Regressions.
The best 20 single variable regressions (excluding those on the 
monatomic and diatomic indices for the core atoms) are summarised in 
table 4 .2 .2 .  Figures in parentheses in the variable names signi fy  the 
points at  which e lect rostat ic  potential  etc.  were calculated.
Table 4 .2.2
Deti  20 r c i r c u i o n i  of p I jq on c * l cu l i t e d nd i ce i
P l 50 -  -2 .969 E (1) / - 0 .679  1
* 4.230 
- / - 0 . 22 2
r - 0 . 606. t - .250. F<1.331-19.14
P l 50 -o.ooonn e -  0.989 / - 0 . 0000268 * t * t * / - l  .327
r - 0 . 591. * - .267. F O .  3 3 ) - 1 7 . 73
P l 50 -0.01166 a * I I ’ / - O . 00278
* 4.060 
* / - 0 . 242
r - 0 . 590. « - .268, F ( l , 331-17.65
-1.727 L (1)  
/ - 0 . 424  1
♦ 2.909 
* / - 0 .4 52
r - 0 .578. t - .282. F ( l , 331-16.57
P l 50 0.250 nL / - 0 .063 h° C°
* 4.028 
+/ -0.251
r - 0 .572. 1 - .289. F ( l . 321-16.02
P l 50 -0.2433 AE / -0 . 077
* 6.628 
* / - 0 . 708
r - 0 . 480. $ - .378. FO . 3 3 1 -  9.88
P l 50 -0.8840 V , 0 )  / -0 .322
* 3 .735 
* 1 - 0 . 3 1 6
r - 0 . 431 . s = .418. F (1 .331-  7.52
P l 50 0.0341 V , M3 )  / - 0 .0127
*  2.967 
* / - 0 .721
r - 0 . 424. «- .423. F( 1,33}« 7.25
P l 50 -0.4615 Vt (3) / - 0 . 178
* 1.205 
* / - l .303
r - 0 . 412. s = .432 . F O . 3 3 1 -  6.73
P l 50 -0.2007 v /-O.Of.40
* 7.812 
* / - l .396
r - 0 .3 84. 1' .451 . F (1 .331-  5.72
P150 -0.00539  / - O . 00229
* 6.018 
* / - 0 . 6 79
r -0 .3  7 9. I - .454 . F f l . 3 3 1 -  5.55
P l 50 0.2397 U1(3) / -0 .1059
* 2.522 
* / - 0 . 920
r - 0 . 367, J- .462. F( 1.331-  5.12
P l 50 -0.7655 E (1)  / - 0 . 3  67 y
« 5.098 
♦ / -0 .370
r - 0 .342. 1“ .477 . F(1 .331-  4.36
p I 50 0.R653 E (3 1 / -0 . 452
♦ 2.071 
* / - l .307
r - 0 .316. $- .491 . F O . 3 3 1 -  3.67
P l 50 0.7 948 E (3) / -0 .4186 X
* 2.322 
+/ -1 .188
r - 0 . 314. s * .492. F O . 3 3 1 -  3.61
p , 50 6.855 1/Af  / - 4 .291
♦ 3.603 
* / - 0 .632
r - 0 .268. s - .514, F O . 3 3 1 -  2.55
p I 50 0.17 26 E. / - 0 . U 7  Iur °
♦ 2.6 92 
* 1 - 1 . 1 6 9
r -0 .249. s - .522 . F O . 3 3 1 -  2.18
Pl 50 -C.1710 V (1) / -O.  1252
* 3.602 
* / - .  725
r - 0 . 231 . 4- .529. FO .33 ) -  1 .86
p , 50 0.01566 V ^ t l )  / - 0 .0144
* 4.002 
* / - 0 .549
r - 0 . 186, 4 - .544 . F O . 3 31 -  1.18
p I 50 0.03813 ,, -0.0399 y
* 4 .672 
♦/ -0.303
r - 0 . 164. 4 “ .562 . F O . 3 3 1 -  0.91
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I t  can be seen from the values of r ,  the standard errors s, and the 
variance rat ios F that the great bulk of these regressions are quite  
poor. Six of the F values indicate s ta t is t i c a l  signi f icance at the 99% 
level ,  while a fur ther  six f a l l  between the values fo r  signif icance at  
the 95% and 99% levels (F>7.4 for 99% signif icance, 4.14 for  95%).
The six regressions which are s ign i f ican t  at the 99% level a l l  
involve variables for  which i t  is possible to envisage a re lated  
mechanism: E^  is re lated to the ease with which the molecule can
interact  with e lec t rophi1ic species, and the postulated active s i te  is 
made up o f  three e lectrophi les;  E  ^ the e le c t ro s ta t ic  energy is
related to solvation energies (see chapter 3 ) ,  and may thus r e f l e c t  the 
change in energy on passing from a medium of  high d ie le c t r i c  constant 
(the essent ia l ly  aqueous environment outside the enzyme) to an enzyme 
i n te r io r  which is quite possibly a considerably less polar environment; 
i t  was seen in chapter 1 that the product of  mean molecular 
polar isab i1i t y  and ionisation potential  is related to the a b i l i t y  o f  a 
molecule to take part in van der Waals' in teract ions,  and th is  quant ity  
is seen to have a negative coe f f ic ien t ,  possibly r e f le c t in g  that  a lack 
of polar character is not conducive to in teract ion  with a charged 
receptor s i te ;  the x, y and z components of  the e le c t r ic  f i e l d  at  the 
zinc s i te  might c lear ly  be related to the interact ion  with the z inc,  
( in  the coordinate frame defined, the atom which binds to the zinc is 
around 3 .7 ,  - 2 .8 ,  1 .6 ) .
The absence of  any single var iable  strongly correlated with
a c t iv i t y  is not at a l l  surprising in the l ig h t  o f  the complexity of  the 
system under consideration, with at least  three si tes making major 
contributions to the binding energy. Any single var iable  explaining
the bulk of var ia t ion  in p l 50 values would automatically imply that  
any other variables would necessari ly make only minor contr ibut ions,  
and this would be at odds both with the postulated mechanism and the 
experimental evidence described in chapter 2.
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4.2.2 Two Variable Regressions.
After  re ject ion  of regressions involving indices concerned with the 
core atoms from the best 25 two variable regressions, 20 remain. These 
are summarised in table 4 .2.3 ( F>5.3 for 997. s igni f icance) .
Table 4 .2 .3
F.e * t 20 r cgr c i i l on*  of pI 50
P l 50 -  -3 .117 E (1) + 0.270 E* (3> 1 .955 r -0 .+ / -0 .591 1 + / - 0 .07 8 ♦ - 0 .6  92
P l 50 -  -0 .0148 a* IP  -  8.699 V2 (3) 0.414 r -0.+ / -0 .0025 * 1 - 2 .429 + -1 .266
P l 50 -  0.133 + / -0 .036
M -  2.446 
1 +/ -0 .413
E (1)X 2.040-0.454
r -0.
P l 50 -  - 3 .230  + / -0 .602
E (1) + 1.017 
1 +7-0.311
E (3)X 1.384 -0.893
r -0.
P l 50 = -3.203 E (1)  + 1.081 E(3) 1.138 r -0 .+ / -0 .604 1 +/ -0 .337 + -0.984
P l 50 -  0.119 p -  0.015 a* IP 3 .729 r -0 .+ / -0 .036 1 + / -0 .003 + -0 .234
P l 50 -  -0 .006 p1 -  0.012 a* IP 5.636 r -0.♦ / -0 .002 +/ -0 .002 + -0.526
P l 50 » -0 .205 M -  0.012 a* IP 7.418 r -0 .+ / - 0 .065 + / - 0 .002 + -1.085
P l50 -  -2 .837 E (1) -  0.414 V j O ) 1.261 r -0 .+ / -0 .612 1 +/ -0 .140 + -1.024
P,50 = -2 .788 E (1)  + 0.030 V * (3) 2.665 r -0.+7-0.615 * +7-0.010 + -0 .572
P l 50 -  0.312 F. -  8.241 
a o * / - 2  .511
V2 (3) 0.216 r -0.
+ / -0 .05E "■ -1.312
P l 50 -  0.259 Ev -  0.006 +/ -0 .002
P* 5.617 r-0.
+7-0.055 + -0.537
P l 50 -  -3.493  +7-0.646
E (1) + 0.018 
1 ♦ / -0 .007
V *<2> 
♦
2.900
-0.512
r -0 .
P l 50 = 0.333 + / -0 .062
F.v + 0 . 1 1 6  hoco . ,  _ +/ -0 .066 Mz ♦
3.690 
-0 .248 i
r -0 .
P l 50 -  0.253 F.t -  0.205 homo , „
* / - 0 . 0 6 1
P 7.385 r-0.
+/ - 0 .056 -1 .110
P l50 -  -0  .00011F. -  0.186 + / - 0 . 00002 * t ‘ i / - 0 . 0 6 7
P 2.217
-1.673
r -0.
P l50 -  -0.0001 IF. -  0.005 + / - 0 . 00002 * 1* 1/ -0 .002
P ‘ 0.552 r -0.
- -1 .338
p I 50 -  -0.0052 p >  -  1.706 E (1) 4.376 r -0.+ / -0 .0018 +/ -0 .385 x ♦ -0.657
p I 50 -  -2.013  +/ -0 .399
E (1) -  7.107 
x * / - 2 .528
V2 (3)
+
0.913 
-1 .421
r -0.
p I 50 - -0.186 p  -  1.672 E (1) 5 .998 r -0.+ / -0 .068 +/ -0 .389 4 -1.204
«-1.086.  F ( 2 , 32 ) -18 .55  
* - 1 .088 ,  F ( 2 , 32 ) - 18 . 40  
* -1 . 095 .  F ( 2 .3 2 ) -1 8 . 00  
* -1 . 099 .  F ( 2 ,32 ) -17 .71  
* -1 . 104 .  F ( 2 . 3 2 ) - 1 7 .41 
* - 1 . 112 .  F(2 . 32 ) -1 6 . 94  
* - 1 .115 .  F ( 2 , 32 ) - 16 . 77  
* -1 .1 25 .  F ( 2 , 32 ) -1 6 .2 0  
* - 1 . 125 .  F ( 2 ,3 2 ) -1 6 . 19  
* -1 .128 ,  F(2 , 32 ) -1 6 . 03  
* - 1 .133 ,  F ( 2 . 32 ) - 15 . 76  
r,  , - 0 . 0 5 0 .  * - 1 .136 .  F ( 2 . 3 2 )»15.59 
* - 1 . 138 .  F ( 2 , 32 ) - 15 . 44  
* - 1 .146 .  F ( 2 , 32 ) -1 5 . 04  
* - 1 .149 .  F ( 2 , 32 ) - 14 . 85  
* - 1 . 156 .  F ( 2 . 32 ) - 14 . 52  
* -1 .1 58 .  F ( 2 , 32 ) - 14 . 34  
* -1 .162 .  F ( 2 , 32 ) -1 4 .1 9  
* -1 .166 .  f ( 2 , 3 2 ) - 1 3 .97 
* -1 .173 .  F ( 2 . 3 2 ) - 1 3 .64
1-2  
r 1 2 -0 .290
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Comparing with table 4 .2 .2  i t  can be seen that there is a marked 
improvement in both r and s values, while the F values are well in
excess of that which s ign i f ies  s t a t is t i c a l  signi f icance at the 99% 
level .  The r ^  column is the r factor  for  the cross-corre la t ion
between variables 1 and 2, and should be as close to zero as possible,  
since a value close to unity would imply that p l 50 was being
regressed on two more or less covariant var iables,  and any improvement 
in r and s values would simply be due to the reduction in the number of  
degrees of freedom of  the system. Notice that none of  the two var iable  
regressions has a higher F value than the best single var iable
regression. The signif icance of this and possible reasons fo r  i t  w i l l  
be discussed la te r .
Reasonable mechanistic interpretat ions of  the occurrence of  
variables in the regression equations can be postulated in a l l  cases, 
but rather than examine any par t icu la r  single equation in d e t a i l ,  i t  is 
more instruct ive  to examine the overall  picture presented by the whole 
set of 20 equations. The most frequent ly  occurring var iable  is 
Ez ( l ) ,  the z component of  the e le c t r ic  f i e l d  at the postulated s i te  
of the zinc atom and the best correlated single var iab le .  In f iv e  of  
i ts  six occurrences i t  is associated with variables at point ( 3 ) ,  the 
postulated s i te  of a hydrogen atom hydrogen-bonding to the in h ib i to r  
carbonyl, while in the other case i t  is associated with the square of  
the e lec t ros ta t ic  potential  in the v i c i n i t y  of  the proposed arginine  
residue which binds to the carboxyl group. The x component of  the 
e lec t r ic  f i e l d  at the zinc s i te  makes four appearances in the tab le ,  
once associated with the polar isat ion energy of the carboxyl binding 
site and three times with indices re lated to the dipole moment.
Dipole moment, i t s  square and i ts  z component appear eleven times
2
between them in the table .  \i and \x are reasonably correlated as 
single var iables, so th e i r  appearance is not surpr is ing,  but the three  
occurrences of  piz (which is very poorly correlated with a c t i v i t y  ( r 
= 0.11,  F ( l , 3 3 )  = 0 .41 ) )  are interest ing .  As single var iab les ,  both 
the x and y components are less badly correlated,  yet nei ther  of  these 
appear at a l l .  u appears with E ( l ) ,  the product of mean
Lm X
molecular po lar isab i1i t y  and ionisation potent ia l  a * IP ,  and ,
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and in a l l  cases causes a marked improvement in the values of r and s 
(though not F) compared to the corresponding single var iable  
regressions, suggesting that in teract ion  between the dipole of the 
inh ib i to r  and that of the protein at the active s i te  may make a 
noticeable secondary contribution to the energy of  binding.
As with the single var iable  regressions, i t  would be most 
surprising i f  any of the two var iable  regressions gave very high r 
values in so complex a system, and th is  is ref lected by the r values in 
table 4 .2 .3 ,  none of which are p a r t ic u la r ly  good.
I l l
4.2.3 Three Variable Regressions.
Having postulated that a minimum of  three important groups must be 
present on a molecule for i t  to be an e f fe c t ive  in h ib i to r ,  i t  would be 
hoped that  regressions involving three variables should s ta r t  to give 
reasonable agreement between theory and experiment. Af ter  re ject ion  of  
equations involving core atoms, eleven of  the best 25 remain. These 
are summarised in table 4 .2 .4 .  Once again, a l l  of  the F values are 
well in excess of that which s igni f ies  s ta t is t i c a l  s ig i f icance at  the 
99X level <F>4.5).
Table 4 .2 .4
Rcgrei i iom of pI^^ on three v i r i i b l e i
Pi
Pi
pi
pl
pi
Pi
Pl
Pi.
50
SC-
50
50
50
50
pi 50
Pi.
0 .121 * 0 029 a* IP 4 . 238 v. (2) -  0 808 r-0 840. t - 0 880. F(3. 1 1-24 76
->/ -0 .019 / - 0 .002 * / - R 318 -1 02 8
0 131 P z ♦ 0 .032 r ( i ) * 4 . 131 vn(3) 1 690 r -0 810. i-O 951 . F< 3. 1 ) -19 68
- / -2 716 / - 0 .367 / - 7 . 394 -1 174
0 3 96 ^hoiro * 0 054 7 . 3 90 v2(3) 0 573 r -0 810. * -0 952 . F ( 3 . 11-19 66* / -0 117 /-o 031 * / - 3 . 785 -1 106
0 314 ♦ 0 065 F. (1) ■4 4 . 803 F. (3) 3 079 r -0 803 . 1-0 966. F<3. 11-= 18 81
*1 -2 2 98 / - 0 367 * 1- 6. 267
z -0 517
0 431 ^hocc - 0 058 p , 7. 934 F (2) 3 873 r -0 802. t -0 96 8. F<3. 1 1-18 65*1 -0 198 1 - 0 038 - 1- 5 . 166 y -0 215
0 196 *  0 038 i: ( i ) 5 .093 F (2) 1 933 r -0 799. i«0 975. F ( 3 , 1 )■■18 .25
*1 -2 882 1 - 0 3 94 1 / - 7. 314 y -0 406
-4 267 n < i ) * 0 599 r. (2i - 7 . 11 8 V 2 <2> 2 240 r-0 796 . 1-0 9C1. F< 3 . 1 1-17 87
»/ -0 614 1 - 0 177 >■ _1- 3 . 4 76 i -0 4 85
-3 687 e c u * 0 565 V,2 <2> - 6 .527 r.i <3) 0 377 r -0 7 92 . 1-0 990. 1(3. 11-17 35»/ -0 017 1 - 0 006 - / .901 -0 876
0 136 t - 0 033 o*IP . 4 .157 * <3) 1 327 r -0 791 . 1-0 993. F (3 . 11-17 22* / - -0 015 1 - 0 002 - / -6 .402 -0 822
0 181 pz -  0 ■038 o-I I * . 4 .743 r.v<2> 3 920 r -0 7 90. i«0 993. F (3 . 1 >«= 17 20
* !■-0 01 8 1 - 0 003 * / -7 .099 -0 219
- 0 00017 f * 0 000024 ^ - 7 .050 r*rf 4 942 r -0 790. «* 0 993 . F< 3 . 1 1-17 20-0. 119 1 - 0 032 - / -3 .736 -2 069
Probably the most s t r ik ing  feature of  table 4 .2 .4  is the frequency 
of occurrence of yz - This variable appears in nine of  the eleven 
equations, a lbe i t  with rather large standard errors on the 
coeff ic ien ts ,  and this is quite c le a r ly  not a chance occurrence.  
Electrostat ic  potent ia ls,  po lar isat ion energies, the e le c t r ic  f i e l d  and 
i ts components along the axes are a l l  well represented in the table for  
all  o f  the sites at  which these properties were calculated,  with the
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exception of point ( 4 ) ,  the point not associated with any of  the
postulated binding si tes.  This is ,  of  course, not surprising in the
l ig h t  of  the fact  that the points were selected with a view to 
explaining and quantifying the experimental data, but i t  is very 
encouraging that  a quite small, in te rn a l ly  se l f -consistent  subset of  
the properties calculated for  such a diverse set of compounds is 
capable of providing a number of  reasonably good corre la t ions .  The 
fol lowing pages contain plots o f  calculated a c t i v i t y  (calculated from 
the least squares l ine )  against observed a c t i v i t y  fo r  the eleven 
equations in table 4 .2 .4 .
The appearance of  dipole moment (and most notably i ts  z component) 
in so many o f  the regressions is worthy o f  some comment. I t  should be 
borne in mind that  the concept o f  dipole moment fo r  an ionic species is 
not so simple as for  a neutral molecule since the summation iQr is no 
longer invar iant  to a change in the choice of axes ( th is  is a
consequence of  the def in i t io n  of  dipole moment, however, not a
breakdown of rotational or t rans la t iona l  invariance in the method of  
ca lcu la t ion ) .  Probably a r e l ia b le  quant i ta t ive  estimate of  a dipole  
moment in this circumstance could only be made a f te r  t ra ns la t ing  the 
molecule so that  i ts  centre of  charge is at the or ig in ,  to do this fo r  
a l l  o f  the molecules studied would have been d i f f i c u l t  and very 
time-consuming. Rather, and since a l l  of the molecules were put into  a 
common reference frame, i t  was hoped that  the calculated INDO dipole  
moments would q u a l i ta t iv e ly  r e f l e c t  the true dipoles. The role of  
dipole moment in the i n i t i a l  stages of  binding, where i t  may help in 
orient ing a molecule correctly  fo r  binding to a receptor s i te  by 
in teraction with the large local dipoles produced by the a -he l ices  o f  
protein structure was discussed b r i e f l y  in chapter 1, but i t  should be 
remembered that here i t  was the dipole moment of the bound molecule 
which was being estimated, rather  than of  the free molecule, so i t  is 
more l i k e ly  that  the emergence of  dipole moment in so many o f  the good 
regressions is more probably due to a dipole dipole in te rac t ion  in the 
bound state contributing to the binding energy.
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4.2.4 Extensions Beyond Three Variables
The choice of axes for the calculations performed was en t i re ly  
a r b i t r a r y ,  and simply provided a convenient framework within which to 
place the molecules and the fragments of the postulated receptor s i te .  
Consequently, i t  is quite j u s t i f i a b le  to redefine the axes used for the 
calculation of any of  the vector properties in any way which seems 
useful or appropriate.  Simply in aesthetic terms, with the goal of  
obtaining as good a regression as possible using as few variables as 
possible,  the obvious approach is to use a l l  of the components of the 
vector properties in a regression, and from the equation obtained 
extract  a set of  local axes for  each of the vector properties which
gives the best agreement between calculated and observed a c t i v i t i e s .
As well as being a convenient transformation to try  to improve the 
f i t  of  calculated to experimental data, i t  was hoped that the sets of  
local axes obtained might give a fur ther  insight  into the interactions  
taking place. Accordingly, a regression was performed using a l l  of the 
components of  the e le c t r ic  f i e l d  at the postulated receptor points 
(with the exception of point 4, the "control" point which does not
appear in any of the s t a t i s t i c a l l y  s ign i f ican t  regressions), 12 
variables in a l l .  With only 35 compounds in the data set,  this is
rather  too many variables to allow the equation to be given any real 
credence, since i t  is generally accepted that in regression analysis
the observations should outnumber the independent variables by at  least  
a fac tor  of f iv e .  The equation obtained, though being of  highly 
dubious s t a t is t i c a l  value does, however, al low a choice of local axes 
to be made for  each property.
Table 4 .2 .5
Property X y z
P -0.856 0.162 0.492
EF( 1) 0.456 0.008 -0.886
EF(2) -0.681 0.213 -0.701
EF(3) 0.570 0.427 0.701
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The unit  vectors of the directions of  best f i t  in terms of  the 
global x, y and z axes are shown in table 4 .2 .5 .  Having obtained the 
directions of best f i t ,  the projections of each of the vector  
properties along these directions were then calculated, and these 
quantit ies were used as independent var iables,  replacing the x, y and z 
components of  the vector properties.
I
QCJ
a
4o
o
Equation 4.2.1 gives the resul t ing  four var iab le  regression of  
p l50 on the transformed var iables, and a p lot  of  calculated against  
observed a c t i v i t y  is shown in f i g .  4 .2 .13 .  The values of  r ,  s and F
show the regression to be highly s ig n i f ic a n t ,  and the plot  shows that
the agreement of calculated to observed a c t i v i t y  is quite respectable.
p l 50 = 0 . 4 2 p ‘ + 15.7EJ + 0 . 3 1 5E^ + 4.66E^ -  2.21
+ / - . 0 3  + / - 1 . 3  + / - . 0 6  + / - . 3 9  + / - . 6 2  4 .2 . 1
r = 0 .926 ,  s = 0.662,  F ( 4 , 30 )  = 45.148
This equation, taking account of  both the magnitude and the
direct ion of  the calculated vector properties should provide a s ta r t ing
point for  fu r the r  extension of  the regression equations to larger  
numbers of  var iables,  and should hopefully al low the importance o f  any 
secondary interact ions to be assessed, for  example entropic e f fec ts  and
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t h e  i n f l u e n c e  o f  c o n f o r m a t i o n a l  e n e r g y ,  q u a n t i t i e s  w h i c h  d i d  n o t  a p p e a r  
i n  t h e  o r i g i n a l  e q u a t i o n s .  A c c o r d i n g l y ,  f i v e ,  s i x  a n d  s e v e n  v a r i a b l e  
r e g r e s s i o n s  w e r e  p e r f o r m e d  e m p l o y i n g  a s u b s e t  o f  t h e  d a t a  u s i n g  t h e s e  
f o u r  v a r i a b l e s  a s  t h e  s t a r t i n g  p o i n t .
Tables 4 .2 .6 ,  4 .2 .7 ,  4 .2.8 show the ten best f iv e  and six variable  
regressions and the six best seven variable regressions respectively.  
F values for 991 significance are 3 .7 ,  3 .5 ,  3.4 respect ively
Table 4 .2 .6
Regressions of p150 on five variables
pi50 - 0.4002 p‘ 
W-0.0476
P150 * 0.4169 p‘ 
W-0.0346
pi50 * 0.4180 p’ 
W-0.0347
PI50 - 0.4066 p' 
»/-0.0460
p150 " 0.4070 p‘ 
W-0.0455
p150 ■ 0.4186 p‘ 
W-0.0349
P150 “ 0.4184 p* 
W-0.0348
| p150 - 0.4165 p‘ 
| W-0.0347
| PI50 - 0.4195 p' 
| W-0.0355
=150 * 0.4197 p' 
W-0.0359
15.3182 £1 ♦ 0.2851 £2 ♦ 4.5273 £3 ♦ 1.
/-1.6318 W-0.0837 W-0.4772 W-2.
r- 0.927 s- 0.630 F(5.29)-35.287
15.7023 El * 0.3096 £2 ♦ 4.6609 £3 ♦ 0.
/-1 .3757 W-0.0619 W-0.3977 W-0.
r- 0.926 s- 0.631 f<5.29)-35.124
15.7393 £1 * 0.3088 £2 ♦ 4.6699 £3 * 0.
/-1.3645 W-0,0626 W-0.3980 W-0.
r- 0.926 s« 0.631 F(5.29)-35.1 12
15.6956 £1 ♦ 0.3211 E2 * 4.4776 £3 - 0.
/-1.3831 W-0.0629 W-0.6625 W-0.
r. 0.926 s- 0.631 F<5.291«35.088
15.6849 El ♦ 0.3198 £2 ♦ 4.4822 £3 - 0.
/-1.3901 W-0.0620 W-0.6576 W-0.
r- 0.926 s- 0.631 F(5.29)-35.083
15.7985 £1 ♦ 0.3123 £2 * 4.6804 £3 ♦ 0.
/-I.3598 W-0.0609 W-0.4007 * 1 - 0 .
r. 0.926 s- 0.631 £<5,291-35.083
15.7741 El , 0.3124 £2 ♦ 4.6768 £3. * 0.
/-1.3598 W-0.0609 W-0.3996 W-0.
r. 0.926 s- 0.631 F<5.291-35.079
15.8701 El * 0.3020 £2 ♦ 4.7225 £3 - 0.
/-1.3846 W-0.0726 *7-0.4376 W-0.
r- 0.926 s- 0.632 F<5.291-35.06!
15.7870 El * 0.3147 £2 * 4.6800 £3 - 0.
/-1.3602 W-0.0604 W-0.4021 W-0.
r- 0.926 s- 0.632 F<5.291-35.030
15.6474 £1 , 0.3171 £2 * 4.5635 £3 - 0.
/-1.4638 W-0.0610 W-0.5564 W -2.
r. 0.926 s- 0.632 £<5.291-35.007
‘'O-^Estat - (10-5 w-
0105 omQi 
0271 W-
0216 TIE.
0577 W-
0630 V1< 31 ■ 
1793 W-
0043 vT< 3> - 
0124 w-
0010 SA 
0028 W-
0011 Vol 
0033 W-
1133 V2<21 - 
3513 W-
0004 BE 
0014 ,/.
6464 v-.( 3) • 
5225 ‘ W  ■
2.5230
0.8788
2.4620
0.9108
2.4780
0.9584
2.2680
0.6552
2.0620
0.7612
2.4890 
1.0290
2.4600
0.9708
2.3470
0.7643
2.3880
0.8909
2.4290 
1.0680
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Table 4.2.7
M*r*t«1orn of pl%o on ''x variables
P150 - 0.4001 p‘ 
W-0.0335
pi50 • 0.4008 p1 
♦/-0.0341
pi50 « 0.3980 p‘ 
W-0.0345
p150 * 0.4214 p‘ 
W-0.0333
p150 * 0.4136 p' 
W-0.0342
pi50 * 0.4175 p‘ 
W-0.0334
p150 - 0.3943 p' 
W-0.0354
pi50 ■ 0.3946 p' 
W-0.0355
p150 * 0.4387 p‘ 
W-0.0366
p150 “ 0.4132 p' 
♦7-0.0344
14.6203 El 
/-1.3675
14.5966 El 
/-I.4092
14.4308 El 
/-I.4532
15.6458 El 
/-I.3005
14.8164 El 
/-I.3994
15.2364 El 
/-l.3345
14.2988 El 
/-I.5205
14.4540 El 
/-I.4949
15.5199 El 
/-l.3357
15.2252 El 
/-I.4014
0.2515 E2
-0.0626
- 0.938 s-
0.2633 E2
-0.0624
- 0.936 s-
0.2420 E2
-0.0682
- 0.936 s-
0.2792 E2
-0.0606
- 0.936 s-
0.2853 E2
-0.0599
- 0.935 s-
0.2835 £2
-0.0603
« 0.935 S =
0.2515 E2
-0.0672
- 0.93S s=
0.2608 E2
-0.0655
- 0.934 s=
0.3199 E2
-0.0590
- 0.933 s-
0.2706 E2
-0.0681
- 0.931 s-
♦ 4.5030 
,7-0.3816
♦ 4.4964 
W-0.3887
♦ 4.4481 
W-0.3946
♦ 4.8176 
► /-0.3889
>7-0.3904
* 4.7499 
W-0.3851
♦ 4.4978 
W-0.3917
♦ 4.4296 
W-0.4040
W-0.4019
♦ 4.6432 
W-0.3934
E3 * 0.0102 
W-0.0048 
28)-34.478
E3 ♦ 0.0096 
W-0.0051 
281-33.245
E3 - 0.1578 
W-0.0873 
,281-32.979
E3 - 2.1108 
W-l .0798 
,281-32.716
E3 - 0.0036 
W-0.0022 
,281-32.421
£3 - 1.9951
W-l .0586 
,281-32.397
E3 * 0.1468 
W-0.0777 
,281-32.340
E3 * 0.0607 
W-0.0382 
,281=32.088
E3 - 0.0068 
W-0.0042 
,281-31.177
E3 - 1.0278 
W-0.7738 
,281-30.324
SA
vol
AE
-0.2177 nrot -3.4360 
>7-0.0944 W-l.0440
,7-
0.1828 nrot -2.9720 
0.0884 W-0.9529
> / -
0.1706 nrot -2.8720 
0.0851 W-0.9329
rad
» / -
0.0177 SA W.1710 
0.0090 W-2.1150
BE
► 7-
0.1646 nrot -2.5640 
0.0866 W-0.8583
rad
> / -
0.0192 vol *1.4280 
0.0101 W-2.2630
°nol “ 
* / -
1.8247 rad *1.5320 
0.9797 W-2.3160
a-mo] —0.1426 —2.5820
0.0790 W-0.8799>7-
BE. - 
* / -
1.6392 rad *1.3220 
1.0265 *7-2.4800
rad
W-
0.1774 AE -0.3196 
0.1304 *7-1.8800
Table 4 .2 .8
Regressions of PI50 on seven variables
pi SO * 0.4026 p' *15.3467 El * 0.2193 E2 * 4.5986 £3 * 0.0634 SA -0.0568 vol -0.3109 nrot-5.0820
W-0.0327 *7-1.4123 W-0.0645 *7-0.3772 W-0.0344 W-0.0363 +/-0.1097 ♦ 7-1 .4650
r« 0.944 s- 0.574 F(7,27)«31.424
pl50 - 0.4053 p* *14.7074 El * 0.2372 E2 * 4.6360 E3 - 1.5793 rad *0.0211 SA -0.1805 nrot-0.5350
*7-0.0330 *7-1.3411 *7-0.0621 *7-0.3846 *7-1.0717 W-0.0088 W-0.0959 W-2.2180
r- 0.943 s- 0.577 F<7,277=31.100
PI50 - 0.4253 p‘ *15.8474 El ♦ 0.2670 E2 * 4.8024 E3 - 0.1915 a^i+0.0339 SA -0.3191 nrot-4.8H0 
W-0.0370 -*7-1.5794 *7-0.0623 */-0.4260 */-0.1304 */-0.01G9 */-0.U54 *7-1.3870
r- 0.943 s= 0.577 F(7.277-31.080
pi SO - 0.3695 p' *14.6016 El * 0.1930 E2 * 4.4019 E3 * 0.0098 BE * 0.0315 SA -0.2622 nrot-4.8250 
♦ 7-0.0413 ♦/-1 .3545 *7-0.0779 *7-0.3866 W-0.0079 W-0.0178 W-0.1001 *7-1.5230
r. 0.942 s- 0.583 F<7 .277-30.348
pi50 - 0.3939 p' *14.6999 El * 0.1887 E2 * 4.5663 E3 * 0.0113 SA * 0.0639 E(2)-0.2659 nrot-3.7970
*7-0.0337 W-1.3605 *7-0.0823 *7-0.3831 W-0.0048 W-0.0S48 W-0.1025 *7-1.0830
r. 0.942 s= 0.585 F(7.271-30.127
pl50 = 0.3767 p1 *14.6619 El * 0.2738 E2 ♦ 4.0789 E3 * 0.1363 c1um0*.0147 SA -0.2470 nrot-4.8310 
*7-0.0391 * /-1.3605 W-0.0652 W-0.5303 W-0.1 190 */-0.0062 0.0973 1.6010
r. 0.941 s- 0.586 F<7.271-30.068
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The most s t r ik ing  feature of these tables is the preponderance of
indices which were included to give a measure of entropy changes, thus
the three descriptors of  molecular size (radius,  surface area and 
volume) a l l  occur with reasonable re g u la r i ty ,  as does nro -^» the 
number of  f r e e ly  rotatable  bonds in the in h ib i to r  molecule.
nrot aPPears consistently  with a negative c o e f f ic ie n t ,  which is 
reasonable because a constrained inh ib i to r  w i l l  lose less entropy on 
binding than w i l l  a more f l e x ib l e  in h ib i to r .  Surface area appears 
consistently with a posit ive c o e f f ic ie n t ,  which is also reasonable as 
i t  is a measure of energy required to form a cavity  in the solvent  
which w i l l  contain the molecule. I f  th is energy is large,  then i t  
would be expected that binding to an enzyme would be a favourable  
process.
I t  might be expected that the volume would appear with a posit ive  
coe f f ic ien t ,  as this w i l l  be an ind irec t  measure of  the amount of
solvent which w i l l  be expelled from the act ive s i te  of  the enzyme on
binding, an entrop ica l ly  favourable process. This is found to be the 
case for  the f i v e  and six var iable regressions, but in the seven 
variable regression, i t  appears with a small negative c o e f f ic ie n t .  
There may be a mechanistic explanation fo r  th is .  A l te r n a t iv e ly ,  i t  may 
simply be a chance corre la t ion .
To summarise, i t  appears that  the f i r s t  four variables account for  
the enthalpic interact ions between drug and receptor,  and subsequent 
variables appear to be accounting fo r  the entropic changes in the 
binding reaction.
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4.3 E f fec t  o f  the SQLVATON model on the regressions.
I t  has already been noted that  an isolated molecule in vacuo is in 
a l l  l ike l ihood a very poor re f le c t io n  of  the surroundings of  a drug 
molecule at a receptor s i te .  In an attempt to address th is  c r i t ic ism ,  
calculat ions on the "bound"conformation of  the set of  molecules were 
repeated using the SOLVATON model. I n i t i a l l y ,  the in tent ion  was to 
invest igate the e f fec t  of  the model on the conformational energy change 
required to tw is t  the molecule from i ts  global minimum to the bound
conformation, but when the shortcomings of  the model in calculat ing  
to ta l  energies fo r  charged species became c lear ,  i t  was f e l t  that  i t  
would be more prof i tab le  to examine the e f fe c t  of the model on such 
properties as e lec t ros ta t ic  potent ia ls  and polar isat ion energies rather  
than on a property which is poorly calculated and which, furthermore,  
would be expected to make only a secondary contribution to a c t i v i t y .  
Calculations were performed using a d ie le c t r i c  constant of  4 .0 .  The
calculated data are tabulated in appendix D2.
Examination with the data in appendix D2 and comparison with 
appendix D1 shows that while the numbers have changed fo r  a l l  of  the 
calculated properties,  the di fferences are o f  degree ra ther  than of  
magnitude or sign. Among so many numbers i t  is c lear ly  impossible to 
judge the overall  effects of  the model simply by examination, so the 
multip le  regression technique was once again used.
Table 4.3.1 shows the ten best single var iable  regressions. As was 
the case without the use of  the SOLVATON model, none of  these
regressions is good (as judged by r ,  s or F values),  and these w i l l  be 
discussed no fu r the r .
The best 2 variable regressions are summarised in table  4 .3 .2 .
Comparison with table 4 .2 .2  shows that  agreement between calculated and
observed a c t i v i t i e s  is s l ig h t l y  worse than that  seen in the absence of
the SOLVATON model, but the spread of  variables in the table  is very
2
s im i la r ,  with several occurrences each of  p, p and p , a* IP  and
various properties at points around the molecule, in p a r t ic u la r  at  
point ( 1 ) ,  the postulated zinc s i te .
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Tab l e  4 . 3 . 1
Regressions of p150 on °ne variable
P 150 ' 
P150 ■ 
PI50 * 
Pi50 - 
Pi50 - 
Pi50 - 
Pi50 * 
Pl50 ' 
Pi50 ' 
Pl50 *
- 1 •»10'^Ect-0 .9888 
• /-2.3.10- 5 W-l.3270
-0.0117 a*IP * <.0600 
W-0.0028 W-0.2415
-1.3455 Ex<1 )♦ 3.0330 
► / - 0.3361 W-0.4311
0.2501chomo* 4.0280 
W-0.0625 W-0.2511
-4.3355 V2<13♦ 3.0990 
W-l.1147 W-0.4281
-0.2433 A 
- /-0.0774
- 6.6280 
< /-0.7076
0.1976 E2(l). 3.3030 
W-0.0664 W-0.4736
0.0229 v}(l)« 3.3340 
./-0.0084 W-0.5002
0.5626 E(1) - 3.2670 
W-0.2243 W-0.5582
-0.2151 V,(l), 3.0910 
W-0.0894 W-0.6454
0.591 s 
0.590 s 
0.573 s 
0.572 s 
0.S61 s 
0.460 s 
0.460 s 
0.428 s 
0.400 s 
0.386 s
1.267 f ( 1 
1 .268 f<1 
I .288 f(1 
1.289 £ (1 
1.301 £(1 
1.378 r< 1 
1.395 f (1 
•1.420 m  
1.440 F(1 
1.449 f<1
,33)-17.730 
.335-17.654 
.33)-16.123 
.335-16.015 
.335-15.127 
.335- 9.864 
.335- 8.867 
.33). 7.390 
.335- 6.292 
.335- 5.785
Table 4 .3.2
Regressions of pl5Q on two variables
P JS0 
Pi 50 
Pi 50 
! Pi 50 
pi SO 
PJ50
L cKo 
; p i  so 
i pi so1j
Pl 50
0.1329 pz - 
W-0.0400 W-
0.1455 pz - 
W-0.0414 W-
0.1510 pz - 
W-0.0424 \/-
-0.2320 p - 
W-0 0736 W-
-0.0054 p2 - 
W-0.0017 ./-
-0.0063 p 2 - 
w-0.0018 W  -
-0.2695 p 
w-0.0765 W-
0 C"j56 •..*
. / - 0 oO 18 W-
-0.2416 p 
w-0.0762 W-
0 3817c homo' 
W-0.0700 W
0.0179
0.0031
2.2074
0.3789
7.3290 
1.2743
0.0183
0.0032
0.0173
0.0031
7.1670 
1.2665
7.5744
1 .3518
2 .0879 
0.3764
2 . 1947 
•0.3697
•0.0055
•0.0016
x*IP
W-
£ X < 1 )
W
V2<1)
w
O* I P - 
w
a* I P •
V2 ( 1 5 
- /
V2( 1 5
W-
£,( 1 5 -
3.8750
0.2188
•2.1540
-0.4482
•2.1860
-0.4483
8.2300 
-1.3390
5.8500
-0.6106
•4.5230
-0.5542
•7.1630 
1 .2470
4.3410 
0.5593
£ , < 1 5 •6.7150 
1- I.2230
- 5.8300 
WO.6228
r .  0 . 7 1 6  S -  
r -  0 . 7 1 8  S -  
r -  0 . 7 1 3  S -  
r .  0 . 7 0 9  S -  
r -  0 . 7 0 8  s -  
t -  0 . 7 0 6  S -  
r -  0 . 7 0 6  s -  
r .  0 . 7 0 1  s -  
r -  0 . 6 9 9  S -  
r -  0 . 6 9 4  s -
.111 £(2.325-17.021 
.111 £(2.325-17.015 
.118 £(2.325-16.586 
.125 £(2.325-16.194 
. 127 £(2.325-16.087 
.126 £(2.325-16.048 
.130 £( 2.32 5- 15.924 
.139 f (2.32 5.16.474 
.141 f( 2 . 37 5- 16.291 
.148 £(2.32 5-14.696
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In table 4 .3 .3 ,  as with table 4 .2 .3 ,  the appearance of pz in each 
of the regressions is quite strik ing once again. The other variables
present in the table re f lec t  closely those seen in table 4 .2 .3 ,  with 
properties at a l l  of the postulated receptor points, Eh and <x*IP 
a l l  appearing. The size indices radius, surface area and volume also 
appear. As was the case with two variable regressions, the agreement
between calculated and observed a c t iv i t y  is somewhat worse for the
calculations using the SOLVATON model than for those performed without
i t .
Table 4 .3 .3
Regressions of PI50 on three variables
0.966 F(3.31>-18.772 
0.975 6(3.30-18.257 
0.988 6(3,30-17.490 
0.992 6(3.30-17.295 
0.992 6(3.30-17.287
1
0.995 6(3.30-17.082 
1.000 6(3.30-16.842
I
1.003 6(3.30-16.654 
1 .003 6(3.30-16.649
1.003 6(3.30-16.649
pK <3 - 0.5154cnorrso * 0.2232 p2 * 0.6463 Ey(2)- 4.0930
0-0.0688 0-0.0430 0  -0.1709 0  -0 .2 0 84 r- 0.803 s
pi50 »-l-Sxl0-4Estat*0.1360 p2 - 2.8066 r  ♦ 5.6680
O-3.5xl0~S 0-0.0343 0-0.6287 0-2.0530 r- 0.799 s
PI50 - 0.3478 p2 -2’.6126 EX<1>- 5.8949 E2(3> ♦ 3.0520
0-0.0754 0-0.3619 0-1.9173 0-0.4943 r- 0.793 s
pl50 - 0.1345 p2 -0.0191 a*!P- 5.0030 V2(3) ♦ 1.4010
0  - 0.0357 0  -0.0028 0-1.6529 0  - 0.8402 r. 0.791
plSO - 0.1773 p2 -8.5942 V2(l), 0.8469 E(3) - 0.5086
0-0.0385 0-1.2011 . 0-0.2721 0-0.9528 r- 0.791 s
pi SO - 0.2001 P2 -0.0217 a*IP« 0.4972 Ey(2) ♦ 4.1280
0  -0.0424 0-0.0030 0  -0.1671 0  - 0.2137 r. 0.789 s
pl50 — 2.0xl0-4£stat-0.1403 p2 - 0.0255 vol - 0.3591
0 -2 .8x10-5 O-0.0360 0  -0.0061 0-1.2160 r- 0.787 s
PI50 - 0.3488 p2 -6.6240 V2(l)» 5.7438 E2(3) 3.0730
0-0.0769 -/-1.2242 0-1.9415 0-0.5016 r- 0.786 s
p! 50 - 0.1776 p2 -8.5070 V2(1), 0.7139 Ex(3) -0.0617
0-0.0391 0-1.2108 0 -0 .2414 0  -0.8599 r. 0.785 s
PI50 * 0.2123 p2 -2.6509 Ex(l> - 0.4804 V?(3> -0.0617
0-0.0391 0-1.2106 0-0.2414 0-0.8599 r .  0.785 s
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4.3.2 Extensions beyond three v a r ia b 1es .
As with the calculations without the SOLVATON model, the local axes 
for each of the calculated vector properties were redefined, and the 
projections of the properties along the directions of best f i t  were
calculated as subsidiary variables for  extension of  the regression
equations to 4 variables and beyond. Table 4 .3 .4  shows the d irect ion
cosines of the directions of best f i t  in the global axes, and equation
4.3.1 is the regression equation obtained using the four subsidiary  
vari ables.
Table 4 .3 .4
Property X y z
p 0.280 -0.145 0.949
EF( 1) -0.696 0.576 -0.429
EF( 2) -0.142 0.990 0.001
EF( 3) -0.004 -0.001 0.999
p l 50 = 0 . 387p' + 3 .54E '1 + . 702E' 2 + 4 .18E '3 + 2.05 4.3.1
+ / - .065  + / - .472  +/- .201 + / -1 .79  + / - .657
r=0 .885, s=0.883, F(4,30)=18.660
Figure 4.3.1
QU
O
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Figure 4.3.1 is a plot of calculated against observed a c t i v i t y  for  
this equation. I t  can be c lear ly  seen that agreement with the use of  
the SOLVATON model is considerably worse than that obtained without i t .
Comparison of table 4 .3 .4  with table 4 .2 .4  shows that the directions  
of best f i t  have changed for each of the properties. In each case, the 
changes are not small, and for the e lec t r ic  f i e l d  at point (1) the 
angle between the unit  vector obtained with the SOLVATON model and that  
obtained without i t  is almost 90°. The reasons for this and the i r  
significance can only be guessed at.  I t  is also very noticeable that  
the agreement is much worse than was the case without the SOLVATON 
model.
Tables 4 .3 .5 ,  4 .3 .6  amd 4.3 .7  summarise the best f i v e ,  six and seven 
variable regressions respectively.  Comparison with the equivalent  
tables in section 4.2 show that the regressions are without exception 
considerably worse. Furthermore, the great preponderance of  entropic  
variables seen in tables 4 .2 .5 ,  4 .2 .6 ,  4 .2 .7  is not observed here.
Table 4 .3 .5
Regressions of p150 on f've variables
Pi 50
j Pi 50 
I
! P150
i
i pl 50
I
i pl 50
j
| Pl50
i1
! Pl SO 
I p! 50
i
i PlSO
P 1 50
- 0.3836 
■/-0.0659
- 0.3720 
■/-0.0685
- 0.3895 
./-0.0661
- 0.3683 
W-0.0724
- 0.3843 
W-0.0665
- 0.3877 
►/-0.0663
- 0.3899 
W-0.0666
- 0.3691 
W-0.0665
- 0.3894 
W-0.0668
- 0.3875 
W-0.0665
3.5444 El « 
/-0.4249
3.2571 El • 
/-0.5569
3.5710 El - 
/-0.4285
3.4392 El • 
/—0.4575
3.5232 El • 
/-0.4299
3.5568 El 
/-0.4290
3.5668 El 
/-0.4309
3.6032 El 
/-0.451S
3.S727 El 
/-0.4378
3.5446 El 
/-0.4294
0.6228 E2 » 
W-0.2238
0.6071 E2 * 
W-0.2354
0.6510 E2 ♦ 
W-0.2172
0.6033 E2 * 
W-0.2562
0.6515 E2 . 
W-0.2265
0.6541 E2 . 
W-0.2265
. 0.6506 E2 ♦
*/-0.2 301
0.6990 E2 . 
./-0.2049
0.7122 E2 * 
W-0.2072
0.7348 E2 . 
W-0.2335
4.2818 E 
W-l .8021
4.2074 E 
W-l .8005
4.4125 E 
W-l .8370
3.9648 E 
W-l .8395
4.2944 E 
W-l .8243
4.3466 E 
W-l .8425
4.4051 E 
W-l .8689
4.2634 E 
W-l .8245
4.2049 E 
W-l .8176
4.1572 E 
W-l .8193
0.0729 
W-0.0870
0.0000 
W-0.0000
0.0357 
W-0.0527
1.2655 
W-l .9864
0.0213 
■/-0.0411
0.0026 
W-0.0053
0.0023 
W-0.0047
1.3268 
W-3.1648
0.0552 
W-0.1652
0.0204 
W-0.0694
AE - 1.2430
W-l.1680
BE - 1.2460
W-l .2050
Estdf  1 -4580 
W-l .0970
V2<3) W.3890 
W-l .2320
amo1 * 1.6130 
W-l .0770
v o l  * 1.5610 
W-l. 1960
SA ♦ 1.5050 
W-l .3030
1/A .2.1600
W-0.7165
V2(2). 2.0570 
W-0.6681
E?<3>. 2.2200 
W-0.8843
r- 0.849 s- 0.887 F<5.291-14.921 
r- 0.848 s- 0.888 E(5.29)-14.875 
r- 0.847 s- 0.891 F<5.29)-14.752 
r- 0.847 s- 0.891 F<5.291-14.714 
r- 0.846 s- 0.893 F<5.291-14.617. 
r- 0.846 s- 0.894 F(5.291-14.600 
r .  0.846 s- 0.894 F(5.29)-i4.596 
r -  0 .846 s- 0.895 F(5 .29)- 14.553 
r .  0.845 s- 0.896 F(5.291-14.508 
r -  0.845 S -  0.896 F(5.29)- 14.491
Table 4.3.6
Regressions of p150 °n ^,)l variables
PI5Q - 0 .3609  m '
w - 0 . 0644
P150 * 0 . 3482 p ‘
W - 0 . 0662
P150 * 0.3261 p ‘
W - 0 . 0750
P150 * 0 . 3020  p -
w - 0 . 0815
Pi50 ‘  0 .3426 p ‘
W - 0 . 0729
P150 -  0 .3580  p ’
W - 0 . 0680
PI50 * 0.3765 p'
W-0.0659
. 3 .5526 [1
W - 0 . 4073
. 3.4305 El
W-0.4212
. 3.2274 El
W - 0 . 4665
* 2 .2853 El
W - 0 . 8427
. 3.3091 El
W-0.4596
. 3 .4946 El
W - 0 . 4226
r 3.5781 El 
W-0.4224
* 0.8567 E2 * 2.7757 E3 - 0.2846
W-0.2299 W-l.9229 W-0.1325
■ 0.868 s- 0.846 f(6.28)-14.301
- 0.7072 E2 - 2.7620 E3 - 1.6598
W-0.2251 2.011 1 W-l. 0644
0.862 s- 0.866 f<6,28)-13.453
- 0.6425 E2 - 2.4490 E3 * 0.1832
W-0.2196 W-2.1456 W-0.1125
0.861 s- 0.868 f(6 .28)-13.347
- 0.6311 E2 - 2.5050 E3 - 0.000)
W-0.2309 W-2.0910 W-0.0001
0.861 s- 0.869 7(6.28).13.326
- 0.6911 E2 * 2.8954 E3 - 0.1042
W-0.2153 W-2.0969 W-0.0707
0.858 s- 0.875 F(6.28).I 3.064
- 0.7319 £2 - 3.0985 E3 - 2.2170
W-0.2281 W - 1.9932 W-l.4986
0.858 s- 0.876 F(6.28)-I3.030
- 0.6995 1 2 ♦ 3.5860 E3 - 2.2311
W-0.2280 W-1.9138 -/-1.5094
0.858 s- 0.876 F(6.28)-13.025
Estat -2.9747rad - 8.1800 
W-l.4660 W-3.4730
rad * 0.2834 a£ * 4.9650 
W-0.1595 W-2.6460
AE - 0.1886 nrot *0.8592 
W-0.1256 W - 1.1 720
BE - 1.6327 rad * 4.7950 
W-l.0800 W-2 .6270
E ' S 6 2  nrot *1.1510 
*/-0.1309 */-!.!000
rad * 0.0210 vol 6.1700 
W-0.0135 W-3.3280
rad * 0.0189 SA. 5.6930 
W-0.0122 W-3.1080
Table 4 .3 .7
Regressions of PI50 on seven variables
PJ50 * 
Pi 50 -
I
j
i pi50 "
;
• Pi50 *1
! Pi 50 - 
pi50 - 
Pi 50 * 
Pi50 * 
- Plso - 
1 PlSO *
0.3248  p ‘ 
W - 0 . 0722
r*
0 .3372 p ‘ 
W - 0 . 0662 *
0 .3020  p 1 
W - 0 . 0784
0.2806  p ‘
W - 0 . 0796 •
0.2925 p’ 
W-0.0751
0.3134 p- 
W-0.0752 *
0.3315 p ‘ 
/-«.0695
0.3560 p'  
W-0.0643
0 . 3360  p'
w - 0 . 0616
0.3094 p‘ 
W-0.0738 *
3.7335
0 .5297  
0 .877 s-
3.4701  
-0 . 4072  
0 .877 s-
2.6157  
- 0 . 8 3 20  
0.877 s-
1.9498  
- 0 . 8358  
0 .676  s-
2.8164  
- 0 . 5098  
0 .676 s-
6.0513  
- 2 . 1 2 70  
0 .875 s-
4 .2420  
- 0 . 7466  
0 .874 s-
3.5940  
- 0 . 4076  
0.874 s-
0.4466  
-1 . 8593  
0.874 s-
3.3668  
- 0 . 4624  
0 .874 s*
El * 0. 
* / - 0 . 
0 .836
£1 *  0 . 
* / - 0 . 
0 .836
El * 0.  
* / - 0 . 
0 .836
El * 0.
W - 0 .
0 .839
El * 0.
W - 0 .
0 .839
El . 0.
W - 0 .
0 .840
El * 0.
W - 0 .
0 .843
El  * 0 .  
W - 0 .  
0.843
El * 0.
W - 0 .
0.644
El * 0.
W - 0 .
0 .845
5799 E2 
2141 *
f<7,27).
8285 E2 
2281 * 
F( 7.27 )■
7741 E2
2362 *
F( 7.27 )«
5007 E2 
2351
F< 7 ,27 )■
5726 £2 
216!
F ( 7 .27 )•
7996 E2 
2331 *
F< 7.27)-
8050 E2 
2339 *
F(7.27).
6248 f? 
2310 *
F(7.27).
6016 E2 
2250 •
F <7.277-
5546 E2 
22 07 
F< 7.27)■
* 2.0791 
W-2.0748 
.12.818
* 1.9998 
W-l .9897 
.12.812
* 1.7736 
W-2.0541 
.12.782
* 2.4408 
W-2.0188 
.12.694
* 1.7617 
W-2.1123 
•12.665
* 1.8072 
W-2.0729
* 12.651
* 1.9599 
W-2.0544
* 12.522
* l 9454 
W-2.0613 
.12 514
. 2.7971 
W-2.0389 
.12.489
* 2.2109 
W-2.0938
12.440
E3 * 0.1810 A * 0.3707 AE - 0.3221nrot -2.9550
W-0.1006 W-0.1S02 * /-0.1418 W-2.4010
E3 - 0.2371Estat-3.6680 rad * 0.2088 AE *9.1830 
W-0.13S8 * /-1.5419 W-0.1597 W-3.5150
£3 - 0.0001 BE - 0.2419Es m -3.7Ul rad *9.1800 
W-0.0001 W-0.1351 * /-1.5580 W-3.5200
E3 * 0.1856 A - 0 
W-0.1063 w- 0 .
E3 ♦ 0.1904c1umo’O. 
W - 0 . HOG w- 0 .
£3 - 0 . 3545Es U t -3.  
W - 0 .  14 36 W-l
E3 - 0 . 3G36£s t a r 3. 
W - 0 . 1502 W-l.
£3 - 0 . 3 5 07 Es t a t - 3 .  
W - 0 . 1452 W - 1 .
E3 - 0 .0002 e£ -3.  
W-0.000! W-l
E 3 -  5.7674 1/A 0.
W - 3 . 6 0 8 9  W - 0 .
0002 BE - 
0001 */-
3728 AE - 
1548 */■
2.5057 rad 
1.1562 */
0 . 2996  nr 0 { 
0 . 1376
6567 rad 
5625 * /
7433 rad 
6)91 W
6520 rad 
5866 W
-0.6779E?< 1 )• 
- 0 . 5666  W-
►2.7220
-2.8000
- 2 . 2450  
- 2 . 1300
8 . 9500
3.5060
- 0.0261V?(1) •  
- 0 .0237 W ■
0.0700V](2). 
-0.0640 W-
0688 rad . 
3677 W-
3004 a£ - 
1317 */■
1 .8693 E] * 
1.1424 W
0 .2 5 96  nr0. 
0.1301 * /
9 . 5330  I 
3.6720
9.8030
3.7660
6.9430
-2 .8700
* 0 . 3542  
- I .1840
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4.4 General Comments on the Regression Equations.
The dangers of searching through large sets of numbers for  good 
s t a t i s t i c a l  correlat ions has been highlighted in the context of  QSARs 
by Topliss and Edwards (219) .  C lear ly ,  the "blunderbuss" approach 
employed in this work in the development of  one, two and three var iable  
regressions and the extension of  the four var iable equation to larger  
numbers of  var iables,  t ry ing a l l  possible combinations of  variables and 
simply picking out the good corre la t ions,  is l i k e ly  to produce chance 
corre la t ions.  However, the reg u la r i ty  of  appearance of  the variables  
in the equations in tables 4.2.1 to 4 .2 .3  (and indeed in the 
regressions which were neglected fo r  the reasons already stated)  
suggests that  chance is un l ike ly  to be the reason for  th e i r  occurrence.
The only c r i te r io n  by which the reasonableness of the equations can 
be judged (aside from the s t a t is t i c a l  s igni f icance)  is the a b i l i t y  to 
f ind a reasonable mechanistic in te rp re ta t ion  for  the occurrence of  the 
variables there in .  In the q u a l i ta t iv e  sense, the choice of  variables  
to be examined in this study almost automatically forces the 
p o s s ib i l i t y  of  a mechanistic in te rp re ta t io n ,  in p a r t ic u la r  the choice 
of the three points corresponding to specif ic  groups on the postulated 
receptor s i te .  I t  is ,  however, encouraging to note that properties at  
the fourth point do not feature in any of  the s ign i f ican t  regressions.
Q u ant i ta t iv e ly ,  the coe f f ic ien ts  o f  the variables can be examined, 
in conjunction with the numerical values of the corresponding 
propert ies,  and the r e la t i v e  contributions to the a c t i v i t y  of  a 
p a r t ic u la r  molecule can be estimated in this way. The experimental 
evidence suggests that the three pr incipal binding si tes are of  
comparable importance, and removal of  any one o f  these leads to a 
simi lar  loss o f  a c t i v i t y .  S im i la r ly ,  the interact ions which are 
thought to be o f  secondary importance should make a concomitantly 
smaller contr ibut ion.  While a model which does not conform precisely  
to these c r i t e r i a  may well not be completely wrong, and indeed may be 
pointing to a deficiency in the model, or the importance of  an 
in teract ion  neglected in a s im pl is t ic  q u a l i ta t iv e  approach, i t  is only 
reasonable to expect the r e la t iv e  signs and magnitudes of  the various 
contributions to the calculated value o f  pI^Q to bear out broadly the
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l i k e l y  mechanism o f  i n te ra c t io n .
Another very rapid guide to the reasonableness of  any par t icu la r  
regression is. the constant term. C lear ly ,  as values of  pI^Q are 
being regressed on the calculated data, and these vary from around 2.5 
to 8, i t  would be very surprising to f ind  a constant term fa r  outside 
this range. More s p e c i f ic a l ly ,  since a compound lacking any of  the 
specif ic  essential  features would be expected to be a very poor 
i n h ib i to r  ( fo r  example urea is reported (147) to s l ig h t ly  in h ib i t  the 
enzyme at  concentrations in excess of 2M), i t  would be expected that  
the specif ic  interact ions should make a net posit ive contribut ion to 
p l 50. This implies that the lowest p l 50 value should be 
considered as an upper l im i t  on the constant term in the regressions,  
with the numerical value in a l l  p robabi l i ty  being quite close to zero,  
or s l ig h t l y  negative. The equations developed thus fa r  have only been 
commented upon in purely qu a l i ta t iv e  terms, and having now developed a 
framework in which they can be examined, i t  is imperative to do so. 
This framework, while c lear ly  a gross overs impl i f icat ion  of the 
s i tua t ion ,  nonetheless represents a reference point for  an examination 
of the r e la t iv e  importance of the various interactions.
On examination of  the constant terms in the tables in sections 4.2 
and 4 .3 ,  i t  is very noticeable that the best regressions using the 
SOLVATON model have in general quite large posit ive values while those 
obtained with unperturbed INDO calculations are the small negative 
values that  would be hoped fo r .
The quite poor agreement between calculated and observed a c t i v i t i e s  
fo r  the one and two variable  regressions suggests that a consideration 
of the equations in these terms is l i k e ly  to be a f u t i l e  exercise.  For 
the three var iable  regressions, however, a reasonable agreement can be 
seen in a l l  cases. Extensions beyond three var iables,  p a r t ic u la r l y  for  
the unperturbed INDO calculat ions,  gives r ise  to equations which are 
quite s ig n i f ican t  as judged by th e i r  F values, and which furthermore 
explain quite well the var ia t ion  in a c t i v i t y  across the series of  
compounds.
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The in te rpre ta t ion  of  the a c t i v i t i e s  of the chosen group of  
compounds provides an in terest ing  exercise in regression analysis.  
While the values of  p l 50 show a more or less continuous spread 
between 2.5 and 8 .3 ,  the same cannot in general be said of any of the 
properties which were calculated (see Appendix D ) . These tend to f a l l  
into quite c lear ly  defined groups depending on the p a r t ic u la r  type of  
molecule, for  example e le c t ro s ta t ic  potent ia ls at the zinc s i te  are in 
quite d is t in c t  ranges for  the mercaptan inh ib i to rs ,  succinate 
inh ib i tors  and dipeptide inh ib i to rs ,  and the same can be seen for  many 
of the other properties.  I t  seems l i k e ly  that this is one reason for  
the quite poor f i t  o f  calculated to observed a c t i v i t y  that  is obtained 
for  regressions on only a small number of variables: any one property
w i l l  tend to s p l i t  the compounds into  two or three subsets of  similar  
a c t i v i t y ;  addition of  fur ther  variables w i l l  gradually fu r th e r  divide  
up the subsets unt i l  a reasonable agreement with experiment is found.
I t  could doubtless be argued that in such circumstances, simple 
mult ip le l inear  regression analysis is very fa r  from an ideal tool for  
the s t a t i s t i c a l  analysis of  the resu l ts .  However, i t  does have the 
advantage that the equations obtained are readi ly  interpreted in terms 
of properties which are fa m i l ia r  to the chemist. While the techniques 
of pr incipal  component analysis or discriminant analysis might provide 
apparently bet ter  f i t s  of calculated to observed data, they invariably  
involve much more d i f f i c u l t y  in in te rp re ta t ion .  I f  the aim of QSAR 
studies is to provide a framework within which the medicinal chemist 
can more ra t io n a l ly  plan the synthesis of  (hopefully) act ive compounds, 
then th is  s h i f t  of emphasis from the set of  properties understood by 
the chemist to a rather  less obvious set is c lear ly  undesirable.
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4.5 In te rac t ion  w i th a Point Charge Model o f  the Receptor.
In an attempt to model very d i re c t ly  the energy of in teract ion  of
inhib itors  with the postulated active s i te  for the enzyme as described
in chapter 2, calculations were performed on a number of  the inh ib i tors
in the presence of an array of point charges situated at the nuclei of
the atoms constituting the active s i te .  The charges were obtained from
Mu 11i ken analyses of  INDO calculations on the isolated receptor
fragments. For the "unbound" conformations, two sets of calculat ions
were performed: in one a normal INDO calculat ion;  in the other the
SOLVATON model with a d ie le c t r ic  constant of 40 was included. I t  was
hoped that the change in tota l  energy of the system would give a
re f lec t ion  of the enthalpy of binding to the receptor s i te ,  and that
th is ,  along with some measure of the entropy change of  the reaction
could be correlated with pl«.n values (and hence with AG, . ) ^ 50 binding
of the molecules.
4.5.1 Calculations using INDO for  the unbound conformation.
Table 4.5.1 gives the energy changes ( in  Hartrees) calculated for  
each molecule for  going from the unbound conformation to the "bound" 
conformation in the presence of the point charge model receptor.
Table 4.5.1
Molecule Calculated
Interaction
p i  5 O Molecule Calculated
Interact ion
p i  5 0
1 7.41 5.55 2 8.34 6.07
3 10.85 5.80 4 11 .98 6.37
5 10.00 7.00 6 11 .24 7.94
7 9.51 6.49 8 7.90 3.31
9 8.14 2.70 10 9.03 2.87
11 12.97 4.81 12 8.43 5.82
13 8.80 5.26 14 9.78 3.04
15 10.74 2.96 16 11 .36 3.21
17 11.48 2.98 18 12.57 3.26
19 8.21 3.65 20 9.37 3.94
21 11.76 3.68 22 12.75 4.19
23 10.41 3.20 24 11 .61 3.72
25 14.03 4.28 26 15.01 3.03
27 9.90 3.62 28 13.10 5.07
29 8.12 2.96 ■ 30 16.08 8.35
31 9.35 3.62 32 9.46 3.19
33 7.89 5.62 34 15.91 4.71
35 11.64 6.15
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These values represent Eunbound -  Ebouncj, and thus should 
correspond roughly to the enthalpy of dissociation of the drug-receptor  
complex. More posit ive values thus represent t igh te r  binding. Figure
4.5.1 shows a simple plot  of the calculated energy change against  
p l 50 value. The most s t r ik ing  feature of f igure  4.5.1 is that  
there is ,  sadly, no apparent overall  re lationship ,  and the plotted  
points form a random looking spread. I t  should, however, be borne in 
mind that  the calculated energies of interaction would only be expected 
to r e f le c t  enthalpic terms, whereas p l 50 w i l l  also contain an 
entropic component.
\ 7 . s F igure 4.5.1
BetIvlty
Closer examination of f i g .  4.5.1 shows that  the most act ive  
compounds (those with p l 50 > 5.1) appear to f a l l  in to  two quite  
d i s t in c t  series which l i e  quite well on st raight  l in e s .  This is of  
in te res t  because the calculated energy of interaction is hoped to be a 
re f le c t io n  of  the enthalpy of binding for  the compound, so the plot  can 
be thought of as one of AG against AH. For a given entropy change, 
such a p lot  should be a stra ight  l ine ,  and i t  may be that the two 
series noted are subsets of the compounds whose entropy changes on 
binding are similar.
I f  this were the only factor  operating, i t  would be expected that  
the s t ra igh t  l ines obtained should be p a ra l le l .  This is not the case, 
but any attempt to explain the change in gradient must be purely 
speculative.
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Clear ly ,  attempts to ra t iona l ise  the calculated inte raction  
energies for  the low a c t i v i t y  compounds must be based more on f a i t h  
than on science, and no attempt to do so w i l l  be made here.
Mult ip le  regressions using the calculated interaction energy 
including the number of  rotatable  bonds and molecular volume as 
measures of  entropy changes do not give r ise to good agreement between 
calculated and observed a c t i v i t i e s  when the whole set of compounds is 
considered, but two var iable regressions on the two subsets of  the 
compounds noted above give extremely good f i t s  with r>0.98.
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4.5.2 Calculat ions using SOLVATON fo r  the unbound conformation.
The energy changes shown in table 4.5.1 are fa r  too large to be a
direct  re f lec t ion  of the energy of formation of a drug-receptor 
complex. The reason for obtaining such large values is to be found
largely in the ef fect  of the e le c t r ic  f i e l d  on the k ine t ic  energy terms
in the Schrodinger equation. In r e a l i t y ,  there w i l l  also be an
e le c t r ic  f i e l d  (due to polarised solvent molecules) around the unbound 
inh ib i to r  which wil l  lower i ts  energy, hence making the energy changes
on binding numerically smaller.  The shortcomings of the SOLVATON model
in calculat ing total  energies for  charged systems have been noted on
several occasions, but since the s i tuat ion  here w i l l  be s imi lar  on both 
sides of the reaction (with both the model receptor s i te  and the
solvatons giving a net posit ive charge surrounding the in h ib i t o r ) ,  i t  
was hoped that  use of the SOLVATON model in place of unperturbed INDO 
calculations might lead to a cancella tion of  errors. Since the tota l  
charge on the solvatons is a function of  the net charge on the molecule 
in the calculat ion,  in order that the overall  in teract ion  with the
solvaton f i e l d  be consistent,  only those compounds in table 4.1.1
bearing a double negative charge were selected for  th is  set of
calculat ions. The calculated energy changes ( in  Hartrees) are given in
table 4 .5 .2 .
Table 4 .5 .2
Molecule Calculated
Interaction
plso Molecule Calculated 
In teract ion
plso
1 5.57 5.55 2 6.28 6.07
3 • 7.87 5.80 4 8.74 6.37
5 7.34 7.00 6 8.22 7.94
7 6.97 6.49 8 5.85 3.31
9 5.54 2.70 10 6.12 2.87
11 9.38 4.81 12 6.21 5.82
13 5.71 5.26 14 7.12 3.04
15 7.27 2.96 16 7.63 3.21
18 8.57 3.26 29 6.15 2.96
30 8.15 8.35 31 6.61 3.62
32 6.78 3.19 33 6.02 5.62
35 8.46 6.15
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The f i r s t  point of note when comparing table 4 .5 .2  with table 4.5.1 
is that although the calculated interactions are considerably smaller 
than those obtained without the SOLVATON model, they are s t i l l  
numerically too large to be physically reasonable. With hindsight, the 
reason for this is quite obvious: the tota l  charge on the point charge
receptor s i te  is -*-3, while that due to the solvatons for the unbound 
molecule is approximately +1. I t  may be that scaling of the solvaton 
charges by a factor of three would bring the interaction energies down 
to the extent that they could be considered to be a quant i tative  
re f lec t ion  of  the enthalpy of binding. However, whether or not this  
would represent a reasonable starting point for the binding reaction is 
not c lear .
Figure 4 .5 .2  is a plot of calculated interaction energy against 
p l 50, and once again the most active compounds f a l l  quite well on 
two s t ra igh t  l ines,  but the remainder of the points are quite scattered.
Figure 4.5.2
g . 0 . 0
7 . S
Regressions of  p l 50 on the calculated energy of  binding once 
again give no good regressions for the whole set of compounds, but for  
the 9 compounds forming the larger subset, the regression is extremely 
good, with r= 0.98,  s= 0.23,  F =180. The regression equation obtained
CD«fc«vAs I , 12. ,Vi , 5 0 , ^  J}-Wdc. k . \ . \  («. 
p l 50 = 1.07E -  0.75
and f igure  4 .5 .3  is a plot of calculated against observed a c t i v i t y  for 
the nine compounds. F>10.0 represents signi f icance at the 997, level .
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Reasons for the poor f i t  of  the remaining compounds are unclear,  
but i t  cannot be doubted that the very crude modelling of  entropic 
ef fects  is l i k e ly  to play a large part ,  and i t  may well be that the 
model receptor s i te  introduces fur ther  errors.
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4.6 Trans i t ion  state model l ing.
Results of attempts to model the course of reaction for  hydrolysis 
of a peptide were extremely disappointing. I t  was intended that attack  
of  OH-  on the carbonyl carbon and cleavage of the C-N bond via proton 
transfer  (as described in chapter 2) should be modelled using a 
geometry optimising SCF programme (modified special ly  to take account 
of the d o rb i ta ls  in z inc ) ,  both in the presence and absence of  the
c a ta ly t ic  residues present at  the active s i te .  I t  was hoped that in
this way the energy of  the system could be monitored as the reaction
progressed, and the e f fe c t  o f  the ca ta ly t ic  residues on both the 
act ivat ion  energy and the geometry of  the reactants could be 
ascertained.
A considerable amount of  time was spent attempting to modify the
programme GEOMIN (QCPE 312) to calculate analytica l gradients for
integrals involving d functions, and in extending i ts  INDO 
parameterisation beyond the f i r s t  short period. The second of these 
objectives was achieved, but eventually the analyt ical  gradient  
calculations had to be l e f t ,  and a f i n i t e  di fference method used
instead.
The i n i t i a l  approach was to place a hydroxyl ion perpendicularly
above the carbonyl carbon of the model substrate N-methylacetamide at
approximately van der Waals' contact distance (3 .0  A).  The peptide was 
constrained not to move,and the hydroxyl ion allowed to relax to i ts  
minimum energy posit ion . From this point,  the C-0 distance was 
successively shortened, and the whole system was allowed to relax f u l l y  
at each posit ion subject only to the constraint that the C-0 distance
did not change. I t  was in par t icu la r  hoped to observe the e f fe c t  of
the zinc ion on the act ivat ion energy for  formation of the tetrahedral
intermediate formed by the attack of the hydroxyl ion on the carbonyl
carbon.
I n i t i a l  optimisation of  the posit ion of  the hydroxyl ion caused i t  
to move unt i l  i t  was only 1.48 A from the carbonyl carbon, and th is  was 
pr ior  to any re laxat ion of the bond lengths and angles of  the peptide.  
This is only marginally longer than the C-0 bond length
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observed in ethers, carboxylic acids and phenols, and would seem to be 
fa r  too short to be reasonable for  the i n i t i a l  approach of the 
reactants before any rehybridisation had occurred. Holding the C-0 
distance constant, the N-methylacetamide was allowed to re lax ,  and an 
attempt was made to move the hydroxyl ion in small (0 .2 A) steps 
towards the carbonyl carbon in the hope that the energies might reveal 
a trend that was consistent with the formation of a tetrahedral  
intermediate.  However, no such trend emerged, and attempts to model
the t rans i t ion  state for  the reaction were f i n a l l y  abandoned.
There may be a number of  reasons for  the complete f a i lu r e  o f  th is  
invest igat ion to produce any useful results .  One which has been 
mentioned before in connection with the SOLVATON model is that the INDO 
parameterisation does not allow fo r  distance dependence in the 
resonance integrals (6-values) in the calculation of the Hamiltonian.  
These values are f ixed by comparison with ab i n i t i o  calculations on
experimental geometries, and hence may not provide a suitable basis for
the calculation of  energies of species whose geometries are markedly 
d i f fe re n t  from equil ibrium. An a l te rna t ive  explanation is that  the 
step lengths chosen for  the C-0 distance were so long as to al low the 
system to describe a non-adiabatic path over the energy surface ( in  
this case a surface in 36-dimensional space).
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Chapter 5 
Conclusions and Criticisms
"And there P ig le t  is" said Owl. " I f  the str ing doesn't break."  
"Supposing i t  does?" asked P ig le t ,  re a l ly  wanting to know.
"Then we t ry  another piece of s t r ing ."
The House at Pooh Corner. 
A.A. Milne
5.1 Conclusions.
I t  was the intention of the project to invest igate methods of  
quant i ta t ive ly  modelling the interaction of  a drug with i ts  receptor in 
such a way as to provide a useful predict ive  tool for  the medicinal 
chemist. Certa in ly  the plots of calculated against observed a c t i v i t y  
for the model receptor s i te  shown in the previous chapter i l l u s t r a t e  
that i t  is possible to obtain a reasonable regression l in e ,  but th is  is 
not su f f ic ie n t  for  the model to be a good predict ive  tool .  For th is ,  
i t  is more pertinent to examine how well the model predicts the 
a c t iv i t y  of  any of  the chosen molecules when only the other molecules 
are used to obtain the regression l in e ,  and to observe how the 
regression coeff ic ients  change as one or more o f  the molecules is 
neglected in the calculat ion of the regression equations, that is ,  how 
robust the regression equations are. f igu re s  5.1.1 to 5.1.11 show the 
ef fect  of successively removing the ten most act ive compounds from the 
set o f  compounds used "to  calculate the regression l ine  in equation 
4 .2 .5 ,  and the subsequent use of  this equation to calculate a c t i v i t i e s  
for the whole set of molecules, and table 5.1.1 l i s t s  the equations 
obtai ned.
Table 5.1.1
Effect of successive removal of ten most active compounds
pl50 x 0.4026p' +15.3467E1 ♦ 0.2193E2 ♦ 4.5986E3 . 0.0634SA - 0.0568vol -0.3109nrot - 5.0820
PI50 - 0.401 Op' 1S.2806E1 ♦ 0.2201E2 ♦ 4.5832E3 ♦ 0.0623SA - 0.05S7vol -0.3070nrot - 5.0150
| pi50 -  0.3788p' +14.4761E1 ♦  0.2402E2 4 4.3456E3 ♦  0.0421SA -  0.0374vol -0.2130nrot -  3.7520
! pi50 - 0.367V +14.0501E1 ♦ 0.2517E2 ♦ 4.2169E3 ♦ 0.0308SA - 0.0272vol -O.1572nrot - 3.0920
j pi50 - 0.3655p* ♦14.0464E1 . 0.2458E2 4 4.1400E3 . 0.0372SA - 0.0342vo1 -0.1582nrot - 3.1860
: pi50 - 0.3482p‘ .13.5122E1 - 0.2600E2 4 3.9246E3 4 0.0269SA - 0.0265vol -0.090 nrot - 2.1910
• pl50 - 0.3495p‘ ♦13.5502E1 4 0.2605E2 4 3.9370E3 4 0.0268SA - 0.0262vol -0.0912nrot - 2.2180
: pi50 - 0.3218p* 412.3576E1 4 0.2202E2 4 3.6539E3 4 0.0436SA - O.0361vol -0.2232nrot - 3.4470
| pi50 - 0.3400p‘ 413.1600E1 4 0.2602E2 4 3.8302E3 ♦ 0.0214SA - 0.0205vo1 -0.0803nrot - 1.9360
; PI50 . 0.3389p‘ 413.1160E1 4 0.2597E2 4 3.8172E3 4 0.0212SA - 0.0203vol -0.0802nrot - 1.9190
| pl50 - 0.3285p' 412.6934E1 4 0.2589E2 4 3.7034E3 4 0.0158SA - 0.0145vol -0.0736nrot - 1.5880
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I t  can be seen that even when the ten most active compounds are 
neglected in calculation of the regression l in e ,  the regression 
equation s t i l l  calculates the a c t i v i t i e s  of  these compounds quite  
respectably.  The coeff ic ients of the regression change, but comparison 
of equations in table 5.1.1 with equation 4 .2 .5  shows that these 
changes are not very great,  and the implication of this is that a model 
based on the 25 least active compounds would have provided a reasonable 
predict ive tool for  the ten most act ive .  In this sense at leas t ,  i t  
could be said that the project has provided some useful predict ive  
output, and that  i t  has to some degree been successful.
Further encouragement can be drawn from the experiments in d i r e c t ly  
modelling the binding of inh ib i tor  molecules to the point charge model 
of the act ive s i te .  The emergence of  d is t inc t  series in simple plots 
of calculated interact ion energy against observed a c t i v i t y  immediately 
gives r ise  to the suggestion that these series represent famil ies  of  
compounds which d i f f e r  in the entropic changes on binding. The 
performance of the entropic indices included in the study was quite
disappointing, however. I t  may be that improved methods of  t rea t ing  
the entropic changes associated with binding to a receptor s i te  may in
the future make this a useful method. At the moment, however, the
problem of  deciding which of the series an untested compound belongs to 
renders the method of  extremely l imited value as a predict ive tool .
The overall  performance of the SOLVATON model in the search for
regressions was rather disappointing, and i t  was seen in the last  
chapter that inclusion of  the model generally led to worse regressions 
than those obtained without i t .  In pa r t ic u la r ,  i ts  poor ca lcu lat ion  of  
total  energies for  charged species proved a great handicap. This is
further  discussed in the next section.
In conjunction with the receptor modelling, the SOLVATON model
proved to be somewhat more successful, as was seen in section 4 . 5 . 2 ,  
though i t  seems extremely l ik e ly  that  this is due to the cancel l ing of  
errors between the methods. I t  may well be that  refinement of  both
methods of modelling the environment of a drug molecule may be a means 
by which reasonable quant itat ive agreement can be obtained between
calculated and observed energies of binding.
142
5.2 Cr i t ic isms and sugges t i o ns fo r  improvements
I t  was clear from the beginning of the project that there would be 
considerable d i f f i c u l t i e s  encountered in attempting to model 
comprehensively the binding of a drug to i ts  receptor and obtain 
quanti tative agreement between calculated and observed a c t i v i t i e s .  
Some of  these, for  example the problems of inclusion of  entropic 
ef fec ts ,  were clear from the outset.  Others, in pa r t ic u la r  those 
encountered in attempting to t rea t  the problem of changing d ie le c t r i c  
constant, were unforeseen. I t  is the intention in th is  section to 
outl ine what the author feels  are the largest cr i t ic isms of  the
approach adopted, and to make some suggestions fo r  ways in which the 
methods could be refined in the future.
5.2.1 Choice of  geometries.
The calculation of a molecular energy, whether by molecular 
mechanics or sel f -consistent  f i e l d  methods, is strongly dependent on 
the geometry chosen. A central  theme in this project  was that  a
compound is ,  on average, in i ts  global minimum energy conformation when 
not bound to the receptor. In general,  this conformation w i l l  not be
the same as that which i t  adopts at the receptor s i te ,  and by
def in i t ion  of the global minimum, the bound conformation w i l l  be higher  
in energy. The energy required to bring about the conformational 
energy change may well play a s igni f icant  role in the ordering of  
a c t iv i t y  among a series of  compounds.
The problems associated with determination of the global minimum 
energy conformation of  a system with a number of f r e e ly  rota tab le  bonds 
are well known and need not be discussed here. I t  is simply noted that  
the molecules studied had up to ten rotatable bonds. The computing 
power available was not su f f ic ien t  for  systematic searching of  
conformational space for  such large systems, so a rather  ad hoc 
approach to determination of the global minimum energy conformation 
relying more on s c ie n t i f i c  in tu i t ion  than on systematic searching was 
enforced.
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The model active s i te  was bu i l t  around the global minimum energy 
conformation (or probably more accurately,  the lowest energy 
conformation found) of a model substrate of the enzyme. I t  may be that  
systematic conformational analysis of some known inhib itors  might lead 
to a d i f fe re n t  active s i te  geometry. The e f fec t  of  this on the 
regression equations can only be guessed, but i t  seems l i k e ly  that  
provided that the chosen model active s i te  had the same primary binding 
groups, the differences would not be very great.
The method of  f i t t i n g  the inh ib i tor  molecules into  the receptor  
s i te ,  simply twisting about torsion angles unt i l  a suitable  
conformation was found leaves a great deal to be desired. A fa r  better  
approach would have been to allow the inhib itors  to relax within the 
active s ite to f ind the i r  optimum position and conformation.
The problem of allowing relaxation of  a molecule under the 
influence of one or more s ta t ic  species is mathematically non - t r iv ia l  
i f  a f u l l  matrix Newton-Raphson method is employed due to the presence 
of off-diagonal two centre terms in the matrix of second der ivat ives.  
However, for the diagonal or block diagonal approaches these terms are 
neglected, and the problem is quite simply solved by sett ing to zero
those terms involving those atoms constrained to be f ixed .  Late in his 
research, the author produced a modified version of  the molecular
mechanics programme used in this work which allowed the relaxat ion of
one or more mobile fragments in the presence of  one or more s ta t ic  
fragments. In su f f ic ien t  time prevented the exhaustive test ing of th is  
programme, or i ts  application to the problem of  f i t t i n g  molecules into  
the model active s i te ,  but i t  may well be that the use of such a
programme would represent a considerable improvement over the methods 
used. The programme has since proved to be of  considerable u t i l i t y  in 
considerations of this and similar problems (228).
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5.2.2 D ie le c t r i c  constant.
The i n i t i a l  intention in introducing the SOLVATON model to the 
calculations was to investigate the e f fec t  of  d ie le c t r ic  constant on 
the conformational energy changes associated with binding of the 
inh ib i to r  to the receptor.  To the knowledge of the author, although 
formulations of the model have been used in the past, this is the f i r s t  
time i t  has been applied to charged systems, and i ts  e f fe c t  on tota l  
energies was quite unexpected, though with hindsight quite predictable.
The large changes in tota l  energy observed for  charged species are
due to the interaction of the charge on the molecule (say n) with the
to ta l  charge on the solvatons (which w i l l  be given by - n ( e - l ) / ( 2 e + 2 . 5 )  
) .  For a system of  m atoms there wi l l  be m solvatons, so the "solvent"  
could be restored to e lec t r ica l  neu tra l i ty  by adding a constant amount 
of n(e- l  ) /m(2e+2.5) to the charge of each of the solvatons. Although 
this hypothesis remains untested, i t  is the opinion of  the author that  
i f  such corrections were added to the solvaton charges, the e f fects  of  
the model on the electronic d is tr ibut ion  would be quite small,  and the 
energies obtained for charged systems would be much more reasonable.
5 .2 .3  Dipole Moments.
The def in i t io n  of dipole moment given in equations 3 .3 .5  and 3 .3 .6  
is only su f f ic ien t  fo r  an uncharged species. For a charged species,  
the dipole moment is no longer invariant  to choice of axes due to the
displacement of the centre of  charge away from the or ig in  of
coordinated. The coordinates of  the centre of  charge w i l l  be given by
r * s f * r d W Z
where the integral is over a l l  space. Evaluation of  th is  integral  
would be a tedious and time consuming process fo r  a molecule, so to a 
f i r s t  approximation this can be writ ten
where the summation is over a l l  atoms, Q_ is the net charge on thea
atom (obtained for  example by a Mull iken analysis) and Z is the to ta l
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charge on the system (the centre of charge is ,  of  course, undefined for  
an uncharged species).
I f  in the def in i t ion  of the density contribution to the dipole 
moment (equation 3 .3 .5 )  the r term is replaced by ( r  -  r * )  where r*  is 
as defined above, the e f fect  of the overall  charge w i l l  be removed, and 
the numbers obtained wil l  once again r e f le c t  the electron d is t r ib u t io n  
within the molecule. The "dipole moment" as used in this study is more 
accurately thought of as a descriptor mostly of  the posit ion of  the 
molecular centre of charge and of the magnitude of that  charge, 
modified s l ig h t ly  by the electron d is t r ibut ion  within the molecule.
5 .2 .4  Entropy.
The lack of  a method of including entropy changes in a manner with 
a sound theoretical  basis was the source of  great problems in the 
in terpre ta t ion  of the calculated data. The choice of  molecular size 
descriptors (radius,  surface area and volume) and the number of  
rotatable bonds as empirical descriptors o f  entropy changes was 
appealing because of the ir  very obvious re lationship  to the factors  
which w i l l  cause the entropy changes (solvat ion and hindrance of  
internal  ro ta t ions ) .  They are,  however, a rather  naive choice, and the 
very l imited success obtained with these descriptors may be ind icat ive  
of  the fac t  that a more soundly based method should be used. Such 
empirical measures are,  however, l i k e ly  to be of  value due to the ease 
with which they can be included in calculations when compared to ,  for  
example, functions calculated from s t a t is t i c a l  mechanics. A recent  
paper ( 220) has used the number of rotatable bonds as a descr iptor of  
entropy changes with some success.
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5.2.5 Computational problems.
On several occasions, problems were experienced with a t ta in ing  
convergence in the SCF procedures used. Convergence forcing algorithms 
were developed for  such systems, and although experience gradually  
improved these, such algorithms always have the problem that  they 
increase the amount of computer time required fo r  a ca lculat ion.
The a v a i l a b i l i t y  of computer time represented a very severe 
l im i ta t ion  on the scope of the calculations i t  was possible to perform,  
par t ic u la r ly  during the early part of  the project when the Cray 1-S at  
ULCC was not ava i lab le .  In an attempt to circumvent this problem, the 
SOLVATON programme was rewri tten so that i t  ran p a r t i a l l y  on the FPS 
AP120B array processor available at the University  of Surrey. The 
amount of  memory available  in this machine means that the whole of  the 
programme is too large to run, but the whole of  the se l f -consis tent  
f i e l d  procedure was put onto the array processor while the integral
calculations were performed on the host machine (a PRIME 750).  This 
programme was only completed very close to the end of the p ro jec t ,  and 
accordingly was not used for any of  the calculations described.  
Benchmark runs were necessary due to the fac t  that the AP120B is a 38 
b i t  machine, and thus gives lower precision than ws ava ilab le  on the 
host or on the various other computers used in the pro ject .  These
showed that there were noticeable numerical differences in the resul ts  
obtained with the programme, but these were not large, and the i n i t i a l  
impression was that trends would be reproduced in a similar  fashion to 
those observed on other machines.
The enhancement in speed of  ca lculat ion obtained was such that  the 
amount of time required for the SCF calculations was so short as to be 
of no importance in deciding what calculations were to be performed, 
though they were s t i l l  subject to the constraint that the integra ls
could be performed in a reasonable amount of  t ime. In a rather  biased
series of  benchmark runs comparing the performance of  the array  
processor with the Cray 1-S i t  was found that in the SCF section of  the 
programme, the AP120B was faster  than the Cray fo r  systems with more 
than about 60 basis sets. This comparison is rather unfa i r  fo r  a 
number of  reasons: f i r s t ,  only the SCF part of  the programme was
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accounted fo r ,  and no account was taken of the fac t  that the Cray 
performs the integral calculations much more quickly than the PRIME -  
total  execution times on the Cray were actual ly  much shorter; second, 
the AP120B programme was special ly rewri t ten to make optimal use of the 
para l le l  processing capabi l i t ies  of the processor, while the version on 
the Cray had only minor modifications from the INDO programme which 
forms i ts  basis; th ird ,  the Cray is a 64 b i t  machine, and o f fe rs  much 
greater precision than the array processor. I t  may be that  rewri t ing  
the integrals section of  the programme to also run on the array  
processor would increase the execution speed s ig n i f ic a n t ly ,  but the 
nature o f  such calculations does not predispose them to e f f i c i e n t  use 
of the array processor architecture in the same way as the SCF section,  
and i t  is the opinion of  the author that  any increase in speed would be 
r e la t i v e ly  smal1.
The increased a v a i l a b i l i t y  o f  such computational tools great ly  
increases the scope of  computationally intensive methods such as 
self -consistent  f i e ld  calculations in applications to molecules of  
biological in terest.  In the context of  this pro ject ,  i t  would have 
been inte resting to perform SCF calculations on the in h ib i to r  molecules 
in the presence of the model active s i te  ( ra ther  than simply a point  
charge representation as described in the last chapter).  The size of  
the available  computers meant that i f  such a study had been undertaken,  
only a few of  the inhibitors would have been small enough fo r  the 
calculation to be done. The increasing a v a i l a b i l i t y  of  v i r tua l  
storage machines seems l ik e ly  to fu r the r  increase the scope of  the 
techniques of computational chemistry into  the f i e l d  of  b io lo g ic a l ly  
important molecules.
F in a l ly ,  the use of high resolution computer graphics devices in 
the f i e l d  of computational chemistry and QSAR studies must be 
mentioned. The work described in th is  thesis was performed without the 
use of  such a device, so c lear ly ,  access to a high performance colour 
monitor is not a prerequisite for  the use of computational chemistry 
techniques in studies of QSARs. However, the value of  such a f a c i l i t y  
as a quick, easy to use system fo r  providing input to computational 
chemistry programmes, as an aid to the in terpre ta t ion  o f  resul ts and as 
an aid to guidance of  the computational strategy cannot be doubted.
148
The use of in te ractive  graphics based systems for  performing 
computational chemistry on large molecules is already making an impact 
in the pharmaceutical industry,  and is already providing the medicinal 
chemist with a po ten t ia l ly  very powerful tool to aid in the rational  
design of novel therapeutic agents
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Appendices
Appendix A.
A1. The Hartree-Fock LCAO-SCF Method.
The l inear  combination o f  atomic o rb i ta ls  s e l f  consistent f i e l d  
(LCAO-SCF) approach to the calculation o f  e lectronic  structure is based 
on the Schrodinger equation which can be stated in i ts  simplest form as
H* = E* A l . l
where H is the Hamiltonian operator fo r  the system, ¥ is the 
wavefunction and E is the energy of the system.
A2. Atomic O rb i ta ls .
For a system containing only one electron and one nucleus, for  
example H, He+ etc.  the Schrodinger equation can be solved exactly  
providing that  the wavefunction *  \ s subject to a set of  very 
reasonable mathematical constraints on i ts  behaviour. These 
constraints are that i t  should f a l l  o f f  to zero at very large distances 
from the nucleus, that  i t  should be single-valued at  any point in 
space, and that  i t  should have a continuous f i r s t  der iva t ive  ( tha t  is 
no d iscont inu i t ies ) .  Solution of the Schrodinger equation under these 
conditions is simple, i f  rather tedious, and leads ( f o r  the hydrogen 
atom) to a set of  solutions for ¥ which are generally  termed 
orb i ta ls .  These o rb i ta ls  are simply three-dimensional mathematical 
functions which describe the behaviour of  the electron in the system.
In the solution of the d i f fe re n t ia l  equations which represent the 
Schrodinger equation a number of parameters emerge, the fa m i l ia r  
principal,  azimuthal and magnetic quantum numbers, n, 1, and m. The 
solution for  ¥ can be separated into radial  and angular parts ,  and 
for  a given set o f  quantum numbers as the nuclear charge on the system 
is changed i t  is only the radial  part o f  the function ¥ ( r , 0 ,0 ) that  
changes. The angular part of  the function gives r ise  to the well known 
character ist ic  shapes of  the Is ,  2s, 2p . . . o r b i t a ls .  The
functional forms of  the atomic orb i ta ls  are described in section A7. 
Dirac (221) showed mathematically in an extension of  Schrodinger1s
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equation into the world o f  r e l a t i v i t y ,  and i t  was well known 
experimentally that  a fourth quantum number, the electron spin quantum 
number is necessary to completely describe the system. The 
wavefunctions obtained for  one electron one nucleus systems are usually 
known as one electron hydrogen-like atomic o r b i ta ls ,  and consist of  a 
radial  part ,  an angular part and an electron spin factor .
In a polyelectronic atom, when a configuration such as
He : I s 2 
2
or Li : Is 2s
is w r i t ten ,  the "orbi ta l  approximation" is being applied, that  is the 
electrons are being treated as being independent in hydrogen-like  
atomic o rb i ta ls ,  with one electron in each spin orb i ta l  (corresponding 
to two electrons in each space o r b i t a l ,  one with each possible value of  
the electron spin quantum number).
A3. Antisymmetry and the Pauli Pr incip le .
The Pauli pr incip le  states that a wavefunction must be 
antisymmetric with respect to interchange of  any two electrons.  When 
the electronic structure of helium is wri t ten
He : I s 2
this is im p l ic i t  shorthand for
He : Is ls„ or ls ls  
a  (3
Clear ly ,  i f  we label the electrons (1) and (2) and swap them over;
* He = 1s ( l >1s(2) - - A3.1
* ' H = 1 s(2) 1?( 1) A3.2
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since the electrons are indistinguishable (save by the labels they have 
been given) then
A3.3
that is ,  the wavefunction is not antisymmetric with respect to electron  
interchange. To overcome this the function could be wr i t ten  as a 
l inear  combination o f  the two possible spin o r b i ta ls ,  which c lea r ly  
sat is f ies  the Pauli pr incip le  (the factor  o f  1/^2 is a normalisation  
f a c t o r ) .
The function on the r ig h t  hand side o f  A3.4 is simply the 
expansion of  the determinant
The diagonal of  such a determinant for  a polyelectronic system is 
suf f ic ien t  to describe i t ,  and because the value of  the normalisation  
factor  is obvious ( 1/Ai !  fo r  an n-electron system) the expanded 
spin orb i ta ls  are usually wri t ten as simple products
*He = 1//2(1s ( D 1 s ( 2 ) - 1 s ( 2 ) 1 s ( D ) A3.4
l s ( l )  1s( 2) 
l s ( l )  l s ( 2)
A3.5
A3.6
2
or even He = Is A3.6a
but i t  should be remembered that  th is is simply shorthand fo r  a 
determinantal re la t ion .
A4. Mol ecu 1ar Or b i t a l s .
The wavefunction for  a molecule is not in pr inciple  any d i f f e r e n t  
from that  fo r  an atom. I f  the nuclei are allowed to move, the 
Schrodinger equation becomes insoluble a n a ly t ic a l ly ,  even fo r  the case 
where there is only one electron in the system. I f ,  however, we apply 
the Born-Oppenheimer separation and assume that motion of  the 
electrons is very rapid compared to that of  the nucle i ,  that  is the 
nuclei are e f fe c t iv e ly  constrained to be f ixed ,  then we can proceed. 
Again using ^ as the symbol to represent the tota l  wavefunction of  
the system, the orbi ta l  approximation can again be applied,
*  = 'M '  .Yn A4.11 2  3 n
where the Y. are three-dimensional functions representing the 
behaviour of  a single electron ( tha t  is one-electron molecular 
o r b i t a ls ) ,  remembering that the wri t ten  "product" is in f a c t  simply 
shorthand fo r  a determinantal expansion of  n spin o r b i ta ls .  The goal 
of a quantum-mechanical calculation is generally the calculat ion o f  the 
function which can c lear ly  be done i f  we can ca lculate the 
constituent Y. . In most current methods, and in p a r t ic u la r  in the 
methods of  interest  to this study, the problem is broken down one stage 
fu r th e r ,  and the molecular o rb i ta ls  are expanded in terms of  the known 
atomic o rb i ta ls  for the system,
*1 ■ iciiA A4-2
where the ^  are a l l  the atomic o rb i ta ls  in the system, and the c.^ 
are simply mixing coeff ic ients .  Molecular o rb i ta ls  constructed in this  
way are termed l inear  combinations of  atomic o rb i ta ls  (LCAO). Now the 
problem of  calculating ¥ has become one of  simply f ind ing the 
coeff ic ients  c.^ since the ^  are known, hydrogen-like one-electron  
atomic o r b i ta ls .  The calculat ion o f  the coeff ic ients  is done by means 
of the secular equations.
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A5. The Secular Equations.
For each molecular o rb i ta l  we can wri te  a one-electron analogue of  
the Schrodinger equation ( A l . l )
H.Y. = e.Y. A5.1
where H. is now a one-electron hamiltonian and e. is the o rb i ta l
energy. Expanding the 'F. in terms of  the atomic o rb i ta ls  of  the
system we can write
H. Ic..<t> = e.2c..4> A5.2
i k  i k  K i k l k  k
Multiplying through by ^ , any member of  the normalised set which 
includes and integrating over a l l  space we obtain
J dx = e, J I c 1k^ d x  A5.3
Using the conventional notation
Hlk = •*" V 1 dT A5-4
and Slk  =  ^ tJT A5.5
where H is the one electron operator defined l a t e r ,  the equations can 
be t id ied  up to give
H1k^c i k = e i i ci k Slk A5' 6a
or | <Hl k ' e i Sl k ) c ik  = 0 A5- 6b
This is a set of  k l inear  simultaneous equations in the c .^ ,  and 
as such only has a non -t r iv ia l  solution i f  the determinant of  
coeff ic ients  is zero. This simple determinantal equation is the basis 
of  a l l  molecular o rb i ta l  methods. Generally the approach is to go 
straight  to the secular determinant. All  o f  the matrix elements 
(the one electron hamiltonian which w i l l  be described l a te r )  and S-^
(the overlap integrals which simply describe the overlap between ^
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and <b-\) are computed. Mult iplying out the determinant gives a
polynomial in e the solutions of which, e . ,  are the allowed orb i ta l1%
energies (eigenvalues) of  the system. Putting each of  the e. back 
into the secular equations then allows the c.^ to be determined.
The differences between the various LCAO-SCF methods l i e  in the 
degree of  sophistication used in the d e f in i t io n  of  the matrix elements 
H of the one electron hamiltonian operator.  In ab i n i t i o  methods the 
hamiltonian is precisely defined, while in simple Huckel theory i t  is 
not defined at a l l ,  but simply parameterised.
To define the elements of the one-electron hamiltonian i t  is 
necessary to include terms for  a l l  of  the contributions to the energy 
of that e lectron. These w i l l  be k ine t ic  energy and potent ia l  energy 
terms. •
(where v is shorthand for  9/ 9x + 9/ 9y + 9/ 9 z ) and the
various electron-nuclear a t t rac t ion  terms are
where i id e n t i f ie s  the electron in question, the summation in m runs 
over a l l  nuclei ,  and Zm is the charge on nucleus m. I f  there were
only one electron in the molecule th is  would be a s u f f ic ie n t  
hamiltonian fo r  the system, and the Schrodinger equation would be
However, i t  is very rare to be interested in a system with only one 
electron, so we must include terms which take in to  account the 
electron-electron repulsions.
A6 . Matrix Elements.
2
The k ine t ic  energy terms are given by the Laplacian /2
A6.1
A6.2
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The electron density due to an electron (2) in volume element 
dT2 is given by the square modulus of  the wavefunction in that  
region of space
J * 2 dx2
or more generally ^ ^ ( fo r  complex wavefunctions). Thus the
interaction between the electron we are considering and the other 
electrons in the system w i l l  be given by integrals of  the form
JJ Y i< l ) * - j<2) _ L  ^jCl )^ i<2) 6 ^ 1 6 ^ 2
r i 2
These integrals ,  the coulomb in tegra ls ,  are included in the hamiltonian 
fo r  the polyelectronic system to give a Schrodinger equation o f  the form
/ _  1 V2 _ 1 Zm + I 5 ^ < 2 > J _  d t 2 \ t .  = C.H-.
( 2  » r 1m J r i 2 j  1 1 1
This equation (due to Hartree) would be correct i f  the wavefunction 
were a simple product rather than a determinant. To account fo r  th is ,  
fur ther  in tegra ls ,  the "exchange integrals" must also be included, to
give the f u l l  Hartree-Fock SCF equations
hscf = hn + Ij . - k. A6.4
j J j J
where \\H _ _ 1 V2 _ J Zm
2 * r im
J j t t d )  =(J M»|<2>J_ d ^ a H i d )
' r i 2 1
K j f i d )  = (f 4 > j ( 2 ) t i ( 2 ) _ L  d ' t z l l ' j d )
r i 2 *
This specif ication of the hamiltonian leads to a large number of
terms. More importantly,  i t  also introduces the various c.^  that  we 
are hoping to determine. Hence we need to know the various c.^ fo r
a l l  other electrons in the system before we can solve the equation fo r
any par t icu lar  electron. This is the or ig in  of  the description " s e l f  
consistent f i e l d . "  I n i t i a l  estimates of  the c.^ are obtained, e i th er  
from educated guesses or approximate ca lculat ions.  The integra ls
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required for  and are calculated and the secular equations
are then solved fo r  the e. which can then be substituted back to give 
new values fo r  the c.^. The new c.^ are then used to recalculate  
the f u l l  hamiltonian (the Fock matrix) and the process is repeated 
unt i l  the di fference between results  on successive cycles is within  
some prescribed l i m i t .  The resul ts  are then said to be se l f -cons is ten t .
In ab i n i t i o  methods a l l  integrals  required fo r  the specif icat ion  
of the are calculated. In less sophisticated methods various
simpli f ications which reduce the number of  integrals  i t  is necessary to  
calculate are employed. Those o f  relevance to th is  study are outl ined  
in chapter 3.
Solution of the Schrodinger equation fo r  hydrogen-like atoms gives 
atomic orb i ta ls  of  the form
where r ,  ©, <b are the spherical polar coordinates centred on the 
nucleus. The angular parts ara the well known spherical
harmonics
A7. Basis Functions.
d<r,©,«*>■ = Rn l <r>Ylm<©,0> A7.1
A7.2
where in real space
©Im^9 ) = ( 2 1 + 1 ) ( 1 - m ) ! p1m(COs # )
2( l+m) 1 1
$m ( 0) = 2ir- 1 ^2cos m$ (m = 0) 
Tr- 1 / 2 cos m<6 (m = 0)
A7.3
$m($) = ( ir)- 1 / 2sin m$
the P*(cos <b) being associated Legendre polynomials. These angular 
functions give r ise  to the fa m i l ia r  shapes of  the s, p, d, . . .
o r b i ta ls .
The radial part of  each solution is a polynomial in r mul t ip l ied  by 
a decaying exponential e~^r where C is the orb i ta l  exponent Z/n,
Z is the nuclear charge and n is the pr incipal quantum number. The
polynomial in r  is necessary to introduce the radial  nodes into the 
wavefunction.
Such functions can be used in molecular o rb i ta l  ca lculat ions,  but 
some of  the integrals involved are d i f f i c u l t  to evaluate due to the 
polynomial in r .  S later  (222) proposed a much simpler form for  the 
R ( r ) ,
r -1/2 -1/2 n-i -Cr
Rn ] ( r )  = <2C) C(2n)!]  r n e r A7.4
These are nodeless functions and are generally termed S la ter  type
orb i ta ls  (STO's). Here C is given by
C = (Z -s ) /n *  A7.5
where s is a screening constant and n* is an e f fe c t ive  principal  
quantum number. Empirical rules fo r  the choice of  s and n* are 
described elsewhere (223)
S later  type o rb i ta ls  are very frequently used in molecular o rb i ta l
calculat ions, but some of  the integrals  involved are s t i l l  rather
cumbersome and time-consuming. A popular a l te rn a t ive  is to expand the
atomic orb i ta ls  as a sum of gaussian functions fo r  which the decaying
2
exponent depends on r rather than r .  Integrals using such functions
are much easier to evaluate,  but single gaussians give a very poor f i t
to the actual shapes of  the atomic o r b i ta ls .  The sum of  gaussians may
be used to mimic the shape of  S la ter  o rb i ta ls  ( fo r  example in the
STO-nG type of ab i n i t i o  calculat ion where n gaussians are used to 
build up approximations to the STO's), or the form of  accurate atomic 
o rb i ta ls  (as in the " s p l i t  valence" ab i n i t i o  type of  ca lcu lat ion  such 
as 6-31G).
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In semi-empirical methods the number of  integrals  to be calculated  
is great ly  reduced (see chapter 3) from that  required fo r  an ab i n i t i o  
calculat ion,  and in consequence the expansion of  the Slater  type 
orb i ta ls  as sums of  gaussians is unnecessary, and STO's can be used 
d i rec t ly .
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A8 Errors in the Schrodinger Equation.
The var iat ion pr inc ip le  states that the more f l e x ib le  a function  
used to describe the system, the more accurate w i l l  be the results  
obtained from that funct ion.  One method of  increasing the f l e x i b i l i t y  
of the wavefunction of the system is to use a larger set of  basis 
functions, including fo r  example hydrogen 2s and 2p funct ions.  A 
fur ther  refinement is to al low fo r  the fac t  that excited electron  
configurations may make some contribution to the ground state  
properties of  the system,
*  = a* + b* + c* . . . A8.1o 1 2
where ¥ etc .  are the wavefunctions fo r  the various contributing  o 3
electronic states, and a, b, c etc. are mixing coe f f ic ien ts .  This is 
known as configuration interaction ( C l ) ,  and very accurate results  can 
be obtained using large basis sets and configuration in teract ion  (but  
only fo r  quite small systems due to computational r e s t r a i n t s ) .  A 
theorem due to B r i l lou in  (224) states that  for  systems with a s inglet  
ground state ,  only doubly excited configurations w i l l  contribute to 
ground state properties. As this study is concerned only with closed 
shell systems, and any doubly excited state would be rather  high in 
energy, inclusion of  Cl would be expected to make only a very small 
difference to the results obtained, therefore no attempt to include the 
ef fect  of  Cl was made.
Large basis set calculations including Cl give an energy and 
wavefunction for  a system which is described as the Hartree-Fock l i m i t ,  
that is the best that can be obtained from the Schrodinger equation.  
The resul ts obtained w i l l  s t i l l  d i f f e r  from the actual energy and 
wavefunction. The source of  these errors is twofold. F i r s t ,  no 
account is taken of  the fac t  that  inner electrons, p a r t ic u la r l y  in 
heavy atoms, may be moving with speeds which are not neg l ig ib le  in 
re la t ion  to the ve loc i ty  of l ig h t .  At such speeds r e l a t i v i s t i c  e f fects  
must be taken into consideration, and th is  is not done in the solution  
of the Schrodinger equation. Second, no account is taken o f  the 
phenomenon known as electron corre la t ion ,  the fact  that two electrons  
associated with the same atom w i l l  tend to avoid one another,  lowering
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the ir  average energy of  in te raction compared to that which would be 
observed i f  the d istribut ions were uniform.
R e la t i v is t i c  effects and the e f fects  of  electron corre lat ion  are 
both contributions to the energy which essent ia l ly  depend only on one 
centre terms, and i t  is generally assumed that the d i fference between 
the calculated (Hartree-Fock l im i t )  energy and the true energy w i l l  be 
approximately constant fo r  a given system, regardless of  i ts  geometry.
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Appendix B.
B1 Molecular Mechanics.
Molecular mechanics is a purely empirical method for the 
calculat ion of molecular structures and of molecular energies as a
function of  molecular geometry. I t  is based on the assumption that the 
bond lengths, angles and torsional angles have certain preferred  
"stra in  free" values, and that  non-bonded interactions can be 
represented by spherical soft-sphere potent ia ls .  Hhile the method
re l ie s  completely on a set o f  empirical force f i e l d  parameters and is 
thus unsuitable fo r  use in systems for  which no experimental data 
exists ( fo r  example t rans i t ion  s ta tes ) ,  i t  is useful for  calculat ion of  
ground-state molecular geometries, and, being e n t i re ly  empir ica l,  has 
the advantage over geometry optimising SCF methods (see section 3.4)  
that  i t  is very much fa s te r .
The tota l  energy, often termed the "ster ic  energy," is calculated  
from a set of empirical potent ia l  functions and the i r  associated 
parameters (the "force f i e l d " )  and the coordinates of  the system are 
systematically adjusted to reduce this energy unt i l  a minimal point is 
found. The calculations can be applied equally well (with in  the 
l im i ta t ions  of the force f i e l d )  to single molecules or to ensembles of  
molecules ( fo r  example one or more crystal lographic unit  c e l l s ,  or a
system of  several in teract ing  molecules).
The ster ic  energy o f  a system, Vs is considered to be made up of
a sum of  contributions,
V = V ( l )  + V<9) + VC(6) + V ( r )  + V(q) + V (p , . )  B l . lS 1J
where V ( l )  is the molecular potent ial  energy due to bond stretching  
from reference values, V(0 ) ,  V ($ ) ,  V ( r ) ,  and V(q) are the corresponding 
terms fo r  bond angle bending, bond torsion,  non-bonded in te ractions and 
charge interactions respect ive ly .  The V(p.^) are "cross terms" where 
the energy is a function of two or more of  the previous var iab les,  
which have been found in general to make very l i t t l e  di fference to 
calculated geometries or thermodynamic properties,  though they do
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have a marked e f fe c t  on calculated vibrat ional  frequencies. The 
properties of  in terest  to this study are thus insensit ive to the cross 
terms, so none were included in the calculat ions,  and they w i l l  be
discussed no fu r the r .  The remaining terms w i l l  now be discussed in
tu rn .
B2 The Ster ic  Energy (225).
Bond Stretching.
Bonds are considered to behave in a Hookean manner, with the
restoring force being proportional to the displacement of the bond
length from i ts  reference value. For a diatomic molecule this can be 
wri tten
Force = - k ( l  -  1 ) B2.1
Integrat ing  this gives
2V = k ' d  -  1 ) 2 B2.2o
since the integrat ion constant is zero (V = 0 when 1 = 1 ) .  For more
complex systems the tota l  energy due to bond stretching (or
compression) can thus be writ ten
V = S k (1,  -  1 . ) 2 B2.3
' S 1 01
where k$ w i l l  generally have a d i f f e re n t  value fo r  each d is t in c t  type 
of chemical bond. This expression is s u f f ic ie n t ly  accurate fo r  systems 
in which bond lengths do not d i f f e r  markedly from th e i r  unstrained
values, but fo r  severely strained systems ( fo r  example t r i - t - b u t y l  
methane) inclusion of  an anharmonicity correction (usual ly  a term in
3
(1 -1Q) ) w i l l  give great ly  improved resul ts .  Such corrections
were not used in this study.
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Angle Bending.
Angle bending is treated in exactly the same manner as bond 
stretching,  that is a simple harmonic function. The relevant  
expression for  V(0 ) is thus
ve  = I  ke se2 B 2 .4
where Se is the deviation of  the bond angle from i ts  relevant  
reference value, and k@ is the relevant force constant fo r  angle 
bending.
Bond angle bending is about one tenth as energet ica l ly  expensive as 
bond stretching, and guite large variat ions from reference values (up 
to ±15°) may be observed. I t  has been estimated that  the simple 
harmonic function of  eguation B2.4 is adeguate for  deformations o f  up 
to about 5°,  but fo r  a force f i e l d  to be used in systems which may 
have considerable angle stra in  an anharmonicity correction is essential  
i f  the energies obtained are to be r e a l i s t i c .  The programme used in 
this work (226) uses
V(r )  = I  kr ($Q2 + k ' 6©3) B2.5
for  the calculation of the angle stra in  contribution to the s ter ic  
energy.
Bond Torsion.
Bond torsional functions are included in order to reproduce the 
barr iers to rotat ion  within a molecule. For single bonds which could 
be considered to be f r e e ly  ro ta t ing ,  such barr iers could almost 
cer ta in ly  be reproduced simply by the non-bonded in te rac t ions ,  but this  
would c lear ly  be inadequate for  a system which prefers a planar  
conformation such as an alkene or amide.
The torsional energy function is included as a generalisat ion of  
the torsional potent ia l  fo r  an ethane molecule, with the torsional  
energy considered to be a sum of  terms due to each individual  torsion  
angle about the central  bond (thus 9 terms fo r  the bond between two 
tetrahedral centres, 4 terms fo r  two tr igonal centres e t c . ) ,  with the
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to rs iona l  energy given by
V* - I I k^( l  + s.cos(n4>)) B2.6
where n defines the number of minima in the function as goes from 
0° to 360° and s is ±1 according as the preferred arrangement is 
staggered or eclipsed. k^ is the torsional "force constant" for a 
par t icu la r  set of four atoms, and the summations are over a l l  torsion  
angles about a part icu la r  bond ( in  1) and a l l  bonds about which torsion  
angles can be defined ( in  m).
Closely re lated to the torsional potential  is the concept of  out of  
plane bending at a trigonal centre such as a carbonyl group. The 
problem is treated in a very similar manner, see f igure B2.1.
Figure B2.1
of such a system is characterised by an 
B -  C -  D, the potential  fo r  which goes 
The potential  due to out of  plane bending
Vx = E kx (180-X)2 B2-7
where x is the improper torsion angle.
The out o f  plane bending 
improper torsion angle A -  
through a minimum at 180°. 
is defined as
166
Non-bonded in te rac t io n s .
There are two main types of  non-bonded potential  function in common 
use in molecular mechanics programmes. These are the Lennard-Jones 9-6 
or 12-6 potent ia ls
with n equal to 9 or 12, and the Buckingham exponential-6 potential
where A, b, c are constants fo r  a pa r t ic u la r  pair  o f  atoms. This 
potential  "folds over" and becomes a t t ra c t iv e  at  very short  
internuclear  distances, but when r  is physically reasonable the 
function gives a good representation of  the potent ia l  between two 
non-bonded atoms.
The treatment of non-bonded interact ions constitutes the major 
difference between the two main types of  fo r c e - f ie ld  in current use. 
In valence fo rce - f ie ld s  (such as that used in this work) non-bonded 
interact ions are only counted fo r  pairs of  atoms which are 1-4 or more 
d is tan t ,  while Urey-Bradley type fo rc e - f ie ld s  (which are generally  of  
more use in spectroscopic studies) also include the 1-3 non-bonded 
in teract ions.  Differences between the two methods are taken up by 
adjustment o f  the other parameters in the f o r c e - f i e ld .
The programme used in th is  work uses a Buckingham potent ia l  
funct ion,
where e is the potent ial  well depth, a is r / ( r L* + r 2* )  and r *  
is the van der Waal s' radius o f  an atom.
V(r )  = I  Ar~n -  Br“6 B2.8b
V(r )  = I  Ae br -  Cr-6 B2.8c
B2.9
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Charge in te rac t io n s .
Each atom in a molecule w i l l ,  in general, carry a par t ia l  charge, 
and the in teract ion of  these part ia l  charges with one another may well 
make a s ign i f ican t  contribution to the energy ( fo r  example in 
intramolecular hydrogen bonding), or be the deciding fac tor  in choice 
of preferred conformation. The inclusion of  a l l  charge-charge 
interactions would be an enormous complication to the molecular 
mechanics method: f i r s t  i t  would necessitate adjustment of  the bond
stretching and angle bending force constants, or the introduction of  
charge dependent parameters, making the force f i e l d  e i ther  very 
complicated or not t ransferrable from one molecule to another; second, 
some method o f  obtaining the par t ia l  charges ( fo r  example an SCF
calculat ion)  would be required pr ior  to the molecular mechanics 
calculat ion.
As a compromise between neglecting completely a term which might 
well be of  importance in the system and having an unmanageably 
complicated computational task, the programme used in th is  work allows 
the inclusion o f  charges in a very naive manner. The user is allowed 
to select "groups" of  atoms within a molecule which carry charges, and
charge-charge interact ions within that group are neglected, but the
charge-charge interact ions between charged atoms in d i f f e r e n t  groups 
are taken into account provided that the atoms in question are 1-4 or 
more d is tant ,  removing the need to adjust bond stretching or angle 
bending parameters.
The charges are considered to be point charges residing on the 
relevant nucle i ,  with the interact ion between them given simply by
^  - H  V|b B2J0
er
where qa , q  ^ are the charges, r  is the internuclear  distance and e 
is the d ie le c t r i c  constant of  the medium between. C lear ly ,  the concept 
of  the d i e le c t r i c  constant of the medium has l i t t l e  meaning at  th is
scale,  and i t  w i l l  ce r ta in ly  not be the bulk d ie le c t r i c  constant o f  the 
substance or a solvent.  I t  is probably better  to consider th is simply 
as a fudge fac tor  which accounts fo r  the fac t  that t rea t ing  the p a r t ia l
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atomic charges as point charges centred on the nuclei is a poor 
approximation which w i l l  give values which are numerically too large.  
"D ie lec t r ic  constants" which are distance dependent ( fo r  example ramp 
or step functions) are sometimes used, but the usual approach is to use 
a constant value, generally between 2 and 4. In this work, a value of  
4 was used throughout for  the molecular mechanics ca lculat ions.
Force f i e l d s .
The term "force f i e ld "  in connection with molecular mechanics is
general ly  taken to mean not only the force constants k$ , k@ e t c . ,
but also th e i r  associated parameters and reference values 1 , 0o o
etc.  The values of  these parameters are f i t t e d  by least  squares 
methods or (more usually) by t r i a l  and error  to thermodynamic and
structural  data for a set of  well characterised compounds. S t r i c t l y  
speaking, each molecule has i ts  own p ar t ic u la r  force f i e l d ,  but in 
molecular mechanics the assumption is made that elements of  the force 
f i e l d  can be transferred from one molecule to another without serious 
erro r .  This is not an e n t i re ly  unreasonable assumption in the l ig h t  of  
the consistency of ,  fo r  example, bond lengths and angles between given 
atom types in d i f fe re n t  compounds, and as indicated by many sets of  
data calculated by molecular mechanics which agree well with 
experiment. However, i t  should be borne in mind that extrapolat ion to 
systems for  which the force f i e l d  is not sp e c i f ic a l ly  designed is 
dangerous, and misleading resul ts  can be obtained even in quite simple 
cases. A s t r ik ing  example of th is  is A l l in g e r 's  "gauche butane"
hypothesis, where i t  was found that  the most stable conformation of  
n-butane was calculated to be the gauche conformer, using a force f i e l d  
which appeared to give good resul ts  fo r  many hydrocarbons. This is 
i n t u i t i v e l y  unreasonable, and the phenomenon has since been shown to be 
force f i e l d  dependent, with other force f ie ld s  giving the f u l l y  
extended trans conformer as the most stable ,  in agreement with
observation and more accurate ca lculat ions.
I t  is also worth pointing out that  the parameters which make up the 
force f i e l d  are quite strongly interdependent, and i t  is not, in 
general,  possible to change one or more parameters in iso la t ion  without 
revis ion of  the rest  o f  the force f i e l d .
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The force constants and reference values used in this work are
l is te d  in section B3 along with the key to the various atom types 
parameteri sed.
Coordinate Adjustment.
Having obtained the ster ic  energy of  the system using the 
expressions in the previous sections and the force f i e l d ,  i t  now
remains to adjust the cartesian coordinates of  the system to f ind a 
minimum energy geometry. As is the case fo r  geometry optimising SCF
methods, the method used in this study is based on the Newton-Raphson
i te r a t i v e  solution described in section 3.4 .
Calculation of  the f u l l  Hessian matrix and i ts  subsequent inversion 
can be very time-consuming processes, and i f  this is done, the system 
is very unstable i f  the start ing approximation is not very good. A
much more robust method is to replace the inverted matrix o f  second
der ivat ives by the unit  matrix, and scale the step length at each
i te r a t io n .  A better  approximation than th is  is to use the matrix whose 
diagonal elements are the second derivat ives of the energy. This
removes the need for  scaling.
An improvement on the diagonal matrix approach is to reduce the 
matrix o f  second derivatives to block diagonal form. The f u l l  hessian
matrix is made up of  terms dE/dx.x^ where x . , x  ^ are one or
other of  the cartesian coordinates of  the system. In the diagonal
approach the only elements considered non-zero are those with i = j .  The 
block diagonal approach uses those elements where x. and x  ^ are
associated with the same atom. This gives a matrix consisting of  a set 
of 3x3 blocks along the leading diagonal, with a l l  other elements 
zero. Inversion of  the block diagonal matrix is much more rapid than 
is the case fo r  the f u l l  matrix,  and gives more rapid convergence than 
the id e n t i ty  matrix or diagonal matrix approximations. The method is 
also much more to le rant  of  poor s tar t ing  geometries than use of  the 
f u l l  matrix.
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This approach allows the energy to be reduced unt i l  the r .m.s.  
value of  the der ivat ives of  the energy with respect to the coordinates 
is around 0.05 kcal mole~^Ang_\  a f te r  which fur ther  i te ra t io n  
generally produces very l i t t l e  change e i ther  in the energy or energy 
gradients. I f  i t  is deemed necessary to approach the minimal point  
even more closely,  the f u l l  hessian matrix of  second derivat ives must 
be evaluated and inverted. The programme used in this work has the 
capab i l i ty  to do th is ,  but the process is extremely time-consuming, and 
in view of  the fac t  that  the force f i e l d ,  however good, is simply a 
col lect ion  of  empirical parameters and thus any solution obtained is a 
function of  those parameters rather than of  any non-empirical standard 
which could be considered to be an accurate answer, i t  was f e l t  that  
the use o f  a large amount of  computer time in this way could not be 
j u s t i f i e d .  Hence only the block diagonal approximation to the hessian 
matrix was used, generally up to the point where i t  produced no fu r ther  
improvement in the energy.
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B3 Key to atom types in force f i e l d .
Atom Type Description
1 sp3 hybridised carbon
2 sp2 (alkene) carbon
3 aromatic carbon
4 sp carbon (not used)
5 nitrogen sp3
6 nitrogen sp3 cation
7 nitrogen sp2
8 nitrogen tr igonal
9 peptide nitrogen
10 ether,  alcohol or water oxygen
11 carbonyl or carboxyl oxygen
12 mercapto sulphur
13 not parameterised
14 not parameterised
15 hydrogen
16 not parameterised
17 not parameterised
18 not parameterised
19 Hydrogen-bonding hydrogen
20 Metal ion
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Force Field (227)
Bond Stretching Parameters
Bond between atom
type and type ks 10
1 316.800 1.520
2 319.500 1.501
3 320.000 1.525
5 570.000 1.460
6 350.000 1.470
9 379.000 1.470
10 250.000 1.450
12 250.000 1.810
15 331.200 1.100
2 2 670.000 1.335
2 3 500.000 1.470
2 9 441.000 1.320
2 10 300.000 1.360
2 11 632.000 1.260
2 15 346.000 1.089
3 3 530.000 1.395
3 6 480.000 1.430
3 7 440.000 1.354
3 8 480.000 1.352
3 9 440.000 1.420
3 10 300.000 1.360
3 15 346.000 1.084
3 16 250.000 1.300
3 17 250.000 1.730
5 5 350.000 1.450
5 19 300.000 1.030
5 20 450.000 2.220
6 19 300.000 1.011
7 8 480.000 1.341
7 19 300.000 1.000
9 19 300.000 1.000
10 19 300.000 0.942
11 20 500.000 2.300
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Non-bonded In te rac t ion  Parameters.
r * i + r * 2 e
1 3.850 0.120
2 3.600 0.080
3 3.600 0.080
5 3.680 0.120
6 3.680 0.120
7 3.680 0.120
8 3.680 0.120
9 3.680 0.120
10 3.560 0.120
11 3.560 0.120
12 3.910 0.120
15 3.350 0.030
16 3.400 0.150
17 3.750 0.015
19 2.000 0.020
20 2.550 0.120
2 4.000 0.076
3 4.000 0.076
5 3.680 0.120
6 3.680 0.120
7 3.680 0.120
8 3.680 0.120
9 3.700 0.120
10 3.560 0.120
11 3.560 0.120
12 3.910 0.120
15 3.530 0.033
17 3.950 0.140
19 2.000 0.020
20 2.650 0.120
3 4.000 0.076
5 3.680 0.120
6 3.700 0.120
7 3.680 0.120
8 3.680 0.120
9 3.700 0.120
10 3.560 0.120
11 3.560 0.120
12 3.910 0.120
15 3.530 0.033
16 3.600 0.140
17 3.950 0.140
19 2.000 0.020
20 2.650 0.120
5 3.300 0.120
9 3.500 0.120
10 3.380 0.120
11 3.480 0.120
12 3.730 0.120
15 3.240 0.040
19 1.850 0.040
20 2.300 0.120
6 3.500 0.120
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Non-bonded In teract ion  Parameters cont. 
r * - j + r * 2Atom types
6 8
6 9
6 10
6 11
6 12
6 15
6 19
7 7
7 8
7 9
7 10
7 11
7 12
7 15
7 17
7 19
8 8
8 9
8 10
8 11
8 12
8 15
8 17
8 19
9 9
9 10
9 11
9 12
9 15
9 17
9 19
9 20
10 10
10 11
10 12
10 15
10 16
10 17
10 19
10 20
11 11
11 12
11 15
11 17
11 19
11 20
12 15
12 19
12 20
15 15
15 16
15 17
15 19
3.300 0.120
3.300 0.120
3.380 0.120
3.380 0.120
3.730 0.120
3.240 0.040
1.700 0.200
3.500 0.120
3.500 0.120
3.500 0.120
3.380 0.120
3.380 0.120
3.730 0.120
3.240 0.040
3.650 0.150
1.700 0.200
3.500 0.120
3.500 0.120
3.380 0.120
3.380 0.120
3.730 0.120
3.240 0.040
3.650 0.150
1.700 0.200
3.500 0.120
3.380 0.120
3.380 0.120
3.730 0.120
3.240 0.040
3.650 0.150
1.700 0.200
2.300 0.120
3.260 0.120
3.260 0.120
3.610 0.120
3.120 0.040
3.250 0.150
3.600 0.150
1.600 0.250
2.300 0.120
3.260 0.120
3.610 0.120
3.120 0.040
3.600 0.150
1.600 0.250
2.300 0.120
3.200 0.040
2.000 0.250
2.600 0.500
3.100 0.016
2.900 0.020
3.250 0.020
1.600 0.005
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Non-bonded In te ra c t io n  Parameters cont.
Atom types r * ] + r *2 e
15 20 2.200 0.030
16 19 1.550 0.020
17 17 3.900 0.250
17 19 1.950 0.020
19 19 0.100 0.030
19 20 2.200 0.030
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Angle Bending Parameters.
Atom types k
1 1 1 0.0120 0.
2 1 1 0.0090 0.
3 1 1 0.0090 0.
5 1 1 0.0120 0.
6 1 1 0.0120 0.
9 1 1 0.0120 0.
10 1 1 0.0120 0.
12 1 1 0.0120 0.
15 1 1 0.0088 0.
2 1 2 0.0090 0.
3 1 2 0.0090 0.
5 1 2 0.0090 0.
6 1 2 0.0090 0.
9 1 2 0.0090 0.
10 1 2 0.0090 0.
15 1 2 0.0088 0.
9 1 3 0.0090 0.
10 1 3 0.0090 0.
15 1 3 0.0080 0.
15 1 5 0.0080 0.
15 1 6 0.0080 0.
15 1 7 0.0088 0.
15 1 9 0.0080 0.
15 1 10 0.0080 0.
15 1 12 0.0080 0.
15 1 15 0.0072 0.
1 2 1 0.0233 0.
2 2 1 0.0120 0.
2 2 2 0.0120 0.
9 2 1 0.0100 0.
9 2 2 0.0100 0.
15 2 2 0.0060 0.
10 2 1 0.0150 0.
11 2 1 0.0130 0.
11 2 1 0.0130 0.
15 2 1 0.0060 0.
9 2 3 0.0120 0.
11 2 3 0.0120 0.
15 2 3 0.0060 0.
9 2 9 0.0120 0.
11 2 9 0.0150 0.
9 2 10 0.0080 0.
11 2 10 0.0150 0.
11 2 11 0.0150 0.
11 2 2 0.0150 0.
15 2 11 0.0060 0.
15 2 15 0.0055 0.
3 3 1 0.0120 0.
7 3 1 0.0120 0.
8 3 1 0.0120 0.
Reference angles for  
1 2  3 4
non-hydrogen substituents
n o . .70 110..40 110.,10 109. 50
0..00 110.,40 n o . .10 109. 50
0..00 109.,50 109.,50 109. 50
0..00 109..50 109.,50 109. 50
0,.00 109..50 109..50 109. 50
0,.00 110.,70 109.,50 109.,50
109.,50 109.,50 108.,10 108. 10
0..00 109.,50 109..50 109. 50
110,.50 109.,50 109.,20 109.,20
0,.00 I l l  .,00 110.,10 109.,50
0..00 110.,00 110.,00 110. 00
0..00 109.,50 109.,50 109. 50
0,.00 109.,50 109..50 109.,50
0..00 109.,50 109..50 109.,50
0.,00 109.,50 109.,50 109.,50
110..50 110..20 110.,20 110.,20
0..00 109..50 109..50 109.,50
0..00 109.,50 109..50 109.,50
109..50 109.,50 109..50 109.,50
109,.50 109.,50 109..50 109.,50
109,.50 109..50 109..50 109..50
109..50 109..50 109.,50 109..50
109..50 108..55 108..55 108..55
109,.50 109..50 109..50 109..50
109,.50 109..50 109,.50 109..50
108,.20 109..10 109..50 109..50
0..00 0..00 116,.40 116..40
0,.00 122..30 121,.00 121..00
0,.00 122..30 121,.00 121..00
0,.00 0..00 117..00 117..00
0,.00 0..00 117..00 117..00
0,.00 120,.00 120..00 120..00
0,.00 123,.00 123..00 122..00
0,.00 120,.00 120,.00 120..00
0,.00 120,.00 120..00 120..00
0,.00 117..50 117,.50 117,.50
0,.00 120..00 120..00 120..00
0..00 120,.00 120,.00 120,.00
120,.00 120..00 120,.00 120..00
0,.00 120..00 120,.00 120,.00
0,.00 123,.00 123,.00 123..00
0,.00 114,.00 114,.00 114,.00
0,.00 123,.00 123,.00 123,.00
0 .00 123..00 123,.00 123,.00
0,.00 120,.00 120,.00 120,.00
120 .00 120,.00 120,.00 120,.00
118 .60 118,.60 118 .60 118 .60
120 .00 120,.00 120..00 120,.00
0 .00 0,.00 120,.00 120 .00
0 .00 120..00 120 .00 120 .00
k'
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0096
0000
0096
0096
0000
0096
0096
0096
0096
0096
0096
0000
0096
0096
0096
0096
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Angle Bending Parameters cont.
Atom types
9 3 1
3 3 2
10 3 2
3 3 3
6 3 3
7 3 3
8 3 3
9 3 3
10 3 3
15 3 3
9 3 7
15 3 7
7 3 8
8 3 8
15 3 8
1 5 1
19 5 1
19 5 19
20 5 19
1 6 1
3 6 1
19 6 1
19 6 19
9 3 10
19 7 3
3 7 3
3 8 3
1 9 1
2 9 1
3 9 1
19 9 1
2 9 2
3 9 2
19 9 2
3 9 3
19 9 3
19 9 19
1 10 1
2 10 1
3 10 1
19 10 1
3 10 3
19 10 3
19 10 19
5 20 5
Reference angles for  
k k ’ 1 2  3 4
non-hydrogen substituents
0.0120 0.0096
0.0120 0.0096
0.0120 0.0096
0.0120 0.0096
0.0120 0.0096
0.0120 0.0096
0.0120 0.0096
0.0120 0.0096
0.0120 0.0096
0.0060 0.0000
0.0120 0.0096
0.0060 0.0000
0.0120 0.0096
0.0120 0.0096
0.0060 0.0000
0.0120 0.0096
0.0080 0.0096
0.0070 0.0096
0.0070 0.0096
0.0120 0.0096
0.0120 0.0096
0.0080 0.0096
0.0070 0.0096
0.0120 0.0096
0.0090 0.0096
0.0120 0.0096
0.0120 0.0096
0.0120 0.0096
0.0170 0.0096
0.0170 0.0096
0.0080 0.0096
0.0170 0.0096
0.0120 0.0096
0.0080 0.0096
0.0120 0.0096
0.0080 0.0096
0.0080 0.0096
0.0120 0.0096
0.0120 0.0096
0.0120 0.0096
0.0080 0.0096
0.0120 0.0096
0.0120 0.0096
0.0120 0.0096
0.0120 0.0096
0.00 120.00 
0.00 120.00 
0.00 120.00 
0.00 120.00 
0.00 120.00
120.00 120.00 
0.00 120.00 
0.00 120.00 
0.00 120.00 
0.00 120.00 
0.00 120.00 
0.00 120.00 
0.00 120.00 
0.00 120.00 
0.00 120.00 
0.00 109.50
109.50 109.50
109.50 109.50
109.50 109.50 
0.00 109.50 
0.00 109.50
108.50 109.50
109.50 109.50 
0.00 120.00 
0.00 120.00
120.00 120.00 
0.00 120.00 
0.00 117.00 
0.00 124.00 
0.00 124.00 
0.00 117.00 
0.00 124.00 
0.00 120.00
119.00 119.00 
0.00 120.00
119.00 119.00
120.00 120.00 
0.00 111.50 
0.00 112.00 
0.00 112.00
106.86 106.86 
0.00 120.00
108.50 109.00 
0.00 104.50
109.50 109.50
120,.00 120..00
120,.00 120.,00
120.,00 120.,00
120,,00 120..00
120,.00 120..00
120..00 120..00
120..00 120..00
120..00 120..00
120.,00 120..00
120.,00 120.,00
120..00 120..00
120..00 120..00
120..00 120..00
120.,00 120..00
120..00 120.,00
109,.50 109..50
109..50 109..50
109..50 109..50
109..50 109..50
109..50 109..50
109,.50 109..50
110,.00 110,.00
109..50 109..50
120..00 120,.00
120..00 120..00
120,.00 120,.00
120..00 120,.00
117,.00 117,.00
124,.00 124..00
124,.00 124..00
117,.00 117,.00
124..00 122..00
120,.00 120,.00
119,.00 119,.00
120 .00 120..00
119,.00 119,.00
120,.00 120..00
111,.50 I l l , .50
112,.00 112,.00
112 .00 112,.00
106,.86 106,.86
120,.00 120,.00
109,.00 109,.00
0 .00 0 .00
109 .50 109 .50
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Torsional Parameters.
Atom types
1 
2 
3 
6 
7 
9 
10 
12 
15 
2 
3 
5 
9 
10 
12 
15 
3 
5 
7 
9 
10 
15 
10 
15 
15 
9 
10 
15 
10 
15 
10 
15 
15 
15 
1 
2
15 
1 
2
15 
15 
1 
3
5
6 
7 
9
10 
15 
1 
9 
10
k s
0.0629 3.0
0.0629 3.0
0.0629 3.0
0.0629 3.0
0.0629 3.0
0.0629 3.0
0.0400 3.0
0.0400 3.0
0.1100 3.0
0.0200 3.0
0.0200 3.0
0.0629 3.0
0.0629 3.0
0.0400 3.0
0.0400 3.0
0.1100 3.0
0.0200 3.0
0.0200 3.0
0.0200 3.0
0.0200 3.0
0.0200 3.0
0.1100 3.0
0.0400 3.0
0.1100 3.0
0.1100 3.0
0.0629 3.0
0.0400 3.0
0.1100 3.0
0.4000 3.0
0.1100 3.0
0.0400 3.0
0.0400 3.0
0.0400 3.0
0.1100 3.0
0.0629 3.0
0.0629 3.0
0.1100 3.0
0.0629 - 3 .0
0.0629 - 3 .0
0.0629 - 3 .0
0.0629 - 3 .0
0.0629 - 6 .0
0.0629 - 3 .0
0.0629 - 6 .0
0.0629 - 6 .0
0.0629 - 3 .0
0.0629 - 3 .0
0.0629 -3 .0
0.0629 - 3 .0
0.0629 - 3 .0
0.0629 - 3 .0
0..0629 - 3 .0
2
2
2
2
2
2
2
3
3
3
3
3
3
5
5
6 
7 
7 
7 
9 
9
10
10
12
15
1
1
1
2
2
2
3
9
9
9
9
9
9
9
9
10
10
10
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Torsional Parameters cont.
Atom types k s
15 2 10 0.0629 - 3 .0
1 2 11 0.0629 - 6 .0
5 2 11 0.0629 - 6 .0
6 2 11 0.0629 - 6 .0
7 2 11 0.0629 - 3 .0
9 2 11 0.0629 - 3 .0
10 2 11 0.0629 - 6 .0
15 2 0.0628 - 6 .0
1 2 15 0.1367 3.0
2 2 15 0.1367 3.0
15 2 15 0.1367 3.0
1 3 3 0.0629 - 3 .0
2 3 3 0.0629 - 3 .0
3 3 3 0.0629 - 3 .0
5 3 3 0.0629 - 3 .0
7 3 3 0.0629 - 3 .0
9 3 3 0.0629 - 3 .0
10 3 3 0.0629 - 3 .0
15 3 3 0.0020 - 6 .0
1 3 7 0.0629 - 3 .0
15 3 7 0.0629 - 3 .0
1 3 8 0.0629 - 3 .0
15 3 8 0.0020 - 6 .0
1 3 9 0.0629 -3 .0
10 3 8 0.0629 -3 .0
15 3 9 0.0629 -3 .0
15 3 15 0.1100 -3 .0
1 5 1 0.0629 3.0
15 5 1 0.1100 3.0
1 5 19 0.0550 3.0
2 5 19 0.1100 3.0
3 5 19 0.1100 3.0
15 5 19 0.0550 3.0
15 7 1 0.0629 3.0
1 6 1 0.0629 3.0
1 6 19 0.0550 3.0
2 6 1 0.0629 3.0
15 6 1 0.1100 3.0
1 6 3 0.0629 - 3 .0
2 6 19 0.0629 3.0
15 6 19 0.0629 3.0
2 7 3 0.0629 - 3 .0
3 7 3 0.0629 - 3 .0
15 6 3 0.0629 - 3 .0
1 7 19 0.0629 3.0
2 7 19 0.0629 3.0
15 7 19 0.0629 3.0
1 9 1 0.0629 3.0
2 9 1 0.0629 3.0
15 9 1 0.0629 3.0
1 9 2 0.0629 - 3 .0
2 9 2 0.0629 3.0
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Torsional Parameters cont.
Atom types
3 1 9
15 1 9
15 1 9
1 1 9
2 1 9
3 1 9
15 1 9
1 1 10
3 1 10
10 1 10
15 1 10
1 1 10
2 1 10
15 1 10
1 1 10
2 1 10
3 1 10
15 1 10
1 1 10
3 1 10
10 10
15 1 10
1 2 2
1 2 2
11 2 2
9 2 2
9 2 2
9 2 2
15 2 2
15 2 2
15 2 2
9 2 3
11 2 3
15 2 3
9 2 3
11 2 3
15 2 3
1 2 9
3 2 9
9 2 9
11 2 9
1 2 9
2 2 9
2 2 9
11 2 9
1 2 9
3 2 9
10 2 9
11 2 9
1 2 9
3 2 9
9 2 9
k s
0.0629 3.0
0.0629 -3 .0  
0.0629 -3 .0  
0.0629 3.0 
0.0629 3.0 
0.0629 3.0 
0.0629 3.0 
0.0315 3.0 
0.0629 3.0 
0.0315 3.0 
0.0550 3.0 
0.0629 3.0 
0.0315 3.0 
0.0629 3.0 
0.0629 3.0 
0.0200 3.0 
0.0200 3.0 
0.0629 3.0 
0.1800 3.0 
0.1800 3.0 
0.1800 3.0 
0.1800 3.0
6.2500 - 2 .0
6.2500 - 2 .0
6.2500 - 2 .0
6.2500 - 2 .0
6.2500 - 2 .0
6.2500 - 2 .0
6.2500 - 2 .0
6.2500 - 2 .0
6.2500 - 2 .0  
0.2500 - 2 .0  
0.2500 - 2 .0  
0.8000 - 2 .0  
0.8000 - 2 .0  
0.8000 - 2 .0  
0.8000 - 2 .0
3.0000 - 2 .0
3.0000 - 2 .0  
0.8000 - 2 .0
3.0000 - 2 .0
3.0000 - 2 .0
3.0000 - 2 .0
3.0000 - 2 .0
3.0000 - 2 .0
3.0000 - 2 .0
3.0000 - 2 .0
3.0000 - 2 .0
3.0000 - 2 .0
3.0000 - 2 .0
3.0000 - 2 .0
3.0000 - 2 .0
2
2
3
19
19
19
19
1
1
1
1
2
2
2
3
3
3
3
19
19
19
19
1
2
2
1
15
11
1
2
15
3
3
3
10
10
10
1
1
1
1
2
1
2
2
3
3
3
3
19
19
19
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Torsional Parameters cont.
Atom types
10 2 9
11 2 9
1 2 10
9 2 10
11 2 10
1 2 10
11 2 10
1 3 3
3 3 3
7 3 3
8 3 3
9 3 3
10 3 3
15 3 3
3 3 3
15 3 3
3 3 3
7 3 3
8 3 3
9 3 3
10 3 3
15 3 3
7 3 3
8 3 3
10 3 3
15 3 3
8 3 3
10 3 3
15 3 3
15 3 3
10 3 3
15 3 3
15 3 3
15 3 3
1 3 7
3 3 6
7 3
8 3
9 3
15 3
3 3
8 3
9 3
15 3
1 3
3 3
7 3
8 3
9 3
15 3
1 3 8
3 3 8
k s
3.0000 -2 .0
3.0000 -2 .0
3.0000 -2 .0
3.0000 -2 .0
3.0000 -2 .0
3.0000 -2 .0
3.0000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0
3.0000 -2 .0
3.0000 -2 .0
3.0000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
1.2000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0
3.0000 -2 .0
19
19
1
1
1
3
3
1
1
1
1
1
1
1
2
2
3
3
3
3
3
3
7
7
7
6
8
8
8
9
10
10
10
15
1
1
1
1
1
1
3
3
3
3
19
19
19
19
19
19
3
3
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Torsional Parameters cont.
Atom types
7 3 8
8 3 8
9 3 8
15 3 8
8 3 9
10 3 9
8 3 9
10 3 9
3 3 9
7 3 9
8 3 9
3 3 10
8 3 10
3 3 10
2 3 10
3 3 10
3 3 10
19 5 20
k s
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0  
0.8000 -2 .0
1.0000 -2 .0
2.5000 -2 .0
3.0000 -2 .0
2.5000 -2 .0
2.5000 -2 .0
1.0000  - 2.0  
0.0629 3.0
3
3
3
3
1
1
19
19
19
19
19
1
1
2
3
3
19
5
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Appendix C.
Torsion Angle Convention.
The torsion angle convention used in this work is the standard 
IUPAC convention. In this convention a torsion angle A-B-C-D is zero 
when the four atoms are coplanar and A and D are f u l l y  eclipsed, see 
f igure C l .1.
A * p
\ /  AJ\ J
B " C R— ^
Figure C1.1
Viewing along the B-C direct ion,  the torsion angle ABCD is given by 
the clockwise rotat ion of A required to bring about the f u l l y  eclipsed 
conformation. By convention, angles >180° are generally reported as 
-<360-n>°.
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Appendix D1
Molecule numbers re fe r  to  tab le 4 .1 .1 .
Em „, e. e1l lm. A, BE, E . . are in eV.m-n homo _-,lumo stat
1/A is in eV .
2 2ji and i ts  x, y and z components are in Debyes, p in D .
is in a * IP in A3eV.mol « ^
r ,  SA, Vol are in A, A , A respect ive ly .
V, is in Vo lts ,  EF and i ts  x, y, z components in Volts/A
2V2 is in eV/electron
nrot  the num^ er rotatable  bonds
All  other quanti t ies are in the relevant  atomic units.
185
Calculated indices at e=l
1 -0.521071 0.005112 0.077632 -0.070370 -36.601486
2 -0.520610 0.005121 0.042133 -0.070408 -36.646420
3 -0.520863 0.005138 0.000224 -0.070386 -36.682039
4 -0.519446 0.005175 0.000225 -0.070472 -36.741205
5 -0.516565 0.005247 0.025184 -0.071060 -36.726905
6 -0.512885 0.005415 0.028091 -0.071288 -36.775179
7 -0.462410 0.006084 0.109129 -0.074477 -36.942321
8 -0.525994 0.005379 0.054172 -0.070133 -37.071035
9 -0.502124 0.047677 0.382692 -0.071392 -37.260084
10 -0.504542 0.050700 0.178246 -0.071278 -37.288725
11 -0.514817 0.005370 0.000220 -0.071156 -36.825252
12 -0.513917 0.005352 0.034887 -0.071218 -36.729940
13 -0.531167 0.006422 0.033750 -0.070813 -36.533850
14 -0.504606 0.005532 0.030829 -0.071740 -36.780782
15 -0.501360 0.049559 0.034389 -0.071438 -37.328010
16 -0.510061 0.001341 0.000818 -0.071019 -37.325977
17 -0.499767 0.046577 0.000398 -0.071499 -37.329168
18 -0.498695 0.000964 0.000118 -0.071532 -37.354964
19 -0.462820 0.028618 0.370908 -0.074343 -38.829439
20 -0.467459 0.027411 0.322728 -0.073955 -38.820959
21 -0.467262 0.027753 0.319758 -0.074128 -38.897290
22 -0.467601 0.027664 0.315979 -0.074110 -38.895357
23 -0.448206 0.039172 0.003990 -0.074708 -38.966390
24 -0.453257 0.038120 0.003678 -0.074305 -38.956612
25 -0.454249 0.038966 0.003554 -0.074416 -39.035096
26 -0.461871 0.041077 0.003570 -0.074035 -38.921943
27 -0.499904 0.007406 0.023507 -0.072097 -38.835366
28 -0.495082 0.007514 0.003730 -0.072464 -38.931406
29 -0.395948 0.009475 0.584345 -0.075908 -37.986939
30 -0.483604 0.007734 0.162671 -0.073795 -37.333538
31 -0.083706 0.009537 0.010275 -0.035998 -18.351044
32 -0.081426 0.002848 0.000175 -0.035488 -18.519337
33 -0.396483 0.009474 0.584238 -0.075882 -37.983029
34 -0.499304 0.007304 0.004171 -0.072357 -38.791639
35 -0.485523 0.006230 0.000331 -0.072954 -38.400182
186
Molecule Q2 F£2
1 0.423722 0.008571
2 0.423126 0.008627
3 0.423289 0.008679
4 0.423469 0.008781
5 0.423176 0.008876
6 0.425842 0.008027
7 0.397741 0.009309
8 0.422996 0.009668
9 0.429508 0.006407
10 0.429235 0.006619
11 0.422553 0.009145
12 0.422803 0.008990
13 0.474745 0.004788
14 0.421133 0.009237
15 0.430878 0.006261
16 0.428657 0.000925
17 0.431920 0.005782
18 0.431673 0.001125
19 0.409462 0.005804
20 0.412961 0.005878
21 0.407544 0.005813
22 0.407629 0.005776
23 0.404219 0.006046
24 0.408260 0.006238
25 0.403419 0.006367
26 0.404514 0.006827
27 0.420906 0.012237
28 0.414831 0.014096
29 0.310947 0.011070
30 0.425960 0.010944
31 0.194293 0.023253
32 0.213864 0.007688
33 0.311316 0.011083
34 0.414583 0.013795
35 0.501728 0.010393
fn2 a  2 Ebind2
.239173 -0.112541 -108.179675
.168729 -0.112592 -108.088995
.001975 -0.112593 -108.051327
.001548 -0.112588 -107.996883
.106659 -0.113078 -107.976770
.116733 -0.113831 -107.885541
.167225 -0.114300 -107.135276
.192260 -0.112455 -107.601938
.852738 -0.112563 -108.067917
.463279 -0.112598 -107.988436
.001689 -0.113017 -107.886898
.146394 -0.112990 -108.030719
.047992 -0.113102 -109.186995
.098393 -0.113050 -107.922908
.150777 -0.112579 -107.997445
.004808 -0.112604 -107.898014
.001250 -0.112555 -108.026654
.001714 -0.112544 -108.014956
.652943 -0.113707 -106.359677
.568536 -0.114161 -106.318044
.588685 -0.114517 -106.101019
.583038 -0.114519 -106.097377
.007847 -0.114164 -106.119762
.007618 -0.114607 -106.090018
.007653 -0.114961 -105.877288
.007699 -0.114521 -105.977267
.128011 -0.114255 -105.699104
.014529 -0.113601 -105.570468
.889322 -0.120157 -104.359625
.252373 -0.114888 -107.098030
.079976 -0.123392 -98.471447
.028963 -0.120757 -99.015541
.889840 -0.120146 -104.363366
.016631 -0.113359 -105.652555
.002813 -0.113953 -107.589100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
187
Molecule Q3
1 -0.189127
2 -0.193488
3 -0.197009
4 -0.197299
5 -0.181487
6 -0.184190
7 -0.136457
8 -0.215669
9 -0.180155
10 -0.184357
11 -0.169619
12 -0.162932
13 -0.206295
14 -0.183297
15 -0.190101
16 -0.183408
17 -0.189825
18 -0.191600
19 -0.169565
20 -0.171851
21 -0.172117
22 -0.172223
23 -0.181130
24 -0.184320
25 -0.183914
26 -0.172605
27 -0.205877
28 -0.194629
29 0.044656
30 -0.168709
31 -0.016741
32 -0.153220
33 0.044862
34 -0.192012
35 -0.331401
0.001759
0.001781
0.001787
0.001791
0.001812
0.001718
0.001375
0.001949
0.118077
0.122594
0.001758
0.001722
0.002666
0.001696
0.122538
0.000221
0.119681
0.000611
0.076354
0.075932
0.075439
0.075420
0.088734
0.088400
0.088966
0.090203
0.002254
0.002876
0.000601
0.001215
0.052392
0.000130
0.000601
0.002822
0.001720
0.596918
0.576736
0.006845
0.006510
0.403140
0.412034
0.015520
0.625233
0.224631
0.463850
0.007109
0.482746
0.060769
0.329321
0.412804
0.014478
0.006586
0.006063
0.130703
0.116482
0.120328
0.118779
0.019909
0.020634
0.020940
0.021413
0.489400
0.151817
0.077889
0.038672
0.311523
0.005148
0.077712
0.160652
0.009478
a  3
-0.102642
-0.103181
-0.103237
-0.103145
-0.105676
-0.105850
-0.107850
-0.102298
-0.104456
-0.105088
-0.105125
-0.104146
-0.104739
-0.105273
-0.104989
-0.105470
-0.104945
-0.104782
-0.108419
-0.108350
-0.108469
-0.108446
-0.105615
-0.105483
-0.105643
-0.106187
-0.103071
-0.102996
-0.122381
-0.108956
-0.133837
-0.107807
-0.122379
-0.103209
-0.070715
Ebind3
-79.548615
-78.994648
-78.877788
-78.883710
-84.952749
-84.904732
-86.050911
-79.866335
-80.325223
-79.787449
-85.658231
-86.688158
-84.050290
-84.949985
-79.588644
-79.936234
-79.518433
-79.400178
-86.241075
-86.210031
-86.220701
-86.215581
-80.223249
-80.144224
-80.165694
-80.497699
-85.749783
-85.232792
-97.738110
-87.396724
-85.081595
-86.714823
-97.740470
-85.240708
-52.104984
188
Molecule E^_2 chomo el umo A
1 -40.993642 -34.675681
2 -41.008876 -34.661012
3 -41.011222 -34.651184
4 -41.028531 -34.604959
5 -41.090373 -34.296550
6 -41.155559 -34.347409
7 -41.277969 -33.043317
8 -40.975108 -34.622273
9 -41.213987 -34.979417
10 -41.205698 -35.005818
11 -41.089151 -34.199361
12 -41.086716 -34.216276
13 -41.282177 -33.880722
14 -41.143004 -34.163796
15 -41.248346 -34.958758
16 -41.164713 -35.017256
17 -41.271371 -34.939563
18 -41.283381 -34.931047
19 -41.138377 -34.994711
20 -41.168089 -35.043491
21 -41.013681 -35.045086
22 -41.013146 -35.037747
23 -41.209541 -34.797277
24 -41.239941 -34.851847
25 -41.083267 -34.856633
26 -40.970834 -35.087491
27 -41.383887 -33.377163
28 -41.338159 -33.234565
29 -41.719169 -29.495160
30 -41.554165 -32.483040
31 -19.808126 -27.173941
32 -19.921091 -27.854121
33 -41.718812 -29.495051
34 -41.227205 -33.413887
35 -42.761857 -31.174907
.144492 13.783630 8.639138
.132703 13.416041 8.283338
.098940 12.293236 7.194296
.050278 9.823537 4.773259
.134532 12.945944 7.811411
.022431 12.864264 7.841833
.053457 11.855791 6.802334
.818649 12.934349 8.115700
.537655 12.833117 13.370773
.635466 12.727142 13.362608
.023408 9.830671 4.807263
.120050 13.344400 8.224350
.047347 12.714968 7.667622
.286875 12.702258 7.415383
.685126 12.568818 13.253944
.762073 11.927597 12.689670
.683966 12.043256 12.727222
.792814 9.388805 10.181619
.111164 8.753374 11.864538
.136913 8.710317 11.847229
.170583 8.653972 11.824555
.169518 8.657583 11.827101
.103521 7.738558 10.842080
.115916 7.742268 10.858184
.147837 7.721225 10.869062
.162350 7.720321 10.882671
.635263 8.968390 6.333127
.600116 6.969715 4.369599
.097882 12.439276 7.341395
.082823 11.191833 6.109011
.424929 7.301818 2.876890
.591712 9.991903 4.400191
.098511 12.439421 7.340910
.619539 7.071260 4.451721
.938471 9.901772 4.963301
5
5
5
5
5
5
5
4
-0
-0
5
5
5
5
-0
-0
-0
-0
-3
-3
-3
-3
-3
-3
-3
-3
2
2
5
5
4
5
5
2
4
189
Molecule 1/A BE Estat
1 0.115752 -188.207583 -47630.9952 -13.905689 -2.288202
2 0.120724 -222.295704 -49804.7514 -14.122495 -2.385552
3 0.138999 -323.967267 -56324.8345 -14.240029 -2.899011
4 0.209500 -389.034677 -62553.9494 -13.709418 -3.886571
5 0.128018 -286.332154 -54089.5443 -14.640311 -2.327084
6 0.127521 -320.309897 -56263.0798 -14.454966 -2.093235
7 0.147008 -271.850472 -54006.1409 -11.361888 -5.724184
8 0.123218 -223.039890 -49806.2398 -16.250914 -13.947773
9 0.074790 -227.984915 -36270.9298 -17.818223 -0.549984
10 0.074836 -262.085262 -38444.7105 -18.891161 -0.633214
11 0.208019 -422.951409 -64727.3628 -14.150737 -3.942360
12 0.121590 -222.439495 -49805.0390 -14.461837 -2.318025
13 0.130419 -254.911982 -56132.2840 -12.175386 -1 .9361 17
14 0.134855 -285.915269 -54088.7105 -11.249069 -2.106553
15 0.075449 -329.978484-42791.6570 -18.326488 -0.316451
16 0.078804 -364.125308 -44965.5306 -21.766694 -1.496690
17 0.078572 -363.857894 -44964.9958 -17.679045 -0.043115
18 0.098216 -428.536232 -51193.3325 -16.830955 -1.079696
19 0.084285 -276.667555 -33346.2351 -0.135613 -12.058496
20 0.084408 -310.594279 -35519.6686 -0.321795 -11.908677
21 0.084570 -378.323927 -39866.2879 -0.393808 -11.489942
22 0.084552 -412.162547 -42039.5451 -0.311776 -11.417640
23 0.092233 -379.509982 -41810.9200 -0.467210 -13.958910
24 0.092096 -413.409614 -43984.2992 -0.642111 -13.724257
25 0.092004 -481.145760 -48330.9315 -0.862677 -13.345989
26 0.091889 -515.089952 -50504.3999 -0.865015 -13.434884
27 0.157900 -286.607831 -46028.9957 -10.501372 11.140387
28 0.228854 -362.045123 -58479.3502 -8.938678 10.120116
29 0.136214 -202.111226 -46776.4825 -11.706020 -0.446255
30 0.163693 -318.941858 -60277.2837 -16.883367 -0.766497
31 0.347598 -270.617366 -50041.1747 -22.309651 -8.021294
32 0.227263 -277.365478 -54071.6110 -21.075470 0.816331
33 0.136223 -202.111042 -46776.4821 -11.699397 -0.446632
34 0.224632 -429.685539 -62825.7911 -8.985672 10.280117
35 0.201479 -378.400714 -63616.1614 -16.461708 -4.315155
190
Molecule \ iz V-
2
P amol a* IP
1 3.604925 14.546461 21 1 .599530 15.300 -78.710728
2 3.366415 14.712868 216.468472 17.196 -88.261955
3 3.045739 14.847869 220.459207 22.884 -116.684151
4 2.605226 14.485882 209.840791 26.892 -135.812074
5 3.178529 15.161038 229.857065 20.568 -105.607061
6 3.406972 14.997838 224.935132 22.464 -112.823892
7 -7.273170 14.654616 214.757780 20.148 -101.817051
8 -13.251535 25.184038 634.235762 17.196 -82.861496
9 -0.590772 17.836495 318.140565 14.791 7.952462
10 -0.719618 18.915464 357.794775 16.687 10.604028
11 2.391994 14.883118 221.507195 28.788 -144.613876
12 3.361488 15.027228 225.817589 17.196 -88.044383
13 3.093486 12.710556 161.558237 22.464 -113.383598
14 -14.504875 18.476215 341.370521 20.568 -108.740445
15 -0.815172 18.347338 336.624815 20.479 14.030696
16 -1.413600 21.863836 478.027324 22.375 17.051379
17 -0.919087 17.702972 313.395204 22.375 15.303745
18 -0.540539 16.874210 284.738960 26.383 20.916817
19 8.220316 14.594496 212.999301 16.700 51.956435
20 8.292462 14.514995 210.685064 18.596 58.334025
21 8.375938 14.224282 202.330199 22.388 70.983005
22 8.333330 14.138745 199.904097 24.284 76.968572
23 8.021917 16.106539 259.420593 23.024 71.455472
24 8.193249 15.996777 255.896879 24.920 77.648623
25 8.331016 15.756442 248.265476 28.712 90.380699
26 8.233890 15.781043 249.041307 30.608 96.793210
27 -6.123522 16.488922 271.884558 19.806 -52.194019
28 -6.222792 14.867409 221.039841 24.570 -63.884847
29 3.280699 12.165238 147.993025 16.001 -81.571203
30 3.205352 17.202031 295.909869 22.740 -115.583392
31 0.601980 23.715481 562.424048 20.292 -89.790653
32 2.903320 21.290164 453.271094 20.568 -115.010331
33 3.278842 12.158379 147.826174 16.001 -81 .581274
34 -6.636009 15.180899 230.459701 28.362 -74.295378
35 3.527246 17.379581 302.049841 26.393 -130.341056
191
Molecule r SA Vol V ^ l ) v2< n
1 3.441473 181.271704 133.829 -6.559012 -1.305501
2 3.544744 202.286700 150.518 -6.555645 -1.306886
3 3.979348 260.406977 199.479 -6.541150 -1.308347
4 4.261525 276.223016 220.612 -6.513150 -1.311534
5 3.593188 222.297115 173.264 -6.571576 -1.312496
6 3.685424 241.431553 189.613 -6.534695 -1.323049
7 3.614951 205.686073 164.959 -6.478271 N-1 .320819
8 3.666725 202.526115 150.547 -6.310824 -1.312284
9 3.579244 190.816712 142.360 -7.241678 -0.159613
10 3.668721 211.835243 159.160 -7.250164 -0.160601
11 4.262573 288.856114 236.379 -6.514407 -1.318361
12 3.469676 199.183136 150.580 -6.563043 -1.312121
13 3.634027 227.534224 184.161 -6.412133 -1.400389
14 3.577313 222.710920 173.662 -6.652472 -1.312466
15 3.847410 252.607339 192.460 -7.247530 -0.162199
16 4.094119 272.320736 209.035 -7.256861 -0.161990
17 3.960433 272.150680 209.153 -7.242466 -0.162837
18 4.357694 293.371836 231.231 -7.218805 -0.163502
19 3.413402 198.264771 152.645 -1.811909 -0.028002
20 3.520113 218.515361 169.160 -1.820105 -0.036574
21 3.773296 249.271508 200.287 -1.845998 -0.058337
22 3.936387 267.070493 216.463 -1.844007 -0.066576
23 3.947200 256.500062 201.500 -1.747054 -0.027672
24 4.098422 276.109879 217.885 -1.756344 -0.036151
25 4.370522 306.753801 248.912 -1.783410 -0.057900
26 4.549715 325.072020 265.049 -1.779096 -0.066214
27 3.527548 211.558750 164.625 -4.742758 -1.353957
28 3.952886 272.582269 211.154 -4.703456 -1.361312
29 3.432801 184.235104 138.690 -6.554319 -1.325023
30 3.714185 243.380368 191.774 -6.695762 -1.353730
31 3.566060 222.004715 174.918 -5.739836 -3.466348
32 3.622878 224.463332 176.063 -7.050930 -1.316728
33 3.432801 184.235104 138.690 -6.553892 -1.325026
34 4.115283 309.836819 244.235 -4.714922 -1.359039
35 4.286354 271.924049 218.062 -6.517102 -1.322372
192
Molecule E (1)X Ey (1 ) Ez(i> E( l ) V*<1)
1 -1.389459 0.581262 -0.317995 1.539345 43.020643
2 -1.387707 0.579746 -0.317668 1 .537124 42.976485
3 -1.385284 0.575970 -0.317743 1.533530 42.786648
4 -1.382456 0.569553 -0.316991 1.528417 42.421126
5 -1.382375 0.584936 -0.321355 1.535050 43.185608
6 -1.375918 0.555442 -0.328358 1.519699 42.702235
7 -1.385479 0.568235 -0.283561 1.524090 41.967991
8 -1.354269 0.537818 -0.267505 1.481503 39.826504
9 -0.523039 2.201981 0.521964 2.322657 52.441903
10 -0.519501 2.203934 0.521653 2.323645 52.564882
11 -1.374768 0.569533 -0.319588 1.522002 42.437502
12 -1.380582 0.581817 -0.321398 1.532258 43.073539
13 -1.422627 0.527523 -0.281378 1.543153 41 .115450
14 -1.418908 0.620178 -0.251328 1.568785 44.255380
15 -0.521134 2.202279 0.521311 2.322365 52.526692
16 -0.509016 2.207206 0.522402 2.324599 52.662027
17 -0.523735 2.199388 0.521351 2.320218 52.453311
18 -0.524124 2.196623 0.521850 2.317798 52.111142
19 -0.184195 0.238822 0.003112 0.301618 3.283014
20 -0.186813 0.235575 0.002515 0.300667 3.312783
21 -0.186936 0.230720 -0.014756 0.297312 3.407709
22 -0.188996 0.237556 -0.009771 0.303723 3.400361
23 -0.185366 0.222386 0.011613 0.289743 3.052198
24 -0.188278 0.219175 0.010581 0.289134 3.084744
25 -0.188146 0.214805 -0.007043 0.285639 3.180551
26 -0.189777 0.221473 -0.001714 0.291666 3.165181
27 -1.244110 0.310155 -0.300999 1.317044 22.493755
28 -1.240615 0.310778 -0.302487 1.314232 22.122502
29 -1.384186 0.575929 -0.332411 1.535631 42.959099
30 -1.311813 0.609538 -0.382343 1.496188 44.833223
31 -1.026174 0.194442 -0.311170 1.089801 32.945714
32 -1.345209 0.750896 -0.380813 1.586963 49.715616
33 -1.383849 0.575809 -0.332920 1.535392 42.953504
24 -1.243315 0.314005 -0.300498 1.317091 22.230489
35 -1.347072 0.573576 -0.337142 1.502417 42.472619
193
Molecule E2( l ) V] (2) V2<2> Ex(2) Ey(2)
1 2.369584 -9.587660 -0.220042 0.622648 -0.963425
2 2.362750 -9.521712 -0.235932 0.606697 -0.959841
3 2.351715 -9.436478 -0.259109 0.592090 -0.966802
4 2.336058 -9.327501 -0.347865 0.558089 -0.989862
5 2.356380 -9.439243 -0.248376 0.592628 -0.941478
6 2.309485 -9.427708 -0.250857 0.592411 -0.941804
7 2.322850 -5.377774 -0.061644 -0.162313 -0.041717
8 2.194852 -4.828625 -0.068431 0.064005 0.068129
9 5.394737 -9.660493 -0.351771 -0.379249 -0.229623
10 5.399327 -10.166411 -0.538900 -0.203863 -0.101415
11 2.316491 -9.273539 -0.352777 0.551024 -0.973226
12 2.347816 -9.521145 -0.225025 0.616238 -0.946243
13 2.381321 -9.465003 -0.255575 0.568630 -0.950075
14 2.461087 -4.694141 -0.108831 -0.135307 -0.230333
15 5.393380 -10.001433 -0.470779 -0.545393 -0.755778
16 5.403759 -10.915822 -1.063515 3.054695 -0.133859
17 5.383413 -9.581842 -0.352853 -0.493996 -0.969275
18 5.372187 -9.313271 -0.305927 -0.284387 -0.817874
19 0.090973 -7.550172 -0.303311 1 .810539 -1.435630
20 0.090401 -7.477539 -0.287023 1.605765 -1.301610
21 0.088395 -7.443027 -0.289507 1.517199 -1.390975
22 0.092248 -7.462278 -0.298849 1.607965 -1.468546
23 0.083951 -7.207488 -0.247782 0.985613 -0.027341
24 0.083598 -7.235511 -0.251964 0.955709 -0.209268
25 0.081590 -7.238820 -0.258668 0.969264 -0.324391
26 0.085069 -7.168547 -0.249918 0.757499 -0.366657
27 1.734605 -1.899407 -0.082462 -0.040045 -0.202819
28 1.727206 1.962363 -1.485218 -13.277171 2.786142
29 2.358163 -9.650447 -0.463547 1.598389 -3.773442
30 2.238578 -9.329758 -0.305516 1.686468 -1.075600
31 1.187666 -8.477698 -1.476883 1.243133 -2.176483
32 2.518452 -8.692766 -0.370213 1.234246 -2.497877
33 2.357429 -9.649328 -0.463709 1.596933 -3.772281
34 1.734730 2.001689 -1.939424 -9.622616 2.180109
35 2.257257 -9.929956 -0.533603 -0.757118 -0.836843
194
Molecule Ez (2) E(2) V2(2) E2<2) V.,(3)
1 2.470574 2.723897 91.923217 7.419614 -8.404098
2 2.438151 2.689601 90.663006 7.233955 -8.390622
3 2.404333 2.658212 89.047118 7.066093 -8.355214
4 2.350936 2.611166 87.002272 6.818189 -8.304577
5 2.407132 2.651768 89.099315 7.031874 -8.327103
6 2.399024 2.644478 88.881679 6.993264 -8.300811
7 0.876055 0.891941 28.920454 0.795559 -9.384050
8 0.719104 0.725154 23.315617 0.525849 -7.556758
9 4.043054 4.067289 93.325127 16.542839 -7.840503
10 5.193708 5.198697 103.355919 27.026446 -7.750091
11 2.333215 2.587409 85.998517 6.694687 -8.242347
12 2.446922 2.694912 90.652200 7.262553 -8.326275
13 2.419356 2.660689 89.586289 7.079265 -8.690896
14 0.700843 0.750028 22.034961 0.562542 -8.633043
15 4.649298 4.741795 100.028662 22.484622 -7.800568
16 5.900504 6.645678 119.155180 44.165033 -7.519992
17 3.619397 3.779359 91.811693 14.283558 -7.888608
18 3.093489 3.212393 86.737020 10.319468 -7.888648
19 2.112151 3.130538 57.005104 9.800268 -5.542638
20 2.035298 2.900881 55.913586 8.415109 -5.507681
21 1.967978 2.847743 55.398648 8.109643 -5.451469
22 1.991154 2.950741 55.685598 8.706872 -5.457734
23 2.294112 2.497025 51.947882 6.235132 -5.733590
24 2.224661 2.430286 52.352618 5.906289 -5.686152
25 2.171632 2.400143 52.400512 5.760688 -5.603983
26 2.201038 2.356440 51.388066 5.552811 -5.601077
27 0.166357 0.265356 3.607748 0.070414 -5.206000
28 5.587305 14.671872 3.850867 215.263830 -5.205623
29 1.596198 4.397904 93.131122 19.341560 -8.636317
30 2.241151 3.003972 87.044377 9.023849 -7.974625
31 1.130673 2.749705 71.871359 7.560877 -5.492962
32 1.278706 3.065590 75.564187 9.397841 -5.645324
33 1.595728 4.396208 93.109538 19.326644 -8.638400
34 4.937593 11.033016 4.006757 121.727432 -5.270036
35 3.201555 3.394626 98.604024 11 .523489 -7.711607
195
Molecule V2<3) Ex(3) Ey(3> Ez<3> E(3)
1 -0.470981 3.170945 0.315401 -0.201351 3.192947
2 -0.476323 3.171901 0.312442 -0.200918 3.193579
3 -0.484198 3.165925 0.302396 -0.199290 3.186572
4 -0.488064 3.150598 0.294587 -0.196233 3.170419
5 -0.494746 3.143169 0.304488 -0.193141 3.163784
6 -0.511780 3.110524 0.296724 -0.199659 3.131017
7 -0.656229 3.295281 1.291108 0.212470 3.545558
8 -0.471734 3.087590 0.094592 0.127363 3.091663
9 -0.462234 3.017067 0.268910 -0.148252 3.032653
10 -0.466406 3.027393 0.221887 -0.132090 3.038386
11 -0.505490 3.120634 0.289503 -0.185511 3.139520
12 -0.490024 3.132284 0.309048 -0.190097 3.153229
13 -0.520112 3.289883 0.183142 -0.188228 3.300348
14 -0.500166 3.069067 0.481992 0.360893 3.127576
15 -0.473560 3.015516 0.246668 -0.162052 3.029925
16 -0.472308 3.040818 0.122153 -0.084171 3.044434
17 -0.476069 3.013387 0.287923 -0.187728 3.032927
18 -0.485600 2.996845 0.303367 -0.188501 3.018053
19 -0.491256 2.523498 0.605178 -0.325180 2.615345
20 -0.501236 2.521089 0.595774 -0.315017 2.609612
21 -0.553362 2.477137 0.612312 -0.292941 2.568453
22 -0.555952 2.477186 0.622292 -0.289540 2.570512
23 -0.561759 2.642987 0.684360 -0.535633 2.782199
24 -0.573186 2.639576 0.656777 -0.523403 2.769958
25 -0.625978 2.597134 0.656369 -0.494260 2.724008
26 -0.626992 2.613831 0.649567 -0.476817 2.735216
27 -0.503104 2.812613 -0.165583 0.075455 2.818493
28 -0.510776 2.712163 -0.101614 0.071674 2.715012
29 -0.527484 2.745825 0.726752 -0.457332 2.876956
30 -0.552463 2.902142 0.295865 -0.199793 2.924018
31 -0.307820 0.507631 0.516376 -0.227047 0.758870
32 -0.174643 0.550314 0.443554 -0.294490 0.765709
33 -0.527325 2.747142 0.727075 -0.457429 2.878310
34 -0.518456 2.730865 -0.080109 0.069680 2.732928
35 -0.484417 2.886510 0.210506 -0.174730 2.899445
196
Molecule V^(3) E2 (3) V] (4) V2<4> Ex<4>
1 70.628862 10.194910 -4.153903 -0.023600 -0.199023
2 70.402536 10.198947 -4.188911 -0.055250 -0.192660
3 69.809595 10.154243 -3.171732 -0.749327 -0.240152
4 68.965993 10.051558 -3.627801 -0.483998 0.483131
5 69.340636 10.009529 -4.189548 -0.067323 -0.183303
6 68.903460 9.803270 -4.178874 -0.067863 -0.183153
7 88.060397 12.570982 -5.093128 -0.111514 -0.563721
8 57.104584 9.558382 -6.486014 -0.089317 -1.198096
9 61.473488 9.196985 -4.201674 -0.022073 -0.149243
10 60.063914 9.231788 -4.236727 -0.047244 -0.129632
11 67.936284 9.856586 -3.627249 -0.487474 0.487230
12 69.326857 9.942851 -4.148496 -0.026482 -0.190840
13 75.531679 10.892299 -4.178424 -0.069679 -0.194023
14 74.529440 9.781730 -4.100792 -0.064471 -0.237078
15 60.848860 9.180443 -4.228338 -0.147882 -0.131106
16 56.550276 9.268580 -4.019356 -0.451005 0.666154
17 62.230133 9.198644 -4.175198 -0.183194 -0.129099
18 62.230767 9.108641 59.735590 -7.746853 225.764397
19 30.720837 6.840027 -2.524040 -0.067274 -0.191951
20 30.334550 6.810072 -2.519234 -0.068290 -0.188379
21 29.718514 6.596948 -2.495285 -0.069034 -0.185603
22 29.786864 6.607533 -2.492200 -0.069135 -0.187045
23 32.874056 7.740629 -2.879625 -0.237359 -0.143938
24 32.332328 7.672669 -2.876977 -0.242032 -0.145502
25 31.404627 7.420220 -2.862316 -0.242044 -0.143039
26 31.372063 7.481404 -2.897650 -0.228873 -0.150682
27 27.102437 7.943904 -1.492010 -0.062824 -0.015697
28 27.098512 7.371291 -1.401820 -0.078239 -0.044140
29 74.585971 8.276877 -3.930545 -0.025118 -0.175870
30 63.594650 8.549883 -4.029437 -0.072790 -0.177317
31 30.172628 0.575883 -4.527981 -0.209660 -0.068389
32 31.869684 0.586310 -4.023307 -0.071816 -0.103889
33 74.621950 8.284667 -3.930461 -0.025118 -0.175940
34 27.773275 7.468895 -1.415441 -0.088718 -0.035268
35 59.468882 8.406783 -3.738136 -0.423349 0.339939
197
Molecule Ey(4) Ez<4)
1 -0.512554 -0.193502
2 -0.535426 -0.171904
3 1.572695 -4.645601
4 0.115701 -0.218157
5 -0.540972 -0.172984
6 -0.538160 -0.173267
7 -0.913210 0.050550
8 -1.118418 0.596245
9 -0.542294 -0.244101
10 -0.556741 -0.227919
11 0.117578 -0.215223
12 -0.509113 -0.189754
13 -0.540273 -0.171991
14 -0.507873 0.143589
15 -0.498267 -0.154432
16 1.147299 -0.797945
17 -0.457223 -0.141217
18 -160.785358 158.947853
19 -0.330278 -0.171509
20 -0.329282 -0.173536
21 -0.324150 -0.169729
22 -0.323489 -0.167484
23 -0.389492 -0.276245
24 -0.391326 -0.271213
25 -0.389797 -0.268221
26 -0.409974 -0.283548
27 -0.159527 0.023795
28 -0.078938 0.038338
29 -0.475010 -0.118976
30 -0.484179 -0.174463
31 -0.656872 -0.065197
32 -0.530744 -0.124054
33 -0.474967 -0.118940
34 -0.089340 0.036373
35 0.035896 -0.118797
E( 4) V2(4) E2(4)
.582894 17.254910 0.339765
.594433 17.546973 0.353351
.910463 10.059883 24.112650
.542581 13.160940 0.294395
.596803 17.552313 0.356173
.594292 17.462987 0.353183
.074378 25.939956 1.154289
.744076 42.068383 3.041801
.613141 17.654064 0.375942
.615396 17.949857 0.378712
.545472 13.156936 0.297539
.575866 17.210021 0.331622
.599267 17.459226 0.359121
.578583 16.816493 0.334758
.537874 17.878840 0.289308
.548151 16.155220 2.396772
.495642 17.432281 0.245661
.508864 3568.3407 102085.914
.418741 6.370779 0.175344
.417166 6.346539 0.174028
.410280 6.226446 0.168330
.409490 6.211062 0.167682
.498732 8.292238 0.248734
.497859 8.276999 0.247863
.494312 8.192853 0.244345
.520753 8.396377 0.271183
.162054 2.226093 0.026261
.098231 1.965100 0.009649
.520307 15.449185 0.270720
.544342 16.236363 0.296308
.663633 20.502614 0.440409
.554861 16.186996 0.307871
.520284 15.448524 0.270695
.102706 2.003474 0.010549
.361884 13.973660 0.130960
0
0
4
0
0
0
1
1
0
0
0
0
0
0
0
1
0
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
198
Molecule nrQt AE p I5Q
1 4 0.012027 5.5528
2 5 0.004678 6.0706
3 8 0.011614 5.7959
4 6 0.000567 6.3665
5 3 0.001991 7.0000
6 4 0.005967 7.9393
7 3 0.000925 6.4881
8 5 0.006448 3.3098
9 5 0.005214 2.7011
10 6 0.005526 2.8729
11 7 0.008273 4.8096
12 5 0.004863 5.8239
13 4 2.383605 5.2596
14 3 0.004363 3.0457
15 8 0.005062 2.9586
16 9 0.008369 3.2417
17 9 0.004549 2.9830
18 7 0.004367 3.2596
19 3 0.011599 3.6478
20 4 0.011447 3.9393
21 6 0.018142 3.6778
22 7 0.021032 4.1871
23 6 0.012251 3.2007
24 7 0.011987 3.7212
25 9 0.018537 4.2757
26 10 0.021176 3.0315
27 3 0.009404 3.6198
28 6 0.000174 5.0706
29 5 0.010242 2.9586
30 4 0.009616 8.3468
31 4 0.611652 3.6198
32 4 0.322277 3.1938
33 5 0.010242 5.6198
34 8 0.000432 4.7099
35 7 0.003542 6.1549
199
Appendix D2
Detai ls are as f o r  appendix D1.
200
Molecule Q( l ) FE 1
1 -0.508718 0.010463
2 -0.508815 0.010429
3 -0.509762 0.010454
4 -0.508695 0.010372
5 -0.505680 0.010082
6 -0.506768 0.009742
7 -0.447188 0.011415
8 -0.516974 0.009372
9 -0.525914 0.051415
10 -0.528490 0.005333
11 -0.505216 0.010009
12 -0.504007 0.010013
13 -0.513613 0.008497
14 -0.494337 0.009958
15 -0.525874 0.052346
16 -0.533628 0.041136
17 -0.523135 0.050039
18 -0.522628 0.051468
19 -0.482744 0.034791
20 -0.488059 0.034281
21 -0.489105 0.034893
22 -0.489406 0.034680
23 -0.479504 0.042230
24 -0.484587 0.041707
25 -0.486383 0.042735
26 -0.487549 0.004227
27 -0.496637 0.007612
28 -0.490562 0.007638
29 -0.376083 0.012160
30 -0.472586 0.008602
31 -0.047026 0.000965
32 -0.049068 0.003403
33 -0.029817 0.004117
34 -0.490829 0.007670
35 -0.468013 0.008830
FN 1 a 1 Ebi nd1
.000321 -0.070062 -38.2526
.000432 -0.070024 -38.2763
.000432 -0.069936 -38.2849
.000411 -0.069995 -38.3252
.000713 -0.070435 -38.3118
.000331 -0.070289 -38.3028
.000627 -0.073382 -38.6766
.000269 -0.069423 -38.6350
.409311 -0.067922 -37.4641
.390277 -0.067787 -37.4927
.000917 -0.070355 -38.3658
.000783 -0.070451 -38.3269
.000737 -0.070727 -38.1668
.000565 -0.071030 -38.3712
.376949 -0.067919 -37.5148
.000783 -0.067487 -37.5563
.005010 -0.068066 -37.5165
.000104 -0.068119 -37.5170
.394997 -0.072020 -38.9851
.356663 -0.071661 -38.9517
.352780 -0.071755 -39.0209
.351664 -0.071732 -39.0200
.002919 -0.071597 -38.9554
.002726 -0.071242 -38.9332
.002592 -0.071300 -39.0069
.002629 -0.071222 -39.0164
.000281 -0.071389 -40.0877
.000583 -0.071870 -40.1535
.000628 -0.074766 -39.5986
.000173 -0.072684 -38.8683
.002049 -0.034210 -19,1205
.000018 -0.033751 -19.1728
.000063 -0.033713 -19.3286
.000608 -0.071848 -40.1313
.000394 -0.072227 -39.9761
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
201
Molecule Q 2 FE 2 fn 2 a 2 E 2 b i nd
1 0.447708 0.009062 0.000134 -0.108063 -109.211
2 0.447434 0.009072 0.000168 -0.108103 -109.144
3 0.447527 0.009092 0.000158 -0.108103 -109.131
4 0.447824 0.009078 0.000151 -0.108132 -109.090
5 0.445478 0.008993 0.000081 -0.108587 -109.045
6 0.444648 0.008701 0.000202 -0.109296 -108.819
7 0.425384 0.009104 0.007845 -0.110148 -108.220
8 0.452365 0.009027 0.000181 -0.107940 -108.803
9 0.440930 0.005999 0.938989 -0.107728 -108.964
10 0.441146 0.006280 0.907166 -0.107763 -108.909
11 0.445262 0.008975 0.000027 -0.108576 -108.994
12 0.446038 0.008955 0.000028 -0.108502 -109.094
13 0.483004 0.002575 0.001789 -0.108640 -109.817
14 0.444278 0.008811 0.005530 -0.108661 -108.988
15 0.442392 0.006040 0.873063 -0.107758 -108.920
16 0.441867 0.011012 0.006516 -0.107743 -108.855
17 0.442482 0.005642 0.014621 -0.107769 -108.932
18 0.441682 0.005423 0.001490 -0.107787 -108.902
19 0.418168 0.006206 0.728331 -0.111059 -106.828
20 0.420580 0.006445 0.663314 -0.111564 -106.769
21 0.411589 0.006390 0.681850 -0.111909 -106.560
22 0.416028 0.006335 0.681440 -0.111906 -106.558
23 0.422651 0.005266 0.006209 -0.110301 -106.967
24 0.425806 0.005551 0.006095 -0.110799 -106.922
25 0.421514 0.005693 0.006019 -0.111141 -106.717
26 0.421791 0.005769 0.006022 -0.111132 -106.713
27 0.447467 0.008569 0.000172 -0.110862 -106.680
28 0.444836 0.008903 0.000068 -0.110318 -106.713
29 0.339796 0.009693 0.000159 -0.115163 -105.309
30 0.448973 0.008691 0.000267 -0.110211 -108.126
31 0.202011 0.007172 0.015724 -0.117136 -98.986
32 0.219009 0.008437 0.000146 -0.116157 -99.653
33 0.078672 0.008769 0.000149 -0.117105 -98.811
34 0.444505 0.008890 0.000066 -0.110309 -106.735
35 0.530559 0.008690 0.000139 -0.109336 -108.886
202
Molecule Q 3
f e 3 FN 3 a 3 Ebi nd3
1 -0.168753 0.002372 0.001813 -0.100785 -80.6177
2 -0.176059 0.002338 0.001075 -0.101396 -80.0272
3 -0.179772 0.002300 0.000931 -0.101494 -79.9003
4 -0.180524 0.002232 0.001000 -0.101455 -79.8957
5 -0.168363 0.002675 0.000251 -0.103349 -85.9098
6 -0.168228 0.002708 0.000475 -0.103643 -85.9094
7 -0.136209 0.002080 0.000208 -0.103374 -87.6506
8 -0.205471 0.002059 0.001382 -0.100765 -80.4307
9 -0.173087 0.121066 0.216699 -0.101185 -80.5793
10 -0.179782 0.123279 0.237964 -0.101886 -79.9884
11 -0.155170 0.002363 0.000363 -0.102871 -86.6261
12 -0.144491 0.002441 0.000356 -0.101726 . -87.6887
13 -0.190244 0.003823 0.000284 -0.102439 -85.2145
14 -0.169313 0.002227 0.000249 -0.102847 -85.9960
15 -0.184613 0.124351 0.241081 -0.101852 -79.8289
16 -0.181924 0.034271 0.026850 -0.102221 -79.9780
17 -0.184514 0.122420 0.030061 -0.101785 -79.7921
18 -0.183531 0.124984 0.005925 -0.101747 -79.8094
19 -0.164239 0.089869 0.146116 -0.106333 ' -86.5476
20 -0.165482 0.090648 0.134165 -0.106270 -86.5266
21 -0.163899 0.090907 0.138227 -0.106427 -86.5569
22 -0.164145 0.090754 0.137616 -0.106399 -86.5504
23 -0.179854 0.088055 0.020495 -0.104338 -80.3766
24 -0.181386 0.088688 0.021098 -0.104226 -80.3605
25 -0.179875 0.089937 0.021150 -0.104420 -80.3967
26 -0.180036 0.090075 0.020890 -0.104416 -80.3942
27 -0.196019 0.001656 0.000525 -0.102838 -86.5375
28 -0.186428 0.001615 0.000219 -0.102787 -86.1225
29 -0.036315 0.000502 0.000267 -0.117501 -95.5727
30 -0.152243 0.001400 0.000416 -0.105906 -88.2824
31 0.034794 0.005543 0.075796 -0.131125 -87.1069
32 -0.141970 0.000108 0.000147 -0.104346 -87.3875
33 0.118513 0.000147 0.001230 -0.116584 -99.2157
34 -0.185695 0.001622 0.000235 -0.102841 -86.1268
35 -0.319258 0.001531 0.000249 -0.696151 -53.4872
203
Molecule 2 
1 -40.993642
F
^2-3
-34.675681
ehomo
5.144492
el umo 
13.783630
A
8.639138
2 -41.008876 -34.661012 5.132703 13.416041 8.283338
3 -41.011222 -34.651184 5.098940 12.293236 7.194296
4 -41.028531 -34.604959 5.050278 9.823537 4.773259
5 -41.090373 -34.296550 5.134532 12.945944 7.811411
6 -41.155559 -34.347409 5.022431 12.864264 7.841833
7 -41.277969 -33.043317 5.053457 11.855791 6.802334
8 -40.975108 -34.622273 4.818649 12.934349 8.115700
9 -41.213987 -34.979417 -0.537655 12.833117 13.370773
10 -41.205698 -35.005818 -0.635466 12.727142 13.362608
11 -41.089151 -34.199361 5.023408 9.830671 4.807263
12 -41.086716 -34.216276 5.120050 13.344400 8.224350
13 -41.282177 -33.880722 5.047347 12.714968 7.667622
14 -41.143004 -34.163796 5.286875 12.702258 7.415383
15 -41.248346 -34.958758 -0.685126 12.568818 13.253944
16 -41.164713 -35.017256 -0.762073 11.927597 12.689670
17 -41.271371 -34.939563 -0.683966 12.043256 12.727222
18 -41.283381 -34.931047 -0.792814 9.388805 10.181619
19 -41.138377 -34.994711 -3.111164 8.753374 11.864538
20 -41.168089 -35.043491 -3.136913 8.710317 11.847229
21 -41.013681 -35.045086 -3.170583 8.653972 11.824555
22 -41.013146 -35.037747 -3.169518 8.657583 11.827101
23 -41.209541 -34.797277 -3.103521 7.738558 10.842080
24 -41.239941 -34.851847 -3.115916 7.742268 10.858184
25 -41.083267 -34.856633 -3.147837 7.721225 10.869062
26 -40.970834 -35.087491 -3.162350 7.720321 10.882671
27 -41.383887 -33.377163 2.635263 8.968390 6.333127
28 -41.338159 -33.234565 2.600116 6.969715 4.369599
29 -41.719169 -29.495160 5.097882 12.439276 7.341395
30 -41.554165 -32.483040 5.082823 11.191833 6.109011
31 -19.808126 -27.173941 4.424929 7.301818 2.876890
32 -19.921091 -27.854121 5.591712 9.991903 4.400191
33 -41.718812 -29.495051 5.098511 12.439421 7.340910
34 -41.227205 -33.413887 2.619539 7.071260 4.451721
35 -42.761857 -31.174907 4.938471 9.901772 4.963301
204
Molecule 1/A ^stat B.E.
1 0.115752 -47630.9952 -11.205864 -18.888180 2.04678
2 0.120724 -49804.7514 -12.835962 -19.103700 2.38945
3 0.138999 -56324.8345 -17.538043 -19.367470 2.29648
4 0.209500 -62553.9494 -20.314253 -18.785080 1.31584
5 0.128018 -54089.5443 -15.895220 -19.202690 3.18013
6 0.127521 -56263.0798 -17.599651 -19.550940 3.26063
7 0.147008 -54006.1409 -15.269116 -16.465420 0.42753
8 0.123218 -49806.2398 -12.681218 -21.023810 -8.14703
9 0.074790 -36270.9298 -13.473284 -18.134000 -0.49980
10 0.074836 -38444.7105 -15.102387 -19.101490 -0.63264
11 0.208019 -64727.3628 -22.022684 -18.851480 1.63403
12 0.121590 -49805.0390 -12.925242 -19.069540 2.61277
13 0.130419 -56132.2840 -15.104772 -17.824880 3.14115
14 0.134855 -54088.7105 -15.892345 -16.557680 3.56083
15 0.075449 -42791.6570 -18.308245 -18.646480 -0.39918
16 0.078804 -44965.5306 -19.833302 -21.606520 -1.47425
17 0.078572 -44964.9958 -19.867041 -18.141220 -2.17781
18 0.098216 -51193.3325 -22.615991 -17.228630 -1.27580
19 0.084285 -33346.2351 -13.084529 -0.695290 -1 1 .87318
20 0.084408 -35519.6686 -14.521052 -0.891570 -11 .76177
21 0.084570 -39866.2879 -17.361445 -1.030870 -11.29075
22 0.084552 -42039.5451 -18.754256 -0.984620 -11.20800
23 0.092233 -41810.9200 -17.366122 -1.182010 -13.67087
24 0.092096 -43984.2992 -18.801157 -1.380780 -13.48153
25 0.092004 -48330.9315 -21.629805 -1.644100 -13.02399
26 0.091889 -50504.3999 -23.014277 -1.710820 -13.12024
27 0.157900 -46028.9957 -12.994499 -14.554380 15.24840
28 0.228854 -58479.3502 -16.092995 -12.578510 14.72321
29 0.136214 -46776.4825 -11.792791 -16.840760 3.78164
30 0.163693 -60277.2837 -17.636994 -21.288270 3.84974
31 0.347598 -50041.1747 -14.983935 -27.734630 5.43414
32 0.227263 -54071.6110 -15.518173 -24.147670 5.68238
33 0.136223 -46776.4821 -11.696355 -19.209110 4.00221
34 0.224632 -62825.7911 -18.828264 -12.926190 16.04732
35 0.201479 -63616.1614 -19.949606 -20.321760 0.69358
205
Molecule l-1 V amol a* IP
1 0.67404 19.01070 361.4067 15.300 -78.710728
2 0.38239 19.25635 370.8070 17.196 -88.261955
3 0.05021 19.50321 380.3750 22.884 -116.684151
4 -0.49943 18.83773 354.8597 26.892 -135.812074
5 -0.02352 19.46425 378.8570 20.568 -105.607061
6 -0.26824 19.82279 392.9430 22.464 -112.823892
7 -9.00076 18.76983 352.3070 20.148 -101.817051
8 -14.32955 26.71536 713.7100 17.196 -82.861496
9 -1.12935 18.17600 330.3670 14.791 7.952462
10 -1.31426 19.15709 366.9940 16.687 10.604028
11 -0.78266 18.93835 358.6610 28.788 -144.613876
12 0.30620 19.25013 370.5680 17.196 -88.044383
13 -1.71957 18.18104 330.5500 22.464 -113.383598
14 -15.12435 22.70643 515.5820 20.568 -108.740445
15 -1.49958 18.71095 350.1000 20.479 14.030696
16 -2.11580 21.75987 473.4920 22.375 17.051379
17 -1.61911 18.21420 331.7570 22.375 15.303745
18 -1.09441 17.31044 299.6510 26.383 20.916817
19 7.63970 14.13580 199.8210 16.700 51.956435
20 7.68839 14.07996 198.2450 18.596 58.334025
21 7.80974 13.76720 189.5360 22.388 70.983005
22 7.77209 13.67458 186.9940 24.284 76.968572
23 7.48556 15.63085 244.3230 23.024 71.455472
24 7.64538 15.55989 242.1100 24.920 77.648623
25 7.82790 15.28409 233.6030 28.712 90.380699
26 7.72967 15.32369 234.8150 30.608 96.793210
27 -8.10090 22.58248 509.9680 19.806 -52.194019
28 -8.25403 21.05043 443.1210 24.570 -63.884847
29 0.42293 17.26530 298.0910 16.001 -81.571203
30 -0.45683 21.63838 468.2190 22.740 -115.583392
31 -4.54130 28.62452 819.3630 20.292 -89.790653
32 -0.34217 24.80961 615.5170 20.568 -115.010331
33 0.16996 19.62235 385.0370 16.001 -81.581274
34 -8.78695 21.69606 470.7190 28.362 -74.295378
35 0.42993 20.33813 413.6400 26.393 -130.341056
206
Molecule R SA Vol V ^ l )
-8.558
v 2 ( i )
1 3.441473 181.271704 133.829 -0.4780
2 3.544744 202.286700 150.518 -8.575 -0.4789
3 3.979348 260.406977 199.479 -8 .584 -0.4801
4 4.261525 276.223016 220.612 -8.561 -0.4819
5 3.593188 222.297115 173.264 -8.610 -0.4823
6 3.685424 241.431553 189.613 -8.568 -0.4856
7 3.614951 205.686073 164.959 -8.535 -0.4854
8 3.666725 202.526115 150.547 -8.345 -0.4763
9 3.579244 190.816712 142.360 -7.274 -0.1506
10 3.668721 211.835243 159.160 -7.284 -0.1515
11 4.262573 288.856114 236.379 -8.576 -0.4844
12 3.469676 199.183136 150.580 -8.584 -0.4805
13 3.634027 227.534224 184.161 -8.394 -0.5095
14 3.577313 222.710920 173.662 -8.696 -0.4843
15 3.847410 252.607339 192.460 -7.284 -0.1530
16 4.094119 272.320736 209.035 -7.296 -0.1527
17 3.960433 272.150680 209.153 -7.280 -0.1535
18 4.357694 293.371836 231.231 -7.257 -0.1542
19 3.413402 198.264771 152.645 -1.794 -0.0272
20 3.520113 218.515361 169.160 -1.801 -0.0355
21 3.773296 249.271508 200.287 -1.826 -0.0568
22 3.936387 267.070493 216.463 -1 .824 -0.0649
23 3.947200 256.500062 201.500 -1 .740 -0.0268
24 4.098422 276.109879 217.885 -1.749 -0.0351
25 4.370522 306.753801 248.912 -1 .775 -0.0564
26 4.549715 325.072020 265.049 -1.771 -0.0645
27 3.527548 211.558750 164.625 -6.793 -0.4945
28 3.952886 272.582269 211.154 -6.797 -0.4912
29 3.432801 184.235104 138.690 -8 .575 -0.4822
30 3.714185 243.380368 191.774 -8 .760 -0.4996
31 3.566060 222.004715 174.918 -8 .914 -0.5154
32 3.622878 224.463332 176.063 -9 .093 -0 .5034
33 3.432801 184.235104 138.690 -8.798 -0 .4790
34 4.115283 309.836819 244.235 -6.817 -0.4918
35 4.286354 271.924049 218.062 -8 .583 -0.4832
207
Molecule E ( l )X V 1} Ez<l> E d ) v i'
l -1.6550 2.459 0.376500 2.987 73.240
2 -1.6550 2.457 0.377400 2.986 73.530
3 -1.6540 2.456 0.377700 2.985 73.690
4 -1.6530 2.451 0.378800 2.981 73.290
5 -1.6550 2.457 0.377700 2.986 74.140
6 -1.6270 2.433 0.388800 2.952 73.420
7 -1.6630 2.447 0.420500 2.989 72.840
8 -1.6280 2.420 0.430900 2.948 69.630
9 -0.5108 2.229 0.527100 2.347 52.900
10 -0.5076 2.232 0.526600 2.349 53.060
11 -1.6520 2.448 0.380900 2.977 73.550
12 -1.6530 2.453 0.378000 2.982 73.690
13 -1.6860 2.345 0.519300 2.932 70.460
14 -1.6770 2.483 0.451200 3.030 75.630
15 -0.5097 2.231 0.526100 2.348 53.050
16 -0.4976 2.237 0.527100 2.351 53.240
17 -0.5123 2.229 0.525900 2.347 53.000
18 -0.5125 2.226 0.526400 2.344 52.660
19 -0.1825 0.234 0.003704 0.297 3.219
20 -0.1848 0.231 0.003744 0.296 3.243
21 -0.1847 0.227 -0.012880 0.293 3.332
22 -0.1869 0.234 -0.008180 0.299 3.328
23 -0.1868 0.219 0.011590 0.288 3.027
24 -0.1894 0.216 0.010850 0.288 3.059
25 -0.1890 0.212 -0.006245 0.284 3.151
26 -0.1903 0.219 -0.001069 0.290 3.136
27 -1.5270 2.191 0.417300 2.703 46.150
28 -1.5510 2.196 0.404200 2.718 46.200
29 -1.6500 2.454 0.372600 2.981 73.530
30 -1.5700 2.498 0.340800 2.970 76.740
31 -1.5980 2.500 0.416000 2.996 79.460
32 -1.6080 2.617 0.309700 3.087 82.690
33 -1.6740 2.543 0.380600 3.068 77.410
34 -1.5520 2.199 0.406100 2.722 46.470
35 -1.6210 2.462 0.364300 2.970 73.670
208
Molecule E2( l ) V1 (2)
/->VCXICNJ
>
Ex<2) Ey <2)
1 8.924 -9.177 -0.2586 0.5802 -0.8902
2 8.917 -9.112 -0.2682 0.5645 -0.8945
3 8.909 -9.039 -0.2882 0.5522 -0.9075
4 8.885 -8.946 -0.3730 0.5225 -0.9314
5 8.916 -9.017 -0.2744 0.5461 -0.8797
6 8.716 -8.998 -0.2750 0.5460 -0.8741
7 8.931 -4.986 -0.0588 -0.2142 -0.0064
8 8.691 -4.458 -0.0708 0.0300 0.1188
9 5.509 -9.715 -0.3295 -0.4254 -0.2206
10 5.517 -10.250 -0.5048 -0.2607 -0.0881
11 8.865 -8.882 -0.3733 0.5117 -0.9165
12 8.893 -9.091 -0.2597 0.5664 -0.8745
13 8.598 -8.983 -0.2806 0.5129 -0.8782
14 9.180 -4.249 -0.1122 -0.1850 -0.1787
15 5.512 -10.080 -0.4401 -0.6035 -0.7574
16 5.528 -11.080 -0.9870 3.1240 -0.1161
17 5.506 -9 .649 -0.3297 -0.5361 -0.9746
18 5.496 -9.379 -0.2857 -0.3152 -0.8202
19 0.088 -7.636 -0.2860 1.8420 -1.4580
20 0.087 -7 .564 -0.2705 1.6310 -1.3210
21 0.085 -7 .530 -0.2731 1.5380 -1.4120
22 0.089 -7 .550 -0.2820 1.6320 -1.4910
23 0.083 -7.273 -0.2336 0.9894 -0.0206
24 0.082 -7.301 -0.2378 0.9580 -0.2059
25 0.081 -7.306 -0.2443 0.9692 -0.3249
26 0.084 -7.239 -0.2356 0.7571 -0.3679
27 7.304 -1.517 -0.0818 -0.0757 -0.1506
28 7.390 2.463 -1.4790 -13.3900 2.8500
29 8.886 -9.235 -0.4949 1.5930 -3.7100
30 8.822 -8.901 -0.3217 1.6665 -1.0100
31 8.978 -7.236 -1.0520 1.0830 -1.9150
32 9.530 -8 .294 -0.3838 1.2120 -2.4550
33 9.411 -9.182 -0.4952 1.6540 -3.6840
34 7.410 2.479 -1.9250 -9.6940 2.2400
35 8.824 -9.527 -5.6220 -0.8083 -0.7550
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Molecule E (2) E (2) V2(2) E2(2) V j G )
-7 .8091 2.321 2.5520 84.21 6.514
2 2.288 2.5190 83.39 6.346 -7 .839
3 2.264 2.5010 81.69 6.256 -7.783
4 2.221 2.4650 80.04 6.074 -7 .743
5 2.262 2.4880 81.31 6.191 -7.757
6 2.260 2.4840 80.96 6.170 -7 .696
7 0.783 0.8120 24.86 0.659 -8 .870
8 0.617 0.6300 19.88 0.396 -6 .994
9 4.076 4.1040 94.38 16.850 -7 .934
10 5.217 5.2790 105.00 27.860 -7 .846
11 2.204 2.4410 78.90 5.960 -7 .700
12 2.296 2.5210 82.64 6.357 -7 .750
13 2.267 2.4840 80.70 6.172 -8.091
14 0.582 0.6364 18.05 0.404 -8 .048
15 4.709 4.8080 101.60 23.120 -7 .904
16 6.117 6.8690 122.70 47.190 -7 .615
17 3.649 3.8150 93.11 14.550 -7.991
18 3.114 3.2350 87.97 10.470 -7 .994
19 2.122 3.1650 58.31 10.020 -5 .635
20 2.045 2.9310 57.22 8.589 -5 .604
21 1 .977 2.8750 56.70 8.268 -5 .553
22 2.000 2.9810 57.01 8.887 -5 .560
23 2.304 2.5080 52.89 6.289 -5 .892
24 2.233 2.4390 53.31 5.948 -5 .943
25 2.180 2.4070 53.37 5.795 -5 .764
26 2.212 2.3660 52.40 5.600 -5 .736
27 0.072 0.1836 2.30 0.033 -4 .643
28 5.557 14.7700 6.06 218.300 -4.697
29 1.448 4.2890 85.29 18.400 -7 .989
30 2.099 2.8640 79.24 8.200 -7.331
31 0.708 2.3110 52.36 5.341 -4 .563
32 1 .155 2.9720 68.78 8.831 -5 .022
33 1 .427 4.2830 84.30 18.340 -5 .774
34 4.883 11.0800 6.14 122.800 -4 .742
35 3.063 3.2570 90.76 10.610 -7 .117
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Molecule V2<3) Ex(3) Ey <3) Ez (3) E (3)
1 -0.4991 2.952 0.3228 -0.2321 ’ 2.979
2 -0.5030 2.956 0.3174 -0.2321 2.982
3 -0.5092 2.957 0.3062 -0.2310 2.981
4 -0.5121 2.945 0.3003 -0.2278 2.969
5 -0.5142 2.935 0.3035 -0.2226 2.959
6 -0.5272 2.911 0.3236 -0.2168 2.937
7 -0.6684 3.093 1.3180 0.1880 3.367
8 -0.4885 2.886 0.0984 0.0947 2.889
9 -0.4347 3.119 0.2675 -0.1561 3.135
10 -0.4384 3.131 2.2000 -0.1396 3.142
11 -0.5201 2.926 0.2900 -0.2157 2.948
12 -0.5077 2.926 0.3088 -0.2196 2.951
13 -0.5474 3.053 0.1724 -0.2147 3.066
14 -0.5203 2.858 0.4753 0.3331 2.916
15 -0.4453 3.122 0.2458 -0.1704 3.136
16 -0.4434 3.145 0.1188 -0.0906 3.148
17 -0.4483 3.117 0.2880 -0.1966 3.137
18 -0.4579 3.102 0.3042 -0.1973 3.123
19 -0.4721 2.600 0.6112 -0.3330 2.692
20 -0.4819 2.601 0.6024 -0.3227 2.689
21 -0.5323 2.561 0.6188 -0.3013 2.651
22 -0.5348 2.561 0.6287 -0.2981 2.654
23 -0.5375 2.766 0.6860 -0.5494 2.902
24 -0.5490 2.763 0.6577 -0.5373 2.890
25 -0.6001 2.723 0.6507 -0.5091 2.847
26 -0.6021 2.719 0.6527 -0.4912 2.839
27 -0.5043 2.622 -0.1383 0.0607 2.627
28 -0.5089 2.528 -0.1002 0.0496 2.530
29 -0.5353 2.490 0.7358 -0.4860 2.641
30 -0.5570 2.678 0.3215 -0.2179 2.706
31 -0.2262 0.164 0.3547 -0.1809 0.430
32 -0.1810 0.299 0.4528 -0.3178 0.629
33 -0.1582 0.387 0.7388 -0.4821 0.963
34 -0.5174 2.535 -0.0781 0.0496 2.536
35 -0.4980 2.660 0.2122 -0.2039 2.676
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Mol ecu!e
1 60.98
2 60.89
3 60.58
4 59.96
5 60.17
6 59.23
7 78.67
8 48.92
9 62.95
10 61.55
11 59.29
12 60.07
13 65.46
14 64.77
15 62.48
16 57.98
17 63.86
18 63.91
19 31.75
20 31.40
21 30.83
22 30.91
23 34.71
24 34.14
25 33.23
26 32.90
27 21.56
28 22.06
29 63.83
30 53.75
31 20.82
32 25.22
33 33.33
34 22.49
35 50.65
8.874 
8.892 
8.889 
8.813 
2.959 
8.627 
11.340 
8.349 
9.827 
9.870 
8.690 
8.707 
9.398 
8.505 
9.387 
9.911 
9.838 
9.752 
7.246 
7.231 
7.030 
7.042 
8.424 
8.353 
8.105 
8.063 
6.900 
6.402 
6.977 
7.322 
0.185 
0.395 
0.928 
6.432 
7.160
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